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ABSTRACT 
Serotonin (5HT) is an indoleamine with potent j vitro and in vivo 
effects on aldosterone biosynthesis in the adrenal zona glomerulosa 
of several species including Man and the rat. Its physiological role 
in the control of aldosterone secretion however, is not well 
understood. The purpose of these studies was to clarify its 
possible role in aldosterone biosynthesis using the rat as an 
experimental model. 
Attempts to localise 5HT within the adrenal gland using a specific 
monoclonal antibody to 5HT with the avidin-biotin detection 
technique, suggested, that serotonergic nerves are not present in the 
adrenal cortex although appreciable levels of 5HT were measured by 
HPLC in adrenal tissue ( 1.7 # 0.2 µg/ g wet weight). The storage 
and metabolism of 5HT in isolated zona glomerulosa cells and inner 
cortical and, medullary cells was investigated using [3 H]-5HT as a 
marker. Zona glomerulosa cells rapidly metabolised 5HT, whereas the 
inner zones were able to store or retain 5HT to a greater extent. 
Stimulation of steroidogenesis by 5HT however, was confined to the 
zona glomerulosa cells of the adrenal cortex. 
The interaction of 5HT with specific 5HT receptors was investigated 
by studying the effects of the 5HT antagonists, methysergide and 
ketanserin on the steroidogenic response to 5HT in isolated zona 
glomerulosa cell suspensions. Methysergide (10-6M) inhibited the 
corticosterone and aldosterone responses to 5HT (10-9M - 10-6)and 
angiotensin II (10-9M, 10-8M). In addition, it significantly 
V 
inhibited the corticosterone response to ACTH. Ketanserin (10-6M) 
also inhibited the corticosterone and aldosterone responses to 5HT 
(10-9M, 10-8M) and All (10-9M, 10-8M) but did not affect ACTH- 
stimulated steroidogenesis. Neither antagonist affected the 
steroidogenic responses to potassium. 
A change in dietary salt intake of rats did not lead to any 
significant change in either the blood levels or adrenal contents of 
5HT. The in vitro- responsiveness of adrenal cells to 5HT however, 
was altered by changing the sodium status. 
An overall view of changing endogenous levels of 5HT in vivo in the 
rat was explored using the 5HT-depleting agent, PCPA and the 
immediate 5HT-precursor, 5-hydroxytryptophan (5HTP). Treatment with 
PCPA led to a decrease in blood 5HT levels and a loss of in vitro 
responsiveness to 5HT and All in subsequent preparations of zona 
glomerulosa cells. Treatment with 5HTP produced higher blood levels 
of 5HT and an enhanced responsiveness of subsequent preparations of 
zona glomerulosa cells. 
These studies suggest that 5HT from central and/or peripheral sources 
such as platelets or mast cells, could exert a tonic effect on 
aldosterone secretion from the rat adrenal zona glomerulosa, which is 
mediated by the activation of specific receptors for 5HT. 
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Chapter 1 
PROPERTIES OF SEROTONIN 
1.1 INTRODUCTION 
Serotonin or 5-hydroxytryptamine (5HT) has been the subject of many 
investigators since it is a ubiquitous compound. One of the major 
discoverers of 5HT, Irvine Page commented "Serotonin in walnuts and 
bananas and in jelly-fish and in carcinoids and in brain leaves me 
with a sense of bewilderment and fear that someone will ask me what 
serotonin does". Rapport et al., (1948) were the first to identify 
the potent vasoconstricting substance originally called vasotonin or 
vasoconstrictin in plasma. as 5HT. Earlier studies by Erspammer and 
t. = 1952) had also unwittingly coworkers in 1933 
(see Erspammer et Al 
revealed the substance in isolated gastric mucosa. 
1.2 ORIGIN OF SEROTONIN 
Serotonin is widespread throughout the plant and animal kingdom. It 
is found in high concentrations in bananas, pineapples, tomatoes, 
strawberries and in some poisonous plant species including the 
stinging fluid of the common nettle. In the lower animal kingdom it 
is found in very high concentrations in the molluscs and annelida, 
particularly in ganglionic structures; in the octopus and the 
blowfly, 5HT exists in the salivary glands (Berridge 1979), and in 
both cases it may serve to augment salivary secretions. It is also 
found in the venom of scorpions, and in the skin of some amphibia 
e. g. bufo mar inns. In mammals, 5HT is localised predominantly in the 
-central nervous system (CNS) and the gastro-intestinal tract (GI). 
It is also present in the blood and to a lesser extent, 5HT has been 
localised in endocrine organs such as the pituitary gland in the rat 
1 
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(Saavedra et al., 1976), the parafollicular cells of the thyroid 
gland, and the pancreas (Koevary et a1., 1983) of the rat and golden 
hamster (Lundvist et al., 1978). The pineal gland which is involved 
in the control of melatonin secretion, the end product of 5HT 
methylation, also contains very high concentrations of 5HT, both in 
the pinealocytes cytoplasm, and in the pineal sympathetic nerve 
endings. However, of major interest in this work, and to be 
discussed later, are the studies by Verhofstadt et al., 1983 and 
Holzwarth et al., 1983 showing localisation of 5HT stores in the 
chromaffin granules of the rat adrenal medulla. 
1.3 BIOCHEMICAL PROPERTIES OF SEROTONIN 
The systematic chemical name for serotonin is 5-hydroxy-3-(2- 
aminoethyl) indole and its chemical structure consists of a diffuse 
10 T! ' electron cloud above and below the heteroaromatic plane which 
is pulled towards the aminoethyl group at position 3 making this the 
most basic region of the molecule . At pH 7.5 the molecule 
is 
completely protonated (cationic form) whilst at pH 10.5 approximately 
30% each of the neutral form and the zwitterionic form exists (see 
Fig. 1.1). At alkaline pH, 5HT in solution is rapidly destroyed 
when heated and because of its instability as a base it is 
commercially sold as the creatinine sulphate salt. However at low pH 
e. g. pH 5.6,5HT has good stability even at elevated temperatures. 
Serotonin exists as three other stable salts the picrate, 
hydrochloride and salicyclate. The creatinine sulphate salt which 
3 
has a molecular weight of 405.4 (C14 H23 N5 07), has a very high 
solubility in water which increases with temperature. In contrast 
it is only sparingly soluble in lipids. Three different 
dissociation constants have been determined related to the creatinine 
moiety (pKal = 4.9), the terminal amino group (pKa2 = 10), and the 
hydroxy group within the benzyl ring (pKa3 = 11.1). 
1.4 BIOSYNTHESIS OF SEROTONIN 
Approximately, 2% of tryptophan is utilised in most animals by the 
gut, in the synthesis of serotonin. The gut is equipped with a 
transport carrier system in the enterchromaffin cells which actively 
transports the amino acid into the cytoplasm of, the cell. 
Hydroxylation of both the D- and L-tryptophan (the naturally occuring 
amino acid), requires the enzyme tryptophan hydroxylase. This 
enzyme has been isolated in e. g. the venom producing glands of the 
toad (Udenfriend et al., 1953) but has been found in variable amounts 
in all tissues that contain 5HT except platelets, which store but do 
not synthesise serotonin. 
The reaction catalysed by tryptophan hydroxylase (Fig. 1.2) is: 
L-Tryptophan + tetrahydrobiopterin + 02 
5-hydroxytryptophan + H2 0+ quinoid dihyrobiopterin 
The Michaelis constant (Km) of the enzyme is fairly high (3x10-5M) 
and under normal circumstances the concentration of tryptophan would 
be far-below the Km value so that in vivo the enzyme would be sub- 
saturated. However, at concentrations of 2x10-4M tryptophan the 
enzyme is inhibited. Tryptophan hydroxylase requires Fe2+ as a 
cofactor and is easily inactivated by molecular 02 so that sulphydryl 
compounds such as dithioreitol which are potent reducing agents, are 
added to enzyme assays containing tryptophan hydroxylase. 
Other important inhibitors of this enzyme include the amino acid 
2-chlorophenylalanine which is a competitive inhibitor of the enzyme 
in vitro, and in vivo is a potent long lasting inhibitor of 5HT 
synthesis. It has been extensively studied and used in depleting 
animals of central and peripheral stores of 5HT e. g Koe and Weissman 
1966. Because the rate limiting step in 5HT biosynthesis is the 
hydroxylation of tryptophan, a diet poor in tryptophan will be 
reflected in lower stores of 5HT; the converse is true for high 
tryptophan consumption. 
The next important step in 5HT biosynthesis (see Fig. 1.2) requires 
the enzyme L-aromatic amino acid decarboxylase. This enzyme is 
capable of decarboxylating several amino acids including, 
phenylalanine, dihydroxyphenylalanine, tryptophan, tyrosine and 
specifically L-5-hydroxytryptophan. The enzyme is present in 
several animal tissues including the mammalian kidney and liver. 
The kinetics of the enzyme have however been determined from crude 
cat liver, kidney and adrenal extracts. The Km for 
L-5-hydroxytryptophan decarboxylase is approximately 8x10-6M but the 
enzyme has a lower activity in the brain compared to the liver and 
the adrenals. It requires pyridoxal phosphate as coenzyme, which 
also inhibits the enzyme when present in excess. The 
decarboxylation of 5-hydroxytryptophan is not rate limiting and 
5 
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administration of 5-hydroxytryptophan to humans and rats for example, 
increases 5HT levels in several tissues including the gut and brain. 
1.5 METABOLISM OF SEROTONIN 
Serotonin is most commonly oxidised to 5-hydroxyindole-acetic acid 
(5HIAA). This requires oxidative-deamination and the reaction is 
attributed to the enzyme monoamine oxidase (Fig. 1.3). This enzyme 
is ubiquitous and is'found tightly bound to the outer surface of the 
mitochondrial membrane (Tipton et al 1976). It exists in two forms, 
monoamine oxidase A and B, each identifiable by the compounds that 
differentially affect their activity. Monoamine oxidase A is found 
both intra- and extra-neurally, whereas type B is solely extra- 
neural. Type A is specifically responsible for the oxidative 
deamination of 5HT and norepinephrine and type B deaminates a series 
of other amines including dopamine, and phenyl ethyl amine. 
In the first step 5HT is deaminated to the intermediate 5- 
hydroxyindole-3-acetaldehyde by the enzyme monoamine oxidase 
(Fig. 1.3), found in many tissues including the brain (Erwin et al., 
1978). Like many other oxidizing enzymes which are involved in 
degradation processes it requires the cofactor NAD+. At this point 
in the pathway the aldehyde product can be shunted into what is a 
minor route of metabolism in mammals, to form 5-hydroxytryptophol. 
The compound is found in several peripheral tissues and is increased 
by the consumption of large amounts of alcohol due to a shunting from 
the oxidative pathway to the reducing pathway. More commonly 
however, 5-hydroxyindole -3-acetaldehyde is oxidised to 5HIAA by 
7 
aldehyde dehydrogenase. In the presence of the cofactor NAD+, 
5HIAA is the major excretory product in mammals and is used as a 
marker in several clinical conditions briefly reviewed below. 
The liver contains an important detoxificating enzyme, 
glucuronyltransferase, which is capable of conjugating glucuronic 
acid to 5HT as well as several other compounds including amino sugars 
and lipids. Serotonin-O-glucuronide is a major metabolite in the 
isolated rat liver perfusate and if monoamine oxidase is inhibited 
5HT is readily converted to this product. 
Serotonin can also be conjugated to a sulphate moiety and the enzyme 
responsible, serotonin-sulfotransferase, has been localised in 
liver, lung, kidney and brain tissue. When 5HT is sulphonated it 
loses biological activity but this may be only temporary since an 
enzyme capable of dissociating the sulphate moiety exists called 
arylsulphatase. However serotonin-0-sulphate accounts for only a 
small proportion of the total 5HT metabolites and although some has 
been detected in rat spinal cord and in the urine of normal 
individuals, its concentration does not increase markedly even when 
monoamine oxidase is blocked. 
Serotonin in the pineal gland serves a special function of being the 
precursor to an important hormone called melatonin or 5-methoxy-N- 
acetylserotonin, which is responsible for blanching the skin of 
amphibians and suppressing gonadal activity in mammals. In this 
pathway '5HT 
is converted first to N-acetylserotonin by the enzyme N- 
acetyltransferase also present in other regions of the brain. The 
enzyme requires acetyl coA to transfer a methyl group to 5HT. The 
8 
activity of this enzyme is under diurnal influence and is 15 times 
more active during the dark phase in parallel with an increase in 
melatonin synthesis and depletion of 5HT precursors. 
The other major enzyme under diurnal influence and present in the 
pineal gland is hydroxy indole-0-methyl transferase. This enzyme 
requires S-adenosylmethionine for the transfer of a methyl group to 
position 5 on the 5HT molecule. Normally it uses N-acetylserotonin 
as substrate to form the end product, melatonin; however the enzyme 
can act on 5HT to form 5-methoxyserotonin and this reaction has been 
detected in the hypothalamus of the rat (Green et al 1973). N- 
methylation of 5HT can also occur, the enzyme requiring the same 
methyl donor as above. The enzyme exists in the rabbit brain and 
lung and the N-methylated 5HT products are psychotoxic e. g. the 
hallucinogen bufotenin (N, N-dimethylserotonin) can be formed in vitro 
by the action of brain N- methyltransferase enzyme in the presence of 
5HT and S-adenosylmethionine, and may be of relevance in some mental 
diseases in which 5HT may play a major role e. g. schizophrenia. 
1.6 MAIN STORAGE SITES FOR 5HT 
1.6.1 Serotonin in the CNS 
In mammals, 511T is localised within nerve terminals of discrete brain 
regions, including the raphe nuclei of the brain stem(Osborne et 
al., 1982). The raphe nuclei are regarded as important sleep-inducing 
centres and selective destruction of this region in rat studies has 
led to a parallel depletion in 5HT content in the brain with 
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concomittant wakefulness, the loss of 5HT being proportional to the 
number of hours sleep'loss. Also of importance, are the rostral 
nuclei which are important innervators of the hypothalamus. In this 
instance-5HT may be an important regulator of temperature control 
e. g. in the rat, injections of 5HT into this area results in a 
reduction in body temperature, but similar protocols in cats, dogs 
and monkeys produced an increase in body temperature, thus the effect 
is species dependent. Another area of the brain containing very high 
concentrations of 5HT is the hypothalamus . The hypothalamus is 
involved in the control of pituitary hormone secretions by the 
release of regulatory factors into the portal blood system. Serotonin 
is thought to act as a neurotransmitter in controlling the release of 
some of these factors including CRF (see section on PCPA). 
In clinical conditions such as Cushings' syndrome where plasma renin 
is low, treatment of patients with the 5HT antagonist, 
cyproheptadine, ameliorated the symptoms by reducing ACTH levels 
(Krieger et al 1977). Circadian surges of ACTH and corticosteroids 
have been dampened by depletion of brain 5HT levels with PCPA 
(Krieger et al., 1970,1977., Vernikos-Danellis et al., 1973). In man 
5HT itself has been shown (Sauerbier (1976) see Smythe 1979), to 
follow a circadian pattern in whole blood, low levels of 
approximately 100pmol/ml maintained from 6pm-6am and reaching a 
peak at approximately 2pm of 540 pmol/ml. Corticosteroids 
themselves have been shown to directly influence 5HT synthesising 
enzymes e. g. tryptophan hydroxylase at the level of the hypothalamus 
both in vivo and in vitro (Azmitra et al., 1974), and thus by 
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modulating their kinetics alter the secretion of CRF and consequently 
ACTH. Serotonin at the hypothalamic level may also be responsible 
for affecting compensatory adrenal hypertrophy in the contralateral 
adrenal of an adrenalectomized rat. Removal of the left adrenal 
prior to PCPA treatment in the rat, enhanced right adrenal 
hypertrophy and this was thought to be related to a possible effect 
of 5HT on ACTH secretion which affects adrenal growth, and a more 
direct effect of 5HT from the hypothalamus (Vernikos-Dane 1lis et al 
1973). Thus it would appear that 5HT in the CNS is involved in 
several regulatory processes. 
1.6.2 Serotonin in the Gut 
The alimentary tract of mammals contains vast stores of serotonin. 
Classically 5HT has been identified in the endocrine cells of the 
gut, the enterochromaffin cells Iby immunohistochemical staining 
techniques, fluorescent staining and autoradiography. Stimulation of 
the release of 5HT is caused by acetylcholine, itself released by 
transluminal pressure, and a lowering of pH. It has been suggested 
that 5HT may be a local paracrinal gut hormone involved in intestinal 
secretions and peristalsis of the intestine. Like most tissues in 
which 5HT is stored the cells from the intestine in rats have uptake 
mechanisms for 5HT and are also capable of synthesising it from 1- 
tryptophan and this capacity is markedly increased in carcinoid 
patients. There is a rapid turnover of 5HT in the gut with a half- 
life of 10-17 hours compared to 33-48 hours in platelets, and this is 
reflected in large excretions of the 5HT metabolite 5HIAA -up to 
9mg 
daily in human urine. The other main storehouse of 5HT in the gut 
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has recently been designated to the intrinsic network of neurons 
running through the gut musculature with an estimated 5HT content of 
100 ng/g. Stimulation of these neurons py for example, release of 
5HT from the enterochromaffin cells on the mucosal side of the gut 
which induces peristalsis by depolarisation of primary a£ferents, 
initiates neuronal release of 5HT on the serosal side of the gut 
lining. The 5HT released on the serosal side causes depolarisation of 
enteric ganglia by a slow excitatory post synaptic potential (epsp) 
and thus inhibits peristalsis. 
1.6.3 Serotonin in the - Blood 
Platelets form the major storehouse of 5HT in the blood where it is 
stored in dense granules in close association with ATP and Ca2+ . It 
has been estimated that during release reactions of platelets e. g. 
coagulation, platelets release approximately 0.21-5.95nmol of 5HT 
per 109 platelets at the local sites of injury. 
There are different indices for the measurement of 5HT in blood. 
Humphrey et a1., 195' has measured 5HT in the dog, at levels 
of 0.4µg/109 platelets and in whole blood 0.35 µg/ml. More recently 
5HT has been measured by radio immunoas say (RIA) (Kellum and Jaffe 
1976) with values of 2.2nmol/mg platelet protein in the rat. 
Approximately 90% of 5HT is-stored as an inactive platelet bound form 
in normal conditions in humansywith adult levels measured by RIA at 
341± 27ng/109 platelets (Kellum and Jaffe 1976); serum levels have 
been estimated at 70±20 ng/ml (Snow et al., 1955) and 
210t53 ng/ml in another study (Davis 1959). 
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There have been suggestions that 5HT levels may alter with age 
since studies-done by Erspammer in 1954 (see Smythe 1979) indicated 
higher levels in adults (mean 6 80pmol /ml; range 410-1140 pinol/ml) 
compared to elderly patients (mean 500 pmol/ml; range 170-850 pmol/ml 
serum). Plasma-free levels or platelet poor plasma (PPP) levels 
have been estimated by Crawford et al., 1963 with a mean free level 
of 13ng/ml (0-165pmol/ml ) and similar levels have been reported by 
other groups. However the results are variable, and since platelets 
are fragile, any slight damage to them will cause release of 5HT into 
the plasma. Thus, on this basis it is not clear whether the values 
represent free 5HT, or an artefact due to platelet release. 
Furthermore, it has been suggested that when blood clots only part of 
the 5HT in platelets is released and therefore, the values quoted for 
serum may not be constant. However, Davis. et a1., 1959 reported 
constant recovery of 5HT if blood was able to clot in the presence 
of ascorbic acid. 
Variations in 5HT levels are prevalent immediately after a meal and 
increase up to twice the normal fasting levels (Kellum and Jaffe 
1976) one hour after food rising from a resting value of 1130/210 
pmol/ml. to 2060=97 pmol/ml. 
There have also been studies on a limited number of individuals which 
suggest that there may be a circadian rhythmicity in 5HT, the levels 
being higher in the early evening and early morning, and lower in 
midmorning and afternoon (Genefke et al., 1968) in parallel to ACTH 
rhythms. 
Serotonin reaches platelets via the gut. In the intestine 5HT 
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ingested or synthesised from the amino acid tryptophan is secreted 
into the gut lumen and transported in the portal vein system to the 
liver where it is inactivated by monoamine oxidase A. The gradient 
of 5HT from the portal vein to the hepatic vein leaving the liver is 
30% but any 5HT that may escape deactivation is rapidly transferred 
to the pulmonary circulation to be degraded in the lung parenchymal 
tissue. The ability of the lung to remove 5HT was first observed 60 
years ago. It has now become apparent that over 90% of 5HT is 
deactivated in the lung by monoamine oxidase A. This is one of the 
major non-aerobic functions of the lung. The lung has a large 
surface area /volume ratio and a large endothelial cell capacity 
which inactivates serotonin. , 
Besides endothelial cells, trapped 
platelets, mast cells (in rats and mice), and adrenergic nerve 
endings may also contribute to a lesser extent to the storage and 
deactivation of 5HT. In the case of platelets, 5HT is taken up over 
longer periods of time than the 4-10seconds transit time through the 
lungs in which inactivation occurs. 
After passage through the lungs 95% of the 5HT passing through the 
lung, is removed and the remaining 5% passes to the left atrium to 
enter the general circulation. 
The measurement of 5HT in tissues is more a consequence of overall 
storage versus release or synthesis versus metabolism so that in 
order to draw up a true identity of its physiological function one 
would require dynamic studies of turnover (see Chapters 8 and 11). 
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1.7 PATHOPRYSIOLOGY OF SEROTONIN 
0 
1.7.1 Carcinoid Syndrome 
As outlined above 5HT is stored in the enterochromaffin cells of the 
gut. The concentration varies along the regions of the gut and it 
has been reported that substance P may be a major co-storage amine in 
these cells. It has been known for a long time that in the Caroinoid 
Syndrome there is tumorous growth of these cells resulting in 
overproduction of 5HT; indeed it has been shown that over 60% of 
ingested tryptophan may be taken up by these cells for 5HT 
biosynthesis. In this syndrome one of the classical symptoms is 
watery diarrohea as a result of excessive peristalsis and increase 
transit time reducing absorption. Blood levels of 5HT may also be 
elevated in this condition up to 5-10 times whilst the urinary 
excretion product 5HIAA can be elevated by as much to 60 times the 
normal (Sjoerdsma, Weissbach and Udenfriend 1956 - see Smythe 1979). 
For this reason urinary measurements of 5HIAA are made in the 
differential diagnosis of this intestinal disease. 
Other intestinal diseases may also manifest abnormal handling of 5HT 
with elevated levels in the blood and produce clinical symptoms 
related to 5HT of flushing, diarrhoea and wheezing. 
1.7.2 Hypertension 
In essential hypertensive patients platelet uptake of 5HT is reduced 
either due to abnormal uptake systems or a more rapid turnover of 
platelets due to increased aggregability (reviewed by Vanhoutte 
1982). In clinical conditions, such as pulmonary embolism or in 
15 
spontaneously hypertensive rats (SHR) where there may be pulmonary 
oedema, there is decreased capacity to inactivate 5HT and therefore 
the blood 5HT levels may increase. Guicheney and coworkers (Guicheney 
et al., 1985) in studies using normal rats and SHR demonstrated an 
increase in blood platelet concentration in the SHR with no change in 
5HT content per platelet number. This was associated with an 
increase in aggregability of the platelets. Vanhoutte's review 
indicated that this could create a positive feedback effect of 5HT in 
that more release from platelets of hypertensive animals, would be 
further augmented by 5HT's capacity to increase platelet aggregation. 
This increase in platelet turnover was associated with an increase in 
free tryptophan levels. An increase in platelet turnover means that 
stored 5HT is released more rapidly from the platelets and so there 
is a net requirement for 5HT synthesis. Hence the essential amino 
acid tryptophan, is made freely available for uptake into the 
synthesising machinery of the enterochromaffin cells. Studies in Man 
by Baudouin-Legros et al., 1985, showed that the 5HT content in 
platelets from hypertensive patients was lower than in normal 
subjects. Kamal et al 1984, has also reported a diminished uptake 
transport system in platelets from hypertensive subjects. Roth et 
al 1980, suggested by his studies on perfused normal and hypertensive 
rat lungs, that there is a reduction in clearance of 5HT in the 
endothelial cells because of slower uptake, rather than a change in 
the content of the monoamine oxidase responsible for oxidative 
deamination of 5HT in these cells. 
The overall effect in aggravating or contributing to the hypertensive 
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state of reduced uptake and metabolism of 5HT in animals, has been 
summarised by Vanhoutte et al 1982 as an overall increase in blood 
vessel wall sensitivity to 5HT and a resultant increase in blood 
pressure. 
More recently a study carried out by Osunkwo et al., 1986, measuring 
5HT levels in the genesis of hypertension in rats, indicated that an 
increase in 5HT may be more important in deoxycorticosterone acetate 
(DOCA)-induced hypertension at its onset, but is increased in 
several hypertensive states including spontaneous hypertension, renal 
hypertension and DOCA-induced hypertension during the later phases. 
However, like previous studies it has not been determined whether 
changes in 5HT induce the hypertension or whether the change in 5HT 
handling is a consequence of the hypertensive state. 
1.7.3 Central Nervous System Disorders 
Primary aldosteronism is characterised by high plasma levels of 
aldosterone but suppressed levels of renin. It has often been 
broadly classified with adrenal hyperplasia but in this case there is 
adrenal hypertrophy not seen in primary aldosteronism. There is 
evidence that 5HT may be involved either peripherally or at the level 
of the central nervous system in stimulating excessive aldosterone 
release from the adrenal. Gross et al., 1981, showed that in humans 
with primary aldosteronism treatment with the 5HT antagonist, 
cyproheptadine, by i. v. administration, suppressed aldosterone 
secretion and further, the effects could be accentuated by the pre- 
infusion of a peripheral inhibitor of 51T synthesis carboxydopa. 
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This suggested to Gross that the effects of 5HT in primary 
aldosteronism were centrally mediated. Mantero et al., 1985 using a 
more specific 5HT antagonist, ketanserin, given i. v. to patients with 
idiopathic hyperaldosteronism and adrenal adenoma showed that 
aldosterone levels in the adenoma patients were decreased 
significantly in 2 out of u patients (not seen in adenoma patients by 
Gross) whereas in 4 out of 6 patients with idiopathic aldosteronism 
there was only a slight decrease in aldosterone levels. However the 
percentage change from individual basal values showed a slight but 
significant drop in aldosterone levels. This study did not 
distinguish between the two disease states or differentiate the site 
of 5HT's possible action. 
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Chapter 2 
THE ADRENAL CORTEX: CONTROL OF GROWTH AND NEURAL INNERVATION 
2.1 
The adrenal glands of the eutherian mammal are paired structures 
lying in the abdominal cavity close to the anterior pole of each 
kidney . They are surrounded by both brown and white fat and vary in 
shape from almost spherical, in foetal life and in the adult species 
of the rat, mouse, and guinea pig, to wedge- shaped flattened 
structures in humans and cattle. Although the size of the gland may 
' vary with species, the thickness of the cortex remains constant and 
this is thought to be due to the arrangement of the blood supply 
which is similar throughout the eutherians, in that there is only a 
single vein leaving each gland which results from the centripetal 
blood flow within the gland . Accordingly, any increase in cortical 
width would cause-the venous end of the capillary bed to be too far 
from the arterial supply. 
The mammalian adrenal gland, consists of two components, 
adrenocortical and chromaffin tissue. In embryonical development, 
adrenocortical cells arise from the mesoderm, in particular from the 
columnar epithelial cells that line the coelom. Chromaffin cells have 
a separate origin, arising from the paraganglion- cells of the neural 
crest. complex. The concentric arrangement of adrenal cortex 
surrounding the medulla is found only in eutherian mammals among the 
vertebrate class. There appear to be important interactions between 
the medulla and the cortex. It is not known what attracts the 
medullary cells to the cortex-but there is little doubt that the 
glucocorticoids play an important role in medullary cell maturation 
e. g. sympathetic tissue from animals of various ages cultured in 
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medium with glucocorticoidsa preferentially differentiate into adrenal 
medullary cells (Coupland et R 
. 
L51965). Further, neonatal rats 
possess clusters of chromaffin cells that surround the aorta (the 
organ of Zuckerkand) which atrophy after birth but can be maintained 
with administered glucocorticoids during the neonatal stage. Other 
studies (Wurtmann et al, 11966) indirectly demonstrated the importance 
of glucocorticoid control of catecholamine synthesis when it was 
discovered that the enzyme activity of phenylethanolamine N- 
methyltransferase (PNMT), was decreased in hypophysectomised rats and 
also in rats where steroid production was inhibited. They concluded 
that the effects of ACTH release on the secretion of glucocorticoids 
were important in the activity and biosynthesis of epinephrine from 
norepinephrine. Conversely, medullary tissue and its hormone 
secretions may augment or maintain the cortical cells and their 
secretions, for example the medulla has been shown to complete the 
synthesis of cortisol when medullary tissue is incubated with C-21 
and other steroid precursors, (Carballeira and Venning 1964). In 
contrast., epinephrine has been shown to inhibit the synthesis of 
cortisol when added to adrenocortical mitochondria by reducing 11- 
beta hydroxylase activity (Sweat and Bryson 1965. ) The addition of 
abscorbic acid prevented this effect, thus indicating that an 
oxidizing agent was responsible for the inhibition of the enzyme. 
This could conceivably be the metabolic end product of epinephrine, 
adrenochrome. This fine control of steroid synthesis by 
catecholamines, may help to regulate the outflow of glucocorticoids 
and their precursors especially during stress. In relation to this, 
20 
it has been discovered that medulleetomised animals, maintain basal 
levels of glucocorticoid output but have a reduced steroid response 
to immobilisation stress (Torda and Kvetnansky 1983); further to this 
it has been observed that immobilisation stress in rats depletes 
catecholamine levels in the adrenal medulla (Kuriyama et al 1984). 
However in vivo perfusions of epinephrine in intact animals have 
varied from having no effect on basal glucocorticoid secretions in 
man and isolated perfused dog adrenals, to reducing the corticoid 
response to ACTH (Sandberg et al., 1953., Cushman et al., L 1966) 
whilst Vogt et al., 1944 showed an increase in steroid output of 
isolated dog adrenals which was independent of the pituitary but 
dependent on the presence of medullary tissue. A recent explanantion 
has been, postulated by Pratt and coworkers ( Pratt et al 1985) which 
explains the lack of effect in isolated fresh adrenal cells and in 
vivo perfusions of catecholamines, as due to the high local 
concentrations of the catecholamines within the cortex leading to 
desensitisation. Cultured zona glomerulosa cells from bovine and rat 
are stimulated by norepinephrine and epinephrine to secrete 
aldosterone, (Pratt et al., 1985", De Lean et al., 1984b., ) and have 
low endogenous levels of catecholamines, whereas freshly prepared 
rat zona glomerulosa cells, appear to have higher endogenous levels 
and do not respond to catecholamines (Sequeira et al., 1985), thus, a 
desensitisation effect could explain some of the variable results. 
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2.2 SYSTEMIC EFFECTS OF ADRENAL CATECHOLAMINES ON HYPOTHALAHIC- 
PITUITARY-ADRENAL FUNCTION 
Catecholamines exert effects both at the level of the pituitary via 
the hypothalamic - hypophysial portal system and also via the 
systemic circulation from the adrenal medullary release. It is well 
recognised that epinephrine-infusions have a significant effect on 
pituitary function and may reach levels as high as 10-8M during 
chronic stress. Indeed, infusions of epinephrine have been used in 
clinical studies in discerning pituitary-adrenal axis function 
(Sandberg et a1, )1953). Direct in vitro studies using cultured 
pituitary cells have shown that epinephrine can stimulate the release 
of ACTH via alpha receptors (Giguere et al., 1982) . At the higher 
level of control, the release of corticotrophin releasing factor 
(CRF) from the hypothalamus, is stimulated by epinephrine and, 
inhibited by norepinephrine (Jones and Hillhouse 1977). However the 
overall effects are variable and complex with reports of falls in 
ACTH levels with epinephrine infusions (Wilcox et al., 1975) to an 
early fall and later rise in ACTH secretions reported by Few et al. ) 
1980. 
2.3 BLOOD SUPPLY 
The rat and guinea pig give typical examples of the blood supply 
arrangement to the adrenal gland. In general the arterial blood is 
derived from several vessels. In, the. rat, the anterior part of each 
gland is supplied by an artery arising from the aorta which divides 
into two branches, and after further sub-division ramifies across the 
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surface of the gland without apparent anastomoses. This compares to 
the cat which has numerous small arteries arising from the aorta. In 
man the major portion of the blood supply to the adrenal is derived 
from the inferior adrenal arteries arising from the renal artery. 
2.4 
. 
VASCULAR PATTERN WITHIN THE ADRENAL. 
In 1900 Flint described the pathway of the blood vessels within the 
gland by use of the injection of dye to follow its pathway (see 
Idelman 1978). The adrenal arteries form a network across the 
capsule to supply the whole gland and may either : - 
(1) be confined to the capsular region and terminate in an irregular 
capillary network which is gathered into anastomosed venous channels; 
(2) penetrate into the cortex and immediately break up into a vast 
capillary network confined to this region - arteriae corticis; 
(3) penetrate the cortex without branching and then branch out into a 
capillary network within the medullary region- arteria medullae. 
The cortical vessels that penetrate (2) initially break up into 
straight capillaries that embrace the zona glomerulosa cells forming 
anastomises of the 'arcade' type. Within the zona fasoiculata the 
capillaries become straighter and follow the connective tissue septa 
that runs radially within the gland towards the inner cortical 
region, the zona reticularis. Here the vessels widen into 
anastomising blood spaces and sinuses that drain into the central 
vein. The capillaries of the cortex are of the sinusoid type, which 
includes both endothelial cells and histiocytes. These vessels due 
to their composition, have the capacity to store exogenous matter 
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including India ink, protein, trypan blue and silver nitrate (see 
discussion in Chapter 11). 
2.5MICROANATOMY OF THE ADRENAL CORTEX 
Arnold in 1866 (Idelman, 1978) first described the histology of the 
adrenal cortex with its three concentric zones, the zona glomerulosa 
(glomus-ball), zona fasciculata (fascis-bundle) and zona reticularis 
(rete- net). The organisation of these zones is due to the growth 
and organisation of the internal blood vessels (see below). Under 
the light microscope the zona glomerulosa may be well defined in 
some species such as dog, sheep and horse and less defined in monkey, 
rat, hamster and mouse. The zona reticularis may not be prominent in 
some species such as the mouse, and may be marked in others e. g. pig 
and guinea pig. The volume of the gland varies with the species and 
the physiological state of the animal. In man the zona glomerulosa 
occupies 15% of the total gland compared to 38% in the rat and 20% in 
the ox. Similarly, the zona fasciculata occupies 78% in man , 54% in 
the rat and 51% in ox. The rat is exceptional in having a zona 
intermedia region occupying 3% of the gland. 
2.6 MORPHOLOGICAL. CHARACTERISTICS OF EACH ZONE 
The zona glomerulosa lies just inside the capsule and consists of 
cells arranged in ball-like clusters 20-30 cells per cluster with a 
zonal width of 4-6 layers (Fig. 2.1). The cells approximate 13 µm 
diameter with a high nuclear/cytoplasmic ratio. The nuclei vary in 
shape and contain one or two nucleoli. The cytoplasm contains a 
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variable amount of lipid, being particularly high in the dog, rat and 
hedgehog (as reviewed by Idelman, S. 1978). 
The zona fasciculata cells lie below the zona glomerulosa layer and 
are arranged in columns radiating towards the zona reticularis and 
medulla. They lie juxtaposed with the connective tissue septa and 
intermittently interrupted by the sinuses passing through the cortex. 
The cells are larger than the zona glomerulosa cells with a 
diameter of approximately 21 µm and have round nuclei with one or 
two nucleoli and although often being called 'clear cells' because of 
their vacuolated appearance in tissue sectioning, they do in fact 
contain a large amount of lipid within the cytoplasm compared to 
glomerulosa cells. Frequently the lipid droplets are more numerous 
and larger in the outer layers than in the inner fasciculata layers. 
Interdigitating with the fasciculata zone lies the zona reticularis 
which is smaller in width. The cells are arranged in cords that 
anastomise and surround the large blood sinuses. The cells are small 
and lipid content is sparse. There has been some speculation on the 
apparent diehroism of zona reticularis cells since as early as 1886 
Dostoiewsky (see Idelman 1978) had noted that there were two types of 
cells, light or clear cells, and dark or compact cells. A modified 
theory expounds that the clear cells in this region and the zona 
fasciculata may provide a precursor steroid store, and compact cells 
provide the immediate steroid requirements. Therefore after ACTH 
stimulation the clear cells transform to compact cells to give 
increased output of steroid (Symington 1962). Studies with 
prolonged ACTH administration indicated marked hypertrophy of the 
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zona reticularis, `and a dense nerve plexus was evident in studies 
carried out by Mikhail (1961,1965) and in several mammals including 
the rat and mouse`(Migally 1979). This indirectly suggests that 
nerve supplies in this region , thought to affect adrenal growth, may 
be regulatory in the zona reticularis. 
2.7 CONTROL OF GROWTH AND M SS'OF THE ADRENAL CORTEX 
The rate'of secretion or-production of a given hormone is the product 
of the activities of the enzymes involved in its synthesis and the 
mass of the adrenal cortex'involved"in this process. Thus the mass 
of the cortex is an important means of controlling the steroid output 
in the different zones. 
In the case of aldosterone, the mass of the zona glomerulosa is 
solely responsible for the secreted amount in all mammals since 
aldosterone synthesising enzymes are specifically located in this 
region. However, in the case of corticosterone and cortisol 
secretion, the zona fasciculata, zona reticularis, and in the case of 
corticosterone, the zona glomerulosa to a lesser extent, are all , 
involved in the production of these steroids. Hence the mass of the 
adrenal cortex as a whole, becomes the determining factor. In some 
species, androgen production becomes an important secretory product 
of the inner zones including the zona fasciculata and the zona 
reticularis e. g. in human foetal and adult tissue these regions 
actively secrete androgens and there is a concomittant increase in 
adrenal mass, reflective of the increased mass of the inner zones. 
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2.7. lControl of the Mass of the Cortex 
Although as discussed above the mass of the zones are important 
determinants in the secretion of specific steroids, this may not be a 
direct regulatory mechanism but rather a slower feedback control 
mechanism, secondary to a change in zonal width function. The zonal 
width may be argued as being controlled by dynamic changes in the 
functional and morphological characteristics of the cells 
constituting the zones, as has been discussed by Hornsby and 
coworkers (Hornsby and Crivello 1983., Hornsby P. J., O'Hare M. J., 
and Neville A. M. 1974), and will be discussed further under the 
heading 'Functional Zonation'. 
2.7.2 The Origin of the Growth of the Adrenal Cortex 
The basic pattern of growth is similar in all mammals and only 
differs in detail such as occurs in the X zone in the female mouse or 
the human foetal zone that later convolutes. In general the adrenal 
gland assumes a spherical shape with layers of cells clustered 
together so that realistically, cell division is most likely to be 
restricted to the outer regions of the zona glomerulosa. In fact two 
theories have been postulated to account for cell division within the 
cortex, ' each of which may not be-totally exclusive. Originally 
Gottschau 1883 (Idelman, 1978) postulated the 'cell migration ' or 
'escalation' theory in which cells divide in the outer zones and 
migrate inwards and are progressively transformed into the cells 
characteristic of the different zones. Since then several groups 
have shown that-cell division does occur more markedly in the outer 
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regions. Indeed, pulse chase experiments in young rats stressed with 
carbon tetrachloride which stimulates adrenal growth, and later 
injected with [3H]-thymidine, revealed that cell division in the 
outer cortical regions was more marked in 2 and 3 week old rats 
compared to one and four weeks (Jones (1967) cited in Idelman 1978), 
and further, tracer experiments in 6 day to 10 week old rats showed 
that [3H]-thymidine could be located at different regions further 
into the cortex with time reaching the zona reticularis by the end of 
two months (Ford and Young 1963). Others have also found that in 
both embryonic and postnatal growth, most cell division appears to 
occur in the outer zona glomerulosa and outer zona fasciculata 
(Wright 1971,1973). The situation is similar in the mature cortex 
with 
.a 
predominance of division in the outer zone. However the rate 
of cell division is less in the mature gland, yet enough to balance 
the rate of cell death. Wright in his studies in the rat, (Wright 
1971,1973), found that the rate of cell division in the zona 
glomerulosa was higher than that required for its own maintenace, 
whereas the rate of cell division was too low in the zona reticularis 
for maintenace, thus reinforcing the idea that the outer cortex is of 
primary importance for whole cortical growth. The zona reticularis 
has often been called the 'senescent' zone and deposits of large 
amounts of age pigments (lipofuscin) are found here. Lipofuscin is 
thought to be a product of the lipid peroxidations that occur in the 
outer zones as steroids interact with zonal enzymes (see later). 
Apoptotic bodies (dead cells) are also found in this zone, so it 
would seem a reasonable proposition that zonal maintenance is 
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achieved by migration of dividing cells in the outer zone. There are 
however, reports of zona reticularis cells actively dividing, for 
example [3H]-thymidine studies by Riter and Hoffman in 1967 (see 
Idleman 1978), showed that cell division occurs in this region; 
further, when adrenocortical tissue fragments were transferred to 
another region of the body, regeneration and functional and 
morphological zonation ensued. In bovine adrenocortical cells in 
primary culture, all cells entered DNA synthesis and were 
proliferating (Hornsby and Aldern 1984). All zones therefore appear 
to be capable oferegeneration when required even though the inner 
regions appear to be quiescent. or, less active, possibly due to their 
location relative to the vasculature. The zona glomerulosa layers 
being closer to the arterial blood supply may have more access to 
oxygen and, nutrients and circulating growth factors than the inner 
zones and because. of this, are in the main. the most mitotically 
active. This latter idea of separate integrity of the zones and 
their maintenace was crystallised by Deane and Greep in 1946 in the 
'Zonation Theory' and in essence they postulated that each zone was a 
functional and morphologically separate zone. This theory however 
is too limiting for adequate interpretation of, the experimental, 
findings to date and the concept which has emerged, considers that 
cells dividing in the outer zona glomerulosa zone are pushed inwards 
towards the medullary region, and in the process. are undergoing a 
functional transition from mineralcorticoid secreting, to 
glucocorticoid, to androgen secreting and finally, to cell death in 
the inner zone. This idea is interwoven with the role played by the 
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vasculature and its blood-borne substance/s in zonal integrity, 
discussed in later sections. 
2.8 STIMULATION OF GROWTH OF ADRENAL MASS 
There are two parameters that can be included under the heading 
growth: - 
(1), adrenal cell size; 
(2) adrenal cell number. 
2.8.1 ACTH 
Adrenocorticotropin (ACTH) is the major regulator of adrenocortical 
cell growth in vivo. A classic example of this is in Cushing's 
syndrome in which an excess of ACTH secretion is associated with 
adrenal hyperplasia producing an increase in cell size rather than 
cell number or DNA synthesis. Conversely blocking of ACTH secretion 
by administering glucocorticoids or removal of the pituitary causes 
adrenal atrophy (Wright, AplTeton and Morley 1974). In cell culture 
experiments ACTH alone inhibits cell proliferation, but in 
combination with a directly acting mitogen, cellular hypertrophy 
ensues (Gill et aL, 1982) hence, in vivo the effects of high levels of 
ACTH would appear to be due to the indirect effects of ACTH as well 
as a directly acting mitogen possibly also derived from the pituitary 
or the hypothalamus (Holzwarth et at, 1980., Lowry et aL, 1983)( see 
also other factors below). The sole effects of ACTH can however be 
seen in vivo when synthetic or natural ACTH is administered and there 
is a-resultant increase in cell growth within 24 hours due to 
increase in cell size. In anecephalic foetuses where the pituitary 
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is absent, adrenal growth is poor but is restored by ACTH 
administration ( Parker et alý1983). Whether the effects are solely 
a result of ACTH's indirect mitogenic effects or possibly due to 
contaminating ACTH fragments such as pro-gamma MSH (Lowry et al., 1983) 
is not known. 
2.8.2 Mitogenic Peptides 
A family of polypeptides exist that are directly mitogenic to 
cultured adrenocortical cells. Fibroblast growth factors (FGFs) are 
the most potent and are found in both the brain and pituitary gland. 
They exert mitogenic effects on mesodermal tissue including the gut 
but their physiological role and the circumstances in which they may 
be stimulated are not known. Epidermal growth factor (EGF) also has 
mitogenic effects in cultured human foetal adrenocortical cells. It 
is secreted by the sub-mandibular gland and is also thought to 
influence medullary secretions. Binding sites in vitro in foetal rat 
tissue and also in vivo in adult rats have been identified (Crickard 
et a1., 1981., Chabot et al. 1986) but the mitogenic and steroidogenic 
effects are species specific since there is no effect in bovine cells 
whereas steroid synthesis and secretion occurs for example, in sheep 
adrenals. 
2.8.3 Pituitary Factors 
Early work on crude pituitary fractions revealed that as ACTH 
concentrations were increased, so the mitogenic properties of the 
extract decreased. However, it has been demonstrated that growth 
factor alone (cited in Vinson's paper 1981) and in combination with 
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ACTH are mitogenic both in normal sodium balance and in sodium 
depleted rats (Palmore et al., 1970). 
Hyperprolactinaemia also causes adrenocortical hypertrophy and indeed 
prolactin receptors have been found in the adrenal cortex. However 
in cultured adrenal cells both growth hormone and prolactin fail to 
stimulate mitogenesis (Gill et al., 1982). 
It has also been shown that pituitary factors other than ACTH 
stimulate mitogenesis, for example, pituitary tumour cells and their 
secretory products have been shown to stimulate growth in Y-1 
adrenocortical tumor line cells (Kudlow et al., 1983) and recent 
experiments have suggested that älpha MSH may also stimulate growth 
(Whitehouse et al., 1982). In cultured rat zona glomerulosa cells, 
Payet and coworkers (Payet et a1., 198u), demonstrated a specific 
growth promoting effect of vasopressin, a hormone of the posterior 
pituitary gland. 
2.8.4 Angiotensin II (AII) 
It was shown by Mark et aLy1963 that chronic administration of 
angiotensin II in rats increased adrenocortical mass and sodium 
deprivation also increases the mitotic index of adrenals. Although 
angiotensin II receptors are in highest concentration in the zona 
glomerulosa, there is an increase in mitotic activity both in the 
zona glomerulosa and the zona fasciculata. The effects of All may 
involve an interaction with ACTH since All at the level of the 
pituitary may affect ACTH secretion. 
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2.8.5 Insulin and Insulin-like Growth Factors 
Early work using bovine adrenocortical cells indicated the mitogenic 
effects of insulin, somatomedins, multiplication- stimulating 
activity (MSA), and insulin-like growth factors. Insulin type 
receptors have since been identified in vivo in rat adrenal cortex, 
(see cited reference in Hornsby, P. (1985) Chapter 1, Adrenal Cortex, 
Anderson and Winter 1985), although the specific effects in vivo have 
not been demonstrated. However, in vitro insulin and insulin -like 
factors appear to synergise with All or FGF in stimulating 
mitogenesis (see Chapter 1, P. Hornsby, Adrenal 'Cortex). 
2.8.6 Neural Involvement in Growth Regulation 
As early as 1951, Kiss had suggested that neural innervation may in 
part, be responsible for adrenal growth after bilateral 
adrenaleetomy, since they demonstrated an increase in size of cell 
bodies in the hypothalamic ventromedial nucleus, at the side 
opposite to adrenalectomy. Labelled [3H]-leucine uptake has also 
been shown to increase on the enlarged nuclei side. That stretch 
receptors may be involved in relaying afferent signals to the 
hypothalamus, was also suggested by Niijima (1968) and Dallman 
(Dallman et al., 1977). However, Holzwarth (1980) demonstrated 
that adrenal regeneration caused by unilateral enueleation 
procedures, i. e. removal of the inner cortex and medulla, resulted in 
compensatory adrenal growth which was independent of hypothalamic 
connections, since the observations were made in rats which had 
hypothalamic lesions; Thus, a, dichotomy of both neural and humoral 
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involvement (possibly derived from the anterior hypothalamus) in the 
control of growth in unilateral adrenalectomy and adrenal enucleation 
respectively, has been proposed by Holzwarth and coworkers (1984). 
2.8.7 Vascular Control of Growth 
The vasculature has also been postulated by Hornsby (Hornsby, 
P. J. 1985, chapter 1 in Adrenal Cortex, Anderson and Winter, eds) to 
indirectly control the size of *the adrenal . It is already known 
that ACTH stimulates increased blood flow to the adrenal gland (Payet 
et al., 1980) by virtue of local prostaglandin release since 
indomethacin blocks the hyperaemia. This increase in blood f low may 
augment an increase in growth factors and nutrients that will 
increase adrenocortical growth. An acute increase in blood f low and 
hence volume of the gland could also trigger neural reflexes in the 
baroreceptors in the cortex and potentate growth via the neural- 
hypothalamic reflex in the contralateral gland and since both glands 
would receive an increased blood supply due to ACTH, both would 
increase in size. The chronic effects of an increase blood f low may 
involve an increase in capillary proliferation in the cortical 
tissue, stimulated by prostaglandins , thus increasing the flow of 
nutrients and factors such as FGF and EGF. Capillary proliferation 
may also produce an increase in secretion by endothelial cells of 
extracellular matrix, in particular fibronectin, which has potent 
growth stimulating properties and it has already been shown in 
cultured bovine and human foetal adrenocortical cells that coating or 
the substratum with extracellular matrix or fibronectin, increases 
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adrenocortical growth (Simonian, White and Gill 1982., 
Crickard et al., 1981). 
2.9THE ZONATION OF ADRENOCORTICAL. FUNCTION 
Since the isolation and characterisation of aldosterone, the Close 
association of the level of secretion of this steroid in altered 
sodium status and the width of the zona glomerulosa in relation to 
this has become apparent. Several groups have confirmed the 
specificity of the zona glomerulosa for aldosterone secretion in 
several species including man , rat and cattle (Tait et al., 
1972,1975,1980a, 1980b., Haring et al., 1970, Fraser et al., 1979, 
McKenna et al., 1978a, 1978b, 1979). In contrast, the 
inner zones secrete-the glucocorticoids including cortisol in man, 
and corticosterone in the rat. 
However, there are species differences in relation to some of the 
closely related 18 hydroxylated products thus in the rat, 18 
hydroxycorticosterone (180HB) and 18 hydroxydeoxycorticosterone 
(18OHDOC) are produced by the inner zones , in contrast to the ox. 
Deoxycorticosterone is a weak salt retaining hormone and was 
originally thought to be involved in salt and water balance in the 
1940's and thus was thought to be located specifically in the zona 
glomerulosa but it has since been synthesised by addition of 
radioactive precursors such as progesterone and pregnenolone in the 
inner zones (Whitehouse and Vinson 1971,1973). The specificity of 
steroid products was further investigated by the Taits using isolated 
rat adrenal tissue perfused in a column system and comparing the 
36 
output of the inner zones to the capsular zones (Tait 1970). The 
secretory products 180HB, 18OHDOC and B were products of the inner 
zone and subject to suppression in hypophysectomised rat adrenal 
cells. In contrast, the capsular cells secreted aldosterone and the 
other steroids in lower amounts but were'unaffected by hypophysectomy 
thus indicating a dissociation of the zonal regulation and function. 
The reason for aldosterone production being confined to the capsular 
zone, relates to the pretence of a cytochrome p450-dependent 
corticosterone methyl oxidase enzyme. The inner zones are capable 
of 18 hydroxylation of DOC and, corticosterone (B) due to the 18 
hydroxylating activity of the cytochrome p450 11-beta hydroxylase. 
2.10 ZONATION HYPOTHESIS BASED ON VASCULATURE 
Isolated cells from all zones of the adrenal gland lose their 
functional and morphological characteristics when placed in culture 
(Hornsby and Crivello 1983) and it has been postulated that this is a 
result of the removal of the vasculature. Greep and Deane had 
previously associated an important role to the vasculature in 
describing adrenocortical zonation. In support of this it has been 
recognised that the zona glomerulosa layer appears only on the 
arterial side of the vasculature e. g. in the human adrenal a cuff of 
cortex surrounding the central vein penetrates the medulla and a 
capillary, plexus supplying the cortical cuff has an associated zona 
glomerulosa on the arterial side of the capillary bed. In 
adrenocortical tissue fragments that have regenerated, zona 
glomerulosa cells are found on the arterial side, whilst 
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adrenocortical tissue transplanted to the anterior eye chamber shows 
a zona glomerulosa layer on revascularisation, close to the arterial 
side. However in all these circumstances it is only assumed that 
functional secretions follow morphological characteristics. As 
indicated earlier, the cytochrome p1450 CMO, is highly sensitive to 
steroid concentrations, and this may be an important criteria for 
zona glomerulosa appearance on the outer arterial side. It has 
therefore been postulated that it is the presence of a gradient of 
substance(s) carried in the blood supply, which alters the activity 
of the adrenocortical enzymes involved in steroidogenesis. In the 
case of cytochrome p1450 CMO, activity was lost in cultured rat 
glomerulosa cells by'the-addition of cortiso 1 and other steroids due 
to excess ACTH or cAMP stimulation, reverting the cells to zona 
fasciculata/reticularis characteristics and 'therefore not affecting 
the formation of corticosterone and 18-deoxycorticosterone; therefore 
cytochrome p450 11-beta activity was not affected compared to bovine 
adrenocortical cells in culture (Simonian et al., 1979). The way in 
which steroids may affect enzyme activity has been postulated by 
Hornsby and Crivello (983)in'which steroids may act as pseudo- 
substrates and cause the release of lipid peroxidases, which in the 
outer zones where antioxidants may be low, would cause inactivation 
of the enzymes required for aldosterone production. Further into the 
adrenal, other enzymes may be inactivated at higher concentrations of 
steroids e. g. 11-beta hydroxylase in the zona fasciculata of the rat, 
human and bovine-cell cultures (Hornsby et al., 1982., Simonian et 
al., 1979) or 21-beta hydroxylase. This and other studies have 
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created a model, in which the steroid concentrations themselves 
conceivably control the functional characteristics of the zones. 
Thus, in the inner zones a high steroid concentration of androgens 
e. g. in the human foetal adrenal, would stimulate ACTH secretion to 
increase glucocorticoid output, which would further augment androgen 
formation, creating a positive feedback loop where cAMP levels are 
high and preferentially stimulate the inner cortical enzymes such as 
17-hydroxylase, 11-beta hydroxylase and 21-beta hydroxylase, whilst 
3-beta HSD activity paricularly in the human foetal and adult 
adrenals is low (Hornsby et al., 1984). The hypothesis of steroid 
gradients determining function depends on the stimulation by ACTH 
under normal conditions having a tonic influence on homeostasis, but 
also has important effects under chronic changes. During long term 
growth of the adrenal by ACTH, the zonal widths alter, the zona 
fasciculata increases and the zona glomerulosa decreases to maintain 
a constant, adrenal mass. ACTH stimulates glucocorticoid synthesis 
but not aldosterone since cAMP levels are increased thus depressing 
pl450 CMO activity. An increase in steroid production also depresses 
phosphodiesterase activity (Schmidtke et al., 1976) and thus the 
zona glomerulosa width decreases and the zona fasciculata increases. 
Conversely, in sodium depletion in which it becomes necessary for an 
increase in aldosterone production, an increase in All levels and 
possibly K+ levels will stimulate mitogenesis (see above) and in the 
case of All, will increase phosphodiesterase activity and reduce CAMP 
levels, both of which will enhance p450 CMO activity whilst limiting 
p450 11-beta and 17-hydroxylase activity (Crivello and Gill 1983", 
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Hornsby and O'Hare 1977). This will then increase the width and 
secretion rate of aldosterone in the zona glomerulosa at the expense 
of the zona fasciculata. This'movement in zonal function and width 
is central to the concept that all adrenocortical cells are 
essentially the same but the level of activity of the enzymes in the 
zones over ,a period of time are controlled by the substance(s) 
present in the vasculature gradient. ' 
2.1 1NEURAT. INNERVATION 
It has been well recognised that the adrenal medulla has pre- 
ganglionic --- . sympathetic 
innervation since myelinated nerve fibres 
have been visualised running from the splanchnic nerve through the 
adrenal and directly innervating the medulla. However, the existence 
PIkM 
of a pos tgang 1 ionic 7sympathet ic nerve supply to the cortex as well as 
medulla is now gaining credence. At the level of the electron 
microscope, Unsicker 1971 was able to locate nerve fibres in the 
perivascular space independent of blood vessels but in close 
proximity to cortical cells in all zones of the rat, pig, man and 
golden hamster, which suggested a general mammalian characteristic of 
adrenal innervation. However in Unsicker's studies, dense cored 
vescicles and synaptic membrane specialisation with vescicles, were 
rarely observed, although neurotubules and/or filaments were 
numerous. This weakened the idea of neural innervation, but rather a 
theory for sensory fibre involvement was postulated by Niijima and 
Winter in 1968, suggesting the existence of baro- and ehemoreceptors 
in the adrenal gland. 
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Despite these early studies, others such an those carried out by Vogt 
(1944), had shown that in hypophyseotomised dogs, infusions of 
epinephrine caused an increase in cortical secretion and in at least 
half of these experiments, electrical stimulation evoked cortical 
steroid secretions. Dallman (1977) as described in an earlier 
section, indirectly showed a hypothalamic-adrenal connection via 
crossover afferent and efferent nerve fibres. 
In 1961 and 1965 Mikhail and coworkers extended the investigation 
into neural innervation and its localisation, to observations made at 
the light- microscope level in adult mammals and pre- and post 
pubertal rats to compare innervation in the developing zona 
reticularis. Distinctive para- and sympathetic innervation was 
specifically localised to the medulla, whereas the cortex was solely 
innervated by the parasympathetic system. This appeared to be 
densely innervated within the zona retieularis (when it developed) 
and the inner cortical zones. Migally 1979 has corroborated this 
with early reports by Lover (1953) and Kiss (1951), of nerve 
plexuses in the zona reticularis and zona fasoioulata, as wall as the 
presence of a subcapsular plexus cited in the rat adrenal gland. 
Robinson t al., 1977 showed that there were dense nerve plexuses in 
the zona retioularis of sheep, whilst Uno (1977) found the name 
pattern of distribution in the monkey. 
At the electron microscope level, the contents of the neural elements 
including the size and density of the vesoioles contained within the 
fibres, has made it clear that more than one typo of nourotransaitter 
may be secreted. It is believed that cateoholamines are confined to 
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small (60nm) dense vescicles, whilst the larger vescioles are thought 
to contain substances such as substance P or vasoaotive intestinal 
peptide (VIP). In relation to the identity of the neurotransmitter 
substance, Robinson et al., 1977 working on sheep adrenals was able 
to positively identify catecholaminergio fibres by fluorescence and 
more recently cat echo 1 aminergic fibres independent of splanehnie 
derivation, have been positively identified in the rat adrenal cortex 
(Klietman et al., 1985). These fibres appear to be specifically 
localised to the outer cortex and this may be important in 
identifying the possible neurotransmitter involved since in the past 
ten years several neurotransmitter substances have been identified in 
the adrenal cortex. An example was the immunohistochemical staining 
for vasoactive intestinal peptide (VIP) (Hökfelt 1981) throughout the 
rat cortex in comparison to the sparser localised catecholaminergic 
innervation. Other contenders involved in neural transmission have 
included substance P, a transmitter of primary neurons and found 
localised both in adrenal medullary cells in the rat and in nerve 
vescicles in the rat and human adrenal cortex and capsule (Kuramoto 
et al., 1985, Linnoila et al., 1980). Neuropeptide tyrosine (NPY) 
a 36 amino acid originally isolated from porcine brain and widely 
distributed in the mammalian central nervous system and periphery has 
often been found associated with norepinephrine and is also found in 
the adrenal neural elements in the rat cortex (Varndell et al., 1983) 
and may be co-stored with norepinephrine and potentiate any effects. 
Another catecholamine previously thought to be a neural factor in the 
adrenal cortex is dopamine. Dopamine and its receptors of type 2 and 
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1 have been identified in the splanchnic nerve (Missale 1985., 1986) 
and demedullated and denervated adrenals have been shown to have 
depleted stores of norepinephrine (NE) and epinephrine (E) in the 
medulla, whereas dopamine concentration did not change markedly 
suggestive of a cortical origin of dopamine. De novo synthesis was 
not required since an inhibitor of catecholamine synthesis, - 
methyl- Q tyrosine, did not affect dopamine levels (McCarty et al., 
1984). Despite the presence of dopamine receptors in the rat, bovine 
and most recently in human cortical adrenal cells, (Dunn et al., 
1981., Sevilacqua 'et al., 1982, Missale et al., 1985,1986, Stern 
et al., 1986) it has not been possible to localise dopamine to 
cortical neural elements. In contrast, Shima et al., 1984 
discovered functional catecholaminergic- cAMP receptors of beta-2 
type receptors in the glomerulosa cells in the rat, which suggests 
that'norepinephrine may be the important neural transmitter within 
the'cortical nerve'fibres. 'It-cannot be overlooked that Robinson et 
al., in 11977, identified cholinesterase neural cell types in the 
sheep adrenal cortex, and high affinity muscarinic type M1 
cholinergic binding sites have been found in bovine cortical tissue 
compared to nicotinic cholinergic sites in bovine and rat medulla 
(Hadjian et al.,, 1982, Yamanaka et al., 1986). In hypophysectomised 
and medul lectomised rats, Kolta and coworkers (Kolta et al., 1981) 
showed that a peripheral cholinergic pathway could also, in part, be 
responsible for regulating adrenal cortical function. Their studies 
demonstrated that administration of a oholinergic agonist, 
physostigmine, increased corticosterone secretion in medul lectomised 
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rats. In support of this, adrenal re-innervation studies carried out 
by Engeland and colleagues (1982), using whole adrenals from neonatal 
rats (1 day old), transplanted to the anterior chamber of the eye 
demonstrated innervation of cholinergic fibres - monitored by choline 
transferase activity - in contrast to intact control adrenals. They 
concluded that cholinergic fibres may be responsible for adrenal re- 
innervation and specifically supply non-chromaffin tissue. Despite 
sparse innervation as described above, many cortical cells contact 
with their neighbours with characteristic nexuses so that 
neurotransmitters released locally into the extracellular spaces may 
impinge on several cell processes thereby amplifying the effects. 
Catecholamines whether released from nerve fibres or cortical or 
medullary cells, may interact with one another in controlling 
steroidogenesis, or the sensitivity of the adrenal gland to 
glucocorticoid release. Racz et al., (1984) indicated a possible 
catecholamine- dopamine interaction; studies done on cultured 
adrenocortical cells, showed that prior incubation in cell medium 
containing catecholamines or medullary tissue, caused dopamine to 
produce inhibitory effects on sterodogenesis, whereas incubation 
without medullary tissue produced dopaminergie stimulatory effects. 
Thus there may be an interaction between neural, cortical and 
medullary tissue in the overall control of steroid secretion (see 
summary and conclusions, Chapter 12 for further postulates of 
serotonin- catecholamine interactions). Other theories as to the 
importance of neural innervation have focused on the possibility that 
neural elements are involved in controlling adrenal sensitivity and 
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pulsatility to ACTH stimulation. Ottenweller et al., 1978,1982, 
studied the daily rhythms of plasma corticosteroid secretions in 
hypophysectomised and control rats and also in rats transected at 
levelT-7 in the spinal cord. The rats were given ACTH implants and 
the plasma corticosterone rhythmicity was seen to be disrupted by 
spinal cord transection , which suggested to the authors that 
innervation was important in the response rhythm to ACTH. Since then 
however, corticosterone rhythms in denervated rats have been 
detected, so its importance in this respect is debatable. 
Neural innervation may also be of some importance in maintaining 
blood flow to the adrenal' gland, particularly in the haemorrhaged 
state. Engeland and coworkers showed that in conscious dogs 
undergoing slight haemorrhage, the adrenal responsiveness to ACTH was 
increased in splanchnectomised dogs, to offset the decrease in ACTH 
delivery as a result of less neurovascular regulation of the blood 
supply (Engeland et al 1985). 
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Chapter 3 
STEROIDOGENESIS 
3.1 STEROIDOGENESIS 
From 1935-1942 twenty seven steroids were isolated from the adrenal 
glands of cattle. There are species differences in the number and 
importance of steroid products, for example in the rat all steroids 
are produced by all zones of the adrenal gland except the 
mineralcorticoid, aldosterone which is exclusive to the outer 
cortical zone. The other well recognised 18 hydroxylated products 
including 18 -hydroxydeoxycorticosterone (18-OHDOC) and 18- 
hydroxycorticosterone (18-OHB) which also have a degree of 
mineralocorticoid activity are products particularly of the inner 
zones in all species studied including the rat, ox, man, bird and 
reptile. Present evidence indicates that in vivo in man 180HB always 
accompanies aldosterone secretion whereas in the ox, 18-OHB secretion 
is independent of aldosterone. Similarly, New World monkey and 
Antarctic seal adrenal cells in vitro produce 18-OHB without 
aldosterone. In superfusion studies using isolated rat capsular and 
decapsulated portions, Tait and coworkers (Tait et al., 1970) 
demonstrated that the inner zones specifically produce corticosterone 
(B), -18-OHB, and 18-OHDOC whereas the capsular portions specifically 
produce 180HB and aldosterone. 
3.2 BIOSYNTHETIC PATHWAYS 
Adrenocortical cells are the most studied system for steroid 
biosynthetic pathways and the majority of data originates from 
mammalian studies using tissue homogenates, adrenal slices and 
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isolated cells to follow the activity of the steroid hydroxylating 
enzymes by measuring absorbance spectral changes, or using high 
specific activity radiolabelled steroid precursors to follow the 
fate and production of steroid products. Steroid hormones are 
produced in minute amounts and cholesterol is the precursor for their 
synthesis. Cholesterol can be synthesised from a series of 
condensation reactions with 2C acetate molecules within the adrenal 
tissue, or blood borne cholesterol from hepatic or dietary origin can 
be taken up via low density lipoprotein receptors located on the 
adrenal, and esterified to unsaturated fatty acids within intra- 
adrenal lipid droplets before utilisation in steroid biosynthesis. 
The proportion of adrenal and plasma cholesterol utilisation varies 
from species to species, e. g. in man 80% of the cholesterol is 
derived from peripheral sources and of this only 0.1% is necessary to 
meet full steroidogenic requirements. 
Free cholesterol is formed by the action of cholesterol esterase 
acting on cholesterol ester within the lipid droplet. It may then 
be transported to the mitochondria by one of two postulated 
mechanisms. In the first it has been observed that treatment of ACTH 
stimulated cells with a microtubul e/microf i lament inhibitor of 
polymerisation of subunits, such as cytochalasin B, prevents 
transport of cholesterol to the mitochondria. Another postulate is 
that cholesterol is ferried to the mitochondria via sterol carrier 
proteins (SCP) which have been described in adrenal, ovary and testis 
tissue. At this point, it may be pertinent to refer to the in vitro 
work of Whitehouse and Vinson (1971,1975) and Vinson and Whitehouse 
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(1969,1973, ) in which they postulated that aldosterone production in 
particular within the zona glomerulosa of species such as the rat, 
reptile and'teleost fish, may occur by binding of steroid precursors 
before 'pregnenolone formation, to protein moeties (see below). The 
control point for steroidogenesis'is considered to be the side chain 
cleavage of cholesterol to pregnenolone and a 6C fragment isocaproio 
aldehyde. ' The cleavage enzyme, or'desmolase, exists as an organised 
complex, and is one of a'group of four distinct forms of cytochrome 
P450 'enzyme complexes that have a characteristic absorption spectra 
at the 450nm wavelength. The cytochrome P450s are a large and 
diverse family of enzymes found in invetebrates, bacteria and yeast. 
Each cytochrome system utilises molecular oxygen and NADPH as 
cofactor and because an adequate supply of oxygen is needed, the 
adrenal gland is equipped with a rich blood supply, this is 
particularly important during ACTH induced stress in which the blood 
supply to the adrenal is enhanced to'increase steroid output. With 
the use of electron microscopy and immunohistochemical staining, the 
cytP450 side chain cleavage complex (cytP450sco) has been located on 
the inner mitochondrial membrane facing the mitochondrial matrix. 
Like'other mitochondrial cytochrome P450 complexes, the other 
components include; an FAD containing flavoprotein (called NADPH 
adrenodoxin'reductase), a cytochrome P450 haemoprotein, and an Fe2-S2 
iron- sulphur protein, adrenodoxin or testodoxin, depending on its 
tissue of origin, all of, which are located within the inner 
mitochondriäl membrane and matrix. Thus the mitochondrial membrane 
system is a limiting factor in the transfer of extramitochondrial 
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cholesterol to the inner mitochondrial site of cleavage. In acute 
studies using ACTH to stimulate steroidogenesis it was found that 
prior treatment with cycloheximide prevented side chain cleavage of 
cholesterol. Cycloheximide inhibits the transcription of messenger 
RNA into protein, thus a labile protein factor was postulated is 
responsible for transferring cholesterol across the mitochondrial 
membranes to the active site of cytP450scc. More recent studies 
have identified the putative protein in ACTH treated cell cytosol 
fractions, as a large precursor molecule of 28 kilodaltons (kDA) 
which was readily induced by ACTH to increase cholesterol to 
pregnenolone production when added to cycloheximide pre-treated cells 
(Pederson and Brownie 1983). Disruption of mitochondrial membranes 
obviates the need for the labile protein in ACTH induced 
steroidogenesis (Jefcoate et al., 1974) however, it appears that 
cholesterol transport may not always occur by labile protein 
transport since in All stimulated steroidogenesis the early pathway 
is not inhibited by cycloheximide (Kramer 1980). Another 
possibility pertains to the requirement for membrane mobility and 
flexibility and since All stimulated steroidogenesis may influence 
phospholipid membrane turnover and mobility (see section on All 
stimulated steroidogenesis), it may be that All exerts a direct 
effect on mitochondrial membranes, obviating the need for the labile 
protein required in ACTH mediated steroidogenesis. 
In 1956 cholesterol intermediates were first isolated with the 
initial oxidation product identified as 20(S)-20-hydroxyeholesterol, 
followed by production of (20R, 22R)20,22 dihydroxycholesterol an 
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Fig 3.1 Main pathways for steriod biosynthesis in adrenal 
including aldosterone and alternate pathway 
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unstable intermediate that decomposes to pregnenolone. The whole 
reaction sequence requires 3 moles of molecular oxygen and 3 moles of 
NADPH for every mole of pregnenolone produced. Pregnenolone appears 
to be the precursor of all C21 steroids, and follows two alternate 
routes, depending upon the product: (i). through progesterone -> 17-od 
hydroxyprogesterone (17rOH prog) -> 11-deoxyeortisol (DOF) -> 
cortisol (F); or (ii)progesterone -> 11-deoxycorticosterone(DOC) -> 
corticosterone (B) -> aldosterone 
The major routes in steroid production are shown in Fig. 3.1 and are 
described in detail below.. 
The conversion of pregnenolone to progesterone was first demonstrated 
in 1951 to occur via two closely linked steps: (i) oxidative 
dehydrogenation at position 3 of pregnenolone and (ii) transferral of 
the 5-4 double bond to position 4-3. The former reaction requires 3- 
hydroxy steroid dehydrogenase and the latter reaction requires the 
enzyme 5-4- isomerase both of which are bound to smooth surfaced 
membranes within the microsomal fractions. Thus pregnenolone within 
the mitochondrial membranes is transported to the cell cytosol for 
conversion to 17-hydroxypregnenolone or progesterone. In the former 
case, 17-hydroxypregnenolone can be further hydroxylated to cortisol 
in mammals including man and cattle, but also within the inner zones 
of the adrenal, can be converted to androgens and oestrogens; 17- 
hydroxyprogesterone is also sequentially hydroxylated to cortisol and 
both reactions are irreversible. The sequence of hydroxylation is 
not strictly rigid, but in most studies pertaining to man and the 
rat, the hydroxylation occurs sequentially at position C21, C11 and 
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latterly C18 for the production of 18-hydroxylated steroids and 
aldosterone. However, hydroxylation can precede reduction and 21-OH 
pregnenolone can act as a precursor for 11-DOC and B, whereas 17-04 
21- pregnenolone can give rise to 11-DOF. The pathway to aldosterone 
production is not wholly defined and will be discussed in a later 
section. 
In rats the pathway for B production - the main corticosteroid 
product of all zones - is most often studied, and precursor studies 
have delineated the pathway for synthesis. Hydroxylation at position 
C21 of the progesterone molecule, occurs by the action of the 
microsomal localised enzyme, 21- hydroxylase, which unlike the 
mitochondrial cytP450 enzyme complexes, does not contain the 
haemoprotein. The product, 21-OH progesterone, is transported by as 
yet, an unknown mechanism, to the inner mitochondrial membrane to be 
further hydroxylated at position C11 by the eytP450 11 -- 
hydroxylase. The enzyme complex contains the three components 
described for cytP450scc although the absorption spectrum is slighlty 
different allowing for differentiation of the two enzyme complex 
forms. It is capable of both 11- and 18- hydroxylation and in this 
regard, may play an important regulatory role in 18-OHDOC formation 
and subsequent aldosterone secretion as described by Vinson and 
Whitehouse (1973,1975, ) and Fattah (Fattah et al., 1975,1976,1977). 
The primary precursor, DOC is converted to corticosterone in all 
zones of the adrenal and Vinson and Whitehouse have postulated that 
it is formed independently of aldosterone by association of free 
precursor steroids whereas aldosterone and its precursors including 
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the 18- hydroxylated derivatives, are formed via protein bound 
intermediates. These theories arose from experiments with zona 
glomerulosa and faseiculata cells, using dialysis to measure the 
amount of free versus bound labelled steroid products in ACTH and 
cortisol pre-treated cell preparations. Their results showed that B 
is preferentially released whereas aldosterone and 18-OHDOC appears 
to be non-dialysable and thus bound until stimulated by ACTH to 
release aldosterone into the medium. Following the discovery of 18- 
oxygenated steroids the mitochondrial 18- OH- dehydrogenase complex 
has been described in all zones of the adrenal gland, however until 
the enzyme can be solubilsed and isolated the exact mechanism of 18- 
hydroxylation remains undefined. 
3.3 BIOSYNTHESIS OF ALDOSTERONE 
Classically, the biosynthesis of aldosterone was thought to follow 
the reaction sequence cholesterol-> pregnenolone -> progesterone -> 
deoxycorticosterone -> corticosterone -> aldosterone. In 1960 Ulick 
and Solomon (see-Idelman 1978) found that in amphibian adrenal slices 
18 - hydroxycorticosterone (180HB) always accompanied an increase in 
aldosterone secretion, and a similar finding was observed in other 
species such as the rat, man, bird and reptile. In 1967 Greengard 
and coworkers ( Greengard"et al., 1967) studied the transformation 
of B by bullfrog adrenal mitochondria and found by measuring the 
carbon monoxide (CO) induced inhibition of 18- oxygenation, that 
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cytochrome P450 was essential for both the conversion to aldosterone 
and 18-OHB. The implication from these studies was that B was a 
necessary precursor for aldosterone production and required 18- 
hydroxylation before conversion to aldosterone. However, Grekin in 
1973 incubated human tumour and normal tissue with 18- 
hydroxydeoxycorticosterone (18-OHDOC) and found that tumour tissue in 
particular, could easily convert 18-OHDOC to 18-OHB and aldosterone 
and postulated an alternative precursor to B in aldosterone 
biosynthesis. Whitehouse and Vinson (Vinson et al., 1969 and 
Whitehouse et al., 1971), showed that cortisol pre-treatment of rats, 
inhibited the production of B from capsular adrenals, without 
affecting DOC, 18-OHB and aldosterone production. Further, 
labelled precursors such as acetate entered the endogenous steroid 
pool and labelled end products were produced when stimulated by ACTH 
(Whitehouse and Vinson 1973), whereas precursors after pregnenolone 
did not mix with endogenous steroid pools and were freely dialysable 
unlike the endogenous steroids. Cortisol pretreatment blocked the 
activity. of 11-t3hydroxylase, and all 18- oxygenated products were not 
dialysable, indicating the presence of tightly bound steroids in the 
alternative pathway for aldosterone biosynthesis. ACTH 
administration lifted this restraint and allowed free conversion of 
DOC to free B. In this regard they postulated that ACTH may have a 
late pathway effect in stimulating the release of DOC from bound 
components in 11-hydroxylation (see section on ACTH stimulated 
steroidogenesis). The existence of more than one pool or steroid 
has been described for the rat, bovine and guinea pig, as well as in 
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rat ovarian tissue. 
I 
In a series of studies in adrenal capsular portions from control and 
sodium depleted rats, Fattah et al 1975,1976,1977 demonstrated the 
preferential conversion of labelled steroid precursors to 180HDOC and 
aldosterone, independent of an increase in 180HB, with the 
differential suppression of B synthesis, particularly during low 
sodium status. The pathway is_delineated below: 
180HDOC ---` 180HB 
LATE PATHWAY-> DOC- ->B --> ADOSTERONE 
In more recent studies using duck adrenal slices it was found that 
the availability of B rather than 18-OHB was the limiting factor in 
the reaction kinetics for aldosterone production; In All stimulated 
aldosterone production Haning (1970) and Aguilera and Catt (1979a), 
noted that the rate of conversion of B to aldosterone was increased 
by All whereas 11-DOC to aldosterone was not, and studies by Fraser 
et al in_1981 showed that mitochondrial enzyme activity of 11-f3 
hydroxylase was not affected by All stimulated steroidogenesis. Salt 
depletion per se may also have an effect on late pathways(Fattah et 
al 1975., 1976., 1977) as may _ 
ACTH induced or cortisol blocked 
steroidogenesis as demonstrated by Vinson and Whitehouse (see above). 
55 
3.4 EFFECTS OF STIMULI ON EARLY AND LATE PATHWAY FOR ALDOSTERONE 
BIOSYNTHESIS 
3.4.1 ACTH 
It is well recognised that ACTH stimulates the early pathway of 
steroid biosynthesis in acute studies. The rate limiting step in 
steroid biosynthesis lies between cholesterol side-chain cleavage and 
pregnenolone formation. ACTH stimulates cAMP formation and it is 
this activation that is responsible for the early events in ACTH 
induced- steroidogenesis. Initially Haring et al., 1970 and Muller et 
al., 1966 were able to show that labelled precursors were 
preferentially converted to B by ACTH, in an in vitro system. Vinson 
and Whitehouse and coworkers ( Vinson et al, 1969; Whitehouse et al., 
1971, ), further showed that ACTH stimulated conversion of early 
precursors such as acetate and cholesterol to B and possibly 
interacted with later biosynthetic products such as DOC, in 
stimulating aldosterone secretion. The effect of ACTH includes a 
cAMP mediated phosphorylation and activation of a labile protein 
since prior treatment with cycloheximide in ACTH stimulated cells, 
inhibited cholesterol conversion to pregnenolone (Pederson and 
Brownie 1983). The increase in side - chain cleavage of cholesterol 
has been studied in isolated mitochondria in beef and rat adrenal 
homogenates and is paralleled by increases in heat generated type I 
and pregnenolone-induced type II absorbance changes in eytoehrome 
P450 enzymes. Late pathway effects of ACTH were first described by 
Müller et al., 1966 using [3H]-eorticosterone as exogenous precursor. 
56 
Williams and coworkers in 1972 also showed that 
ACTH induced late 
pathway conversion of B to aldosterone. 
However, it was not fully 
clarified whether in fact the availability of 
B, rather than a direct 
effect of ACTH (as well as the other stimuli 
tested) on the late 
pathway enzymes, was responsible for the effect. 
Metabolic 
inhibitors of the early and late pathways have been used 
to dissect 
out the effects of the stimuli on each part of the 
biosynthetic 
machinery. Cyanoketone acts on the early events inhibiting 
the conversion of cholesterol to pregnenolone, and aminoglutethimide 
is used to inhibit the conversion of pregnenolone to 
aldosterone. In 1979 Aguilera and coworkers, (Aguilera et al 1979a) 
studied the effects of both drugs in isolated dog and rat adrenal 
glomerulosa cells, and in both species, ACTH stimulated the early 
pathway conversion when the late portion was inhibited, whereas only 
in the rat was ACTH stimulatory on late alternate pathway. 
This alternate late pathway could not be inhibited with 
aminoglutethimide. A protein synthesis inhibitor, cycloheximide, 
inhibits All induced aldosterone production (Kramer et al 1980) at a 
late step, Le. -after pregnenoolone, it was postulated by Kramer that 
the stimulus induces the de novo synthesis of a protein (possibly 
that postulated by Vinson et al"' 1969), which promotes the 
association of B and/or DOC with'cytochrome P450 18-hydroxylase, and 
increases 18-hydroxylase activity. Puromycin, another protein 
synthesising inhibitor, also inhibits the late pathway conversion of 
B to aldosterone in the rat, whereas in the dog the effects are only 
present in the early pathway, so there may also 
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be species variation in protein induced steroid secretion at 
different loci of the steroidogenie pathway (Davis 1968). 
3. I. 2 Angiotensin II(AII) 
Previous studies have suggested that All has a dual effect on the 
steroidogenic pathway to promote aldosterone output. Muller (1966) 
and Kaplan (1965) were the first to show an early pathway effect of 
All in the conversion of labelled cholesterol to pregnenolone. More 
recent work in rat, dog and bovine adrenal tissue (Williams et al 
1972., McKennna et al )1978b., Aguilera et aL, 1979a ) showed that All 
could stimulate the late pathway conversion of B to aldosterone in in 
vitro systems. Blair West (Blair-West et a L. )1970) showed an in vivo 
late pathway effect on aldosterone production in sheep, and Aguilera 
in 1975 also showed a late pathway effect of All in vivo in the dog. 
However, as Kramer in 1980 indicated, conversion of B to aldosterone 
is not associated with an increase in 18- hydroxylase activity over a 
short exposure to All, unlike the increase in cholesterol side chain 
cleavage enzyme activity, which is induced within 5 minutes, thus the 
late pathway induction effect of All may only be of significance in 
chronic exposure to All. In this respect, chronic exposure to 
ACTH or alternatively hypophysectomy, specifically increases or 
decreases respectively, the steroid cytochrome enzyme activities, and 
chronic exposure to All may act similarly. Kramer indicated that All 
acts to increase the rate of side chain cleavage and is not inhibited 
by cyeloheximidez in the same way as'ACTH induced side chain 
cleavage reactions, thus the mechanism in increasing cholesterol 
side chain cleavage by association with the oytP450 complex, differs 
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with respect to de novo protein synthesis in the early pathway. 
3.4.3 Salt Depletion 
It was first shown in vivo that simultaneous decrease in sodium (Na+) 
and increase in potassium (K+) ion concentration in the fluid 
perfusing the adrenal gland, could increase aldosterone secretion, 
however Davis observed a similar effect by decreasing Na+ 
concentration alone in perfused dog adrenal gland (Davis et al, 1968). 
Ganong ( Ganong et a1., 1965) observed an increase responsiveness of 
adrenal tissue to All and ACTH in Na+ deficient dogs, as did Muller 
1965 in isolated rat adrenal zona glomerulosa cells when rats had 
been on 2 week Na+ deficient diets. In vitro studies with labelled 
precursors indicated to Müller et aL, 1966, that sodium ions exerted 
an early pathway effect on steroid biosynthesis. The effects of 
Na+ per se are difficult to separate from the changes in plasma and 
extracellular fluid volume in most in vivo studies, since the renin- 
angiotensin- system is activated in low salt status acting on 
aldosterone biosynthesis via an early and late pathway effect. 
However Boyd (Boyd et 23,1971) observed an increased conversion of B 
to aldosterone in Na+ depletion and/or K+ infusions over two days, 
and in studying isolated rat adrenal mitochondria Marusic in 1967 
showed that rats in short term (1 day) low sodium status, achieved a 
greater conversion of B to aldosterone (162%), increasing to 239% 
and 242% by the second and fourth day respectively, as well as an 
increased ability to convert B to 18-OHB. Williams et aL, 1972 did 
not observe this additional end product and postulated that this was 
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because 18-OHB was tightly bound to the enzyme complex or endogenous 
protein, before conversion to aldosterone and its subsequent release. 
Saruta and colleagues (Saruta et al., 1972) found that Na+ 
depletion had a late pathway effect in isolated bovine zona 
glomerulosa. It may be that Na+ may have a stimulatory effect on 
18-hydroxylase (Aguilera et a1., 1980) and/or 11 hydroxylase activity. 
3.4.4 Potassium (K'±) 
Over the past couple of decades it has become increasingly clear that 
K+ exerts early and late 
, 
y pathway effects both in vivo and in vitro. 
Muller's early in vitro studies using labelled precursors (Muller et 
al., 1966) showed K+ to have an early stimulatory influence, which 
has been supported by more recent studies in rat and bovine cells in 
isolated pathway experiments carried out by Aguilera et al., 1979a and 
McKenna et a1,, 1978a. In the latter instance the effects of K+ on the 
early steroidogenic pathway were apparent between 0-6mEgK+/l. Tait 
(1980a) demonstrated that B could activate its own conversion to 
aldosterone in the presence of albumin in the incubation medium for 
several stimuli. It was discovered that the output of B was 
proportional to aldosterone such that the ratio Aldosterone/B was 
directly proportional to the B output. However it was considered 
that aldo/B2 compared with B, would reveal more specific effects in 
the late pathway conversion, and Tait (1974) showed that 5.3 - 
5.6mMK+ was the only stimulus capable of inducing a late pathway 
conversion to aldosterone, which resulted in an increase in the ratio 
(A/B2) compared with B alone. M11 in 1980 also showed a specific 
late pathway conversion of [3H]-corticosterone to [3H]-aldosterone in 
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rats infused over a number of hours with a potassium chloride (KCl) 
solution before isolation and incubation of adrenal cells. In the 
converse situation of K+ depletion in rats, Baumann (Baumann et l. g 
1972) observed a decrease rate of conversion of [3H]-corticosterone 
to 3H aldosterone and 18-OHB. Species differences also occur in 
that Haning (Having et a L)1970) observed a late pathway effect of 
range 0-8.5mEgK+/1 in the rat, whereas Burwell (Burwell et al., 1969) 
observed a late pathway effect in dog adrenal slices over a 
concentration range of 4- 8mEq K+/l. The mechanism by which K+ 
stimulates the late pathway was investigated by several groups 
including Greengard in 1967, who demonstrated that the eytochrome 
P450 was involved in the conversion of B to aldosterone. Muller's 
studies in 1970, and more recently by Meuli and Muller in 1985, 
showed that in rats repleted. for 48 hours with K+ after a two week 
potassium deficient diet, mitochondrial cytochrome P450 absorbance 
changes were greater for B-induced type I absorbance changes as well 
as 18-OHDOC induced absorbance changes compared with 18-OHB induced 
changes. Thus, it was postulated that 180HDOC may be a better 
precursor for K+ induced aldosterone biosynthesis. Müller et al. q 
1980, also provided evidence to suggest an alternative pathway for 
aldosterone production from isolated rat studies in the conversion of 
180HDOC and 180HB to aldosterone, which was dependent on Na+ and 
K+restriotion. 
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3.4.5 Serotonin (5HT) 
There have not been extensive investigations into 5HT's early and 
late pathway effects in steroidogenesis, although in vitro studies 
are more prevalent than in vivo work. Müller (Müller et al 1965, 
1967,1968) and later, Haning in 1970, showed that in rat isolated 
zona glomerulosa cells, 5HT has early pathway stimulatory effects in 
aldosterone biosynthesis. In the first studies relating to the 
effects of rat serum on increasing B to aldosterone in rat adrenal 
slices, Müller demonstrated an early pathway effeat and labelled 
precursors such as [3H]-pregnenolone and [3H]-progesterone were not 
readily converted to aldosterone by rat serum. Later identification 
of the rat serum compound as 5HT (Müller et al., 1968) and more 
recently by Mendelsohnn (Mendelsohn et ai,, 1981), led to the postulate 
that 5HT stimulated aldosterone biosynthesis at the step between 
cholesterol and pregnenolone formation. A late pathway effect has 
also been confirmed in the work of Williams, using a high albumin 
medium (Williams et al., 1972). 
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Chapter I 
THE CONTROL OF ALDOSTERONE SECRETION 
14.1 CONTROL OF ALDOSTERONE SECRETION 
Aldosterone is the most important and potent steroid in the animal 
kingdom in regulating salt balance. It is secreted most probably by 
simple diffusion across the cell membrane of the zone glomerulosa 
cells in the outer adrenal cortex although another hypothesis 
discussed by Whitehouse and Vinson (1971) was described in chapter 3, 
and postulates a role for steroid binding protein(s) in the 
biosynthesis and secretion of endogenous steroids. 
In all animals under normal ionic conditions, aldosterone appears to 
be under multifactorial control. The most reviewed and certainly 
some of the most important regulators are ACTH, All, K+, and Na' 
balance. Other possible contenders in the regulation of aldosterone 
have included 5HT and to a lesser extent other indoleamines; over 
the past ten years or so prostaglandins, and peptides including 
atrial natriuretio factor (ANF), somatostatin, a(-MSH, pro- 
'' MSH, 
p-MSH, ý-MSH, and f3-lipotropin as well as dopamine, have all been 
implicated in the control of aldosterone secretion and will be 
discussed below. 
4.1.1 The Renin-Angiotensin System (RAS) 
Angiotensin II is a potent octapeptide which is formed when the 
enzyme renin, is released from the kidney and acts on a circulating 
plasmadC2-globulin to form angiotensin I(AI). This molecule is 
biologically inactive but on passing through the lung, is converted 
by enzymatic cleavage, to All. Thus, under normal circumstances the 
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plasma renin levels parallel the All levels and both are increased 
when the blood supply to the kidney is reduced in sodium depletion. 
Infusions of All in vivo in man, resulted in an increase in plasma 
aldosterone levels (Ames et al., 1965) and 18-hydroxycorticosteroid, 
but not the other corticosteroids. Similar studies with All 
infusions in vivo have been done for example, in sheep and dog at 
very low doses of All (10 - 40ng/ml) (Mulrow and Ganong 1961., Blair- 
West 1962., Ganong 1965) all of which, showed an increase in plasma 
aldosterone. In the rat, the role of All in aldosterone control has 
been debated since in vivo studies done on rats in sodium balance, 
(Marieb et al., 1965., Kinson et al., 1968) suggested that All was 
not an important regulator. Aguilera (Aguilera et al., 1978a) 
impressively demonstrated that in the rat, the effects of All were of 
primary importance in low sodium status - infusions of captopril (an 
ACE inhibitor) into rats on a low sodium diet, blocked the 
compensatory rise in plasma aldosterone, indicating the requirement 
of All (see later section on sodium status). An alternative 
experiment using prolonged low dose All infusions into conscious dogs 
or rats, produced the same effect in increasing the responsiveness of 
the adrenal and by extrapolation, All receptor affinity and number, 
in the salt depleted state (Aguilera et al., 1978b, 1980). Further 
studies pointed to the important role of Na+ status on the 
sensitivity and number of All receptors depending on the Na+ intake 
over a time scale of two weeks. It was seen that in rats, All 
receptor affinity and responsiveness was increased on low Na+ diets 
in rats and the converse was true for high Na"' diets after 36 hours. 
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However after ü days and longer, the affinity of All receptors and 
the initial sensitivity of the response to All, returned to control 
values, although the receptor numbers had increased on low Nay' and 
decreased on high Na+ diet. Hauger (1978) further showed that All 
is able to regulate its own receptor number as a consequence of 
changing circulating levels of All by his studies of infusion in 
conscious rats. Over a number of years, in vitro studies using 
isolated zona glomerulosa cells, have shown stimulation of 
aldosterone by All, particularly in the rat model Waning et al., 
1970., Albano et al., 1974., Tait et al., 1976., Bing and Schulster 
1977., Aguilera et al., 1979., Fredlund et al., _ 
1975). Amongst 
others, the Tait group (Tait et al., 1970., 1976) was able to show a 
specific and more potent response of zona glomerulosa cells to All in 
cells incubated in medium containing 5.6mMK+ compared to 3.6mMK+. 
In both cases, the response was significant at doses of All as low as 
2.5 x 10-10M plateauing at 2.5 x 10-8M. The rat plasma 
concentration of All has been estimated at around 5x 10"11M, thus 
the sensitivity in vitro, is in good agreement with the physiological 
levels of the peptide. Whereas the Taits achieved an 2.6 fold 
increase in aldosterone in vitro with All, Douglas et al., 1976a 
incubating the cells in medium 199 (M199) achieved a 6-7 fold 
increase in aldosterone. However, the maximal response to All was 
only half that achieved with K+ or 5HT at maximal stimulatory doses 
(for the effects of incubation medium Campbell et al., 1982 see 
chapter 6). Although it is well known that renin in the kidney is 
responsible for maintaining the circulating levels of All, Doi 
(Doi 
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at al., 1984) was able to measure renin present within the adrenal 
gland of normal and nephreotomised rats. Ryan at al., in 1967 had 
also located renin in rabbit adrenal glands and further, had found a 
higher concentration of renin in the sodium deficient rabbits as well 
as in nephrectomised rabbits. This was located specifically in the 
zona glomerulosa layer rather than the zona fasciculata and medullary 
zone. This has led some investigators to suggest that adrenal renin 
may act as local regulator of aldosterone release, particularly in 
e. g nephreetomised rats and dogs in which aldosterone levels are 
still maintained despite removal of the kidney (Palmore 1967,1969., 
McCaa at al., 1974). Indeed, there is a positive correlation 
between adrenal renin and adrenal aldosterone which would support 
such a concept. 
4.1.2 Angiotensin III (AIII) 
Angiotensin III is a metabolic breakdown product of All. It is a 
heptapeptide with the Aspartyl N- terminal removed by the adrenal 
aminopeptidase enzyme. In man, infusions of AIII have resulted in 
raised plasma aldosterone levels (Carey et al., 1978) although it 
was shown in Carey's study that AIII had only 15-30% the steroid 
activity and 11-36% the pressor activity of All in human subjects; it 
was postulated that AIII receptor mediated effects are through 
different receptor types in the smooth muscle preparation compared to 
the adrenal tissue. However, its physiological role in humans is 
not thought to be important due to its very low circulating level. 
In rats the circulating levels of AIII are higher than All and, 
studies using isolated adrenal rat zona glomerulosa tissue have shown 
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a stimulatory effect specifically on aldosterone secretion 
(Goodfriend and Peach 1975 ); AIII receptors have been identified in 
the rat adrenal cortex (Devynck et al., 1977). Aguilera and Catt 
(1979b) showed however, that AIII has only 10% the potency of All 
and this potency decreased with incubation time in isolated cells due 
to its rapid metabolism to smaller inactive peptide products. In 
vivo, the potency of AIII relative to All is more difficult to 
assess since the metabolic clearance rate (MCR) of aldosterone also 
has to be considered (Messereli et al., 1977)" Angiotensin III may 
bear more importance in pathophysiological states, such as primary 
aldosteronism, as in vivo infusions into man have demonstrated (Carey 
et al", 1979., Zager et al., 1982) an increased aldosterone 
sensitivity to AIII at lower doses compared with normal subjects. 
4.1.3 Potassium (K+) 
Potassium ions were first noted to specifically stimulate aldosterone 
secretion by Giroud (1956) using isolated rat adrenal slices. 
However the doses were supraphysiological and since then, it has been 
well established that raising the body's potassium by dietary intake, 
systemic or local adrenal-infusion, increases the aldosterone 
secretion or excretion rate. For example, K+ loading in rats (Boyd 
et al., 1971 ) caused a marked increase in the conversion of 
corticosterone to aldosterone in isolated adrenal capsules. Early 
in vivo studies in man (Johnson et al., 1957) showed that K+ depletion 
was associated with a delayed and diminished rise in urinary 
aldosterone during Na+ depletion. Several in vivo studies in dogs, 
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sheep and rats have pointed to an interrelationship between K+ 
stimulation of aldosterone and its trophio effects on the width of 
the zona glomerulosa being dependent on All , ACTH and sodium levels 
in the plasma (Pratt et al., 1982., Mazocchi et al., 1985., Douglas 
et a1.. 1978) and in in vitro studies (Fredlund et al., 1977) the 
responsiveness to both ACTH and All were dependent on the K+ 
concentration of the incubating medium. Baumber (1971) suggested 
that intracellular K+ was possibly the primary factor in the control 
of aldosterone secretion, but the theory was based on studies using 
whole adrenals. Using isolated cells, Mendelsohn (Mendelsohn et 
alp 1975) found that manipulation of intracellular K+ levels or 
inhibition of the influx of K+ with ouabain, did not affect the 
aldosterone biosynthesis induced by physiological stimuli. 
Potassium levels are subject to variation in several instances 
including Postural changes, sex differences and even mild muscle 
activity. Insulin administratation and/or depletion of glucose can 
alter K+ and aldosterone levels in the plasma (Fraser et al., 1979). 
What is known is that plasma K+ levels probably provide the best 
indicator of K+ status, but it's action at the level of the adrenal 
is not wholly known. However, chronic studies carried out by 
Douglas (Douglas et al., 1976b) showed that infusions of potassium 
chloride (KCl) over 1 to 6 weeks into rats on normal Na+ status 
altered the number of All receptors without an increase in PRA and 
hence All levels; further studies over three days of KC1 infusions 
(Douglas et al., 1980) showed that All receptor affinity was increased 
by increasing plasma K+ concentrations (c. f. the work of Aguilera et 
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al, 1978b for Na+ status and All receptor characteristics). 
Although Na+ depletion had previously been shown in rats to affect 
the secretion rate of aldosterone, and increase the width of the zona 
glomerulosa as well as the conversion of corticosterone to 
aldosterone a similar finding was shown with K+ loading (Dean et 
al, 1948p Boyd et al., 1971, Mazzochi et al., 1985). With the 
exception of 5HT, K+ is the only known stimulus specific to the zona 
glomerulosa cells (Tait et al., 1972, Haning et al, 1970, Albano et 
al.,, 1974). The effects of increasing K+ concentrations in vitro 
have been extensively investigated by Haning, Tait, and Bing and 
Sehulster (Haning et al., 1970, Tait et a1., 1972, Bing and Sehulster 
1977). In these studies the maximal aldosterone secretion was 
repeatedly obtained at 8.4mMK+ with further doses being inhibitory. 
Other groups including Fakunding (1979) using isolated cell systems 
incubated in M199, have found a plateauing of the potassium response 
at 13 - 15mM K+. Braley and Williams found maximal aldosterone 
secretion at 18mMK+, whereas Marusie, found 12mMKf to be the 
optimum concentration for aldosterone secretion (Braley and Williams 
1977, Marusic et al., 1967). Although these levels of K'' are not 
achieved in vivo the significance of the aldosterone response to K+ 
being dependent on the composition of the incubating medium are 
interesting and will be discussed later. 
4.1.4 ldrenocortieotrophio Hormone (ACTH) 
Many studies both in man and rat, sheep, ox, dog and duck have shown 
that acute infusions of ACTH stimulates the secretion of aldosterone 
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Fig 4.1 
POMC derived peptides : mRNA precursor molecule 
Putative 7- MSH ACTH(1-39) 0- LPH (42-134) 
Signal Peptide / 
(N - terminal) 
a -M SH CLIP 
7- LPH ß- Endorphin 
(1-13) (18-39) (42 -101) (104 -134) 
B -MSH Met -Enkephalin (84-101) (104-108) 
(amino acid numbers in parenthesis) 
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whereas long term administration of ACTH in sheep for example 
(Blair-West et al. 1963) has either no effect, or an inhibitory 
effect on aldosterone secretion. ACTH is thought to act as a 
permissive factor in the control of aldosterone, for example in 
hypopituitary patients the responsiveness to other regulators of 
aldosterone is attenuated by ACTH removal (Williams et al., 1971). 
Similarly in hypophysectomised rats the in vitro responsiveness of 
the zona glomerulosa cells was not as great in normal sodium status 
compared to control, and was even more blunted in the Nay' deficient 
state. (Palmore et al., 1969,1970, Müller et al., 1976. ). 
In vitro studies by Tait (Tait et al., 1970,1976, ) showed that in 
static and perfused adrenal glomerulosa cells ACTH was able to 
acutely stimulate aldosterone secretion whereas the effects on 
perfused zona faseiculata cells were more prolonged. Mulrow et 
al_Lin 1961, showed that in haemorrhaged dogs the removal of ACTH by 
i, 
hypophysectomy 
also removed the augmentation of aldosterone 
secretion. 
A hypothesis has been presented that ACTH by increasing the blood 
flow to the adrenal arteries and ramifying capillaries, causes 
increased vascularisation with time, and it is this increase in blood 
supply that causes cellular hypertrophy as opposed to hyperplasia. 
It is well recognised that ACTH is derived from a large precursor 
peptide molecule (POMC) produced in the pituitary gland of several 
animal species, however the relative importance of POMC-derived 
peptide in the control of aldosterone secretion is not yet fully 
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established (see Fig. 4.1). 
(L-lipotropin andl_MSH both stimulate 
aldosterone secretion in the rat (Matsouka et al., 1981) although 
Pederson et al., 1980a using synthetic porcine f3- LPH did not find 
any stimulatory effect of this, and several other pituitary fragments 
including, o M5H, synthetic human ýS- endorphin. In vivo fS-endorphin 
specifically stimulated aldosterone secretion in the 
hypophysectomised-nephrectomised dog, without affecting cortisol 
levels (Gullner et al., 1983). The fact that higher concentrations 
of endorphin are present in the dog pituitary compared to the rat 
may point to a species specific concentration dependent variability 
that in turn dictates its importance in aldosterone secretion; P- 
endorphin has also been found in the monkey, and beef pituitary 
glands. 
Vinson t al.. 1980 showed convincingly that o(- MSH had a marked 
stimulatory effect in isolated rat zona glomerulosa cells. It was 
also pointed out that the levels of 0(-MSH are elevated in the pars 
intermedia region of the rat pituitary in salt depletion, so that its 
physiological role may be of importance in varying sodium status. 
However Whitehouse (Whitehouse et al., 1982) could not show a change 
in pt MSH levels in rats on low salt diets, although the in vitro 
sensitivity (defined in this paper as a change in the lowest dose of 
peptide required to elicit a response) of zona glomerulosa cells to 
the peptide was increased (Vinson et'al., 1983). The circulating 
concentration of p, MSH in rats has been estimated'at 10-10M. In 
normal rats this is not enough to stimulate corticosterone from the 
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zona glomerulosa and inner cortical zones; however in the Na* deplete 
rat the sensitivity of the aldosterone response to 
- MSH approaches 
the circulating levels, so that the low Na+ state increases the 
sensitivity of the adrenal zona glomerulosa to this peptide in vitro 
as shown by, Vinson et al., 1981,1983 and in vivo in 
hypophysectomised rats as demonstrated by Shenker et al., 1985. In 
the latter cases-MSH specifically increased plasma aldosterone 
levels to normal in hypophysectomised rats compared to intact rats on 
low salt diets. They postulated thata(-MSH may in part be involved 
in regulating aldosterone levels during low salt status since low 
salt also increases the concentration of o- MSH in the pituitary. 
That D(MSH may act through its-own specific receptor was suggested by 
Vinson et al 1984 in studies done on isolated rat zona glomerulosa 
cells. Using a series of synthetic analogues to p(-MSH, including 
[Nle4, D-Phe7]- -MSH, and the naturally occurring peptide fragment 
MSH, they were able to show thato(-MSH unlike the other two peptides, 
increased aldosterone secretion by interaction with a receptor of 
differing steric requirements to the other peptides. However more 
recently Baumann 1986 showed that 0(MSH was not specific to the zona 
glomerulosa and using a series of 0(MSH and melanotropie peptides 
suggested that the Phe7, Tryp9 sequence, which is common to these and 
the ACTH molecule, may indicate an interaction with a low affinity 
ACTH receptor, which would be in keeping with Vinson's findings that 
MSH at 10SM increases cAMP, possibly through interaction with the 
ACTH receptor. 
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Beta LPH (LPH) is the other major peptide fragment derived from the 
precursor molecule POMC, and can be further degraded to several 
peptides including ' -LPH (42-101), and 13 -endorphin (104-134). 
Gamma LPH can be further digested to P -MSH (84-101), and met- 
enkephalin within the P -endorphin sequence. Both theta- and 0(MSH 
peptides, - share a common amino acid sequence, and may have some 
potentiating effects on aldosterone biosynthesis. Notably, both 
peptides show an enhanced responsiveness to salt depletion in the rat 
(Vinson et al., 1983, Yamakado et al. 1982). Beta LPH was first 
isolated from ovine pituitary glands and Matsouka (Matsouka et al., 
1980) showed that rat capsular cells as opposed to decapsular cells, 
were stimulated to secrete aldsoterone by human and sheep derived 
LPH (10-9M-10-7M). Cortieosteröne was also stimulated in capsular 
preparations but the effects were not cyclic AMP mediated, thus not 
all pituitary fragments appear to stimulate through ACTH-cAMP coupled 
receptors. 
The combined molecular weight of ACTH and ß-LPH only accounts for 
1/3-1/2 the molecular weight of the whole 
(precursor 
mRNA sequences, 
but'Nakanishi in 1979 also identified an amino acid sequence 
occurring at the N-terminal portion of the pro-hormone, preceeding 
the ACTH sequences and followed by basic amino acid sequences 
involved in a common peptidergic cleavage reaction. It was named X- 
MSH and is contained within a 16 kilodalton (kDa) fragment. Gamma 
MSH was identified and sequenced from extracts of bovine pituitaries 
using mRNA to probe the amino acid sequences (Nakanishi et al., 1979) 
0 
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and the naturally occurring petide was also identified in frozen 
human pituitary glands as a 77-amino acid fragment and called pro-? 
'- 
MSH. Pederson et al., 1980a, 1980b, incubated isolated rat zona 
glomerulosa cells with several peptides of ACTH derivation including 
a 16kDa fragment derived from the N-terminal end of POMC. Only the 
16kDa fragment was able to stimulate aldosterone secretion when co- 
incubated with ACTH. Although it was originally thought this 
effect could be due to ACTH contamination, Al-Dujaili et al., 1981a 
using superfused zona glomerulosa cells from the rat , was also able 
to show that pro-ý-MSH could potentiate the response to ACTH, but the 
cells needed to be primed with the peptide before the potentiating 
effect was seen. They argued that this was due to the prerequisite 
stimulation of protein synthesis. By adding aetinomyosin to the 
cells beforehand, the potentiating effect of pro-- MSH was lost. 
Pederson had previously shown that in stressed rats another hormone 
apart from ACTH was responsible for the activation of cholesterol 
ester hydrolaxe, and later work showed that the 16kDa fragment in 
hypophysectomised rats in vivo, was able to activate this enzyme. It 
remained for Pederson (1980b) to synthesise a 
X-MSEI with a further 15 
amino acids added to the C- terminal region that acted identically to 
the l6kDa fragment in potentiating the effects of ACTH on aldosterone 
secretion in vivo in the hypophysectomised rat model. In human 
adenoma tissue the 
ý3-MSH peptide also potentiated the effect of ACTH 
in vitro ( Lis et al., 1981). Pederson most recently (Pederson et 
al., 1986) used isolated human aldosteronoma cells to further 
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investigate the mechanism of aldosterone secretion in the zona 
glomerulosa cells. The aldosterone response is very sensitive to 
doses as low as 10-12M '-MSH and measurement of free cholesterol 
levels within the cytosol have given further credence to the 
suggestion that '-MSH activates cholesterol ester hydrolase (Pederson 
et al., 1986). -_ 
More recently however, Griffing et a1., 1985 has measured the levels 
of pro-X MSH in IHA patients, and found a positive correlation with 
aldosterone levels and pro4-MSH levels. Despite in vitro evidence 
that pro j-MSH can specifically potentiate the effects of ACTH in 
isolated rat adrenals (Al-Dujaili et a1., 1981) the role of this and 
other ACTH precursor molecules in essential hypertension and IHA is 
not clear. Further, in Carey's study (Carey et al 1984) 
dexamethasone treatment did not, prevent the rise in plasma 
aldosterone in IHA, which would suggest that MSH of pituitary source 
at least, was not involved. Despite this, it must be pointed out 
that other sources of these various peptides have been localised to 
the pars-intermedia and it is known that in the rat, there is both 
serotoninergic and dopaminergic input to this area that may regulate 
the release of the peptides. 
Beta LPH ( P-LPH) was shown by Matsouka et al", 1981, to increase 
aldosterone secretion in rat zona glomerulosa cells together with /3- 
MSH (part of the P-LPH sequence). However neither peptide caused 
any apparent increase in cAMP levels. ß -MSH contains the 
heptapeptide sequence (Met-glutamic acid(Glu)-histidine(His)- 
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phenyl al anine (Phe)-arginine(Arg)-tryptophan(Tryp)-glyeine(Gly)- 
common to ACTH and this may explain the peptide core sequence 
requirement for aldosterone stimulation in some species. In the 
same in vitro rat studies, Matsouka 1981 was not able to show a 
stimulatory effect for -endorphin, a peptide fragment derived from 
the C-terminal of the ý-LPH molecule. P -endorphin is 
pharmacologically the most potent endorphin and in hypophysectomised- 
nephrectomised dog it had a potent stimulatory effect in perfused 
adrenals (Gullner and Gill 1983), whilst the smaller cleavage product 
derived from P-endorphint met-enkephalin, had no stimulatory effect 
in the dog or rat (Matsouka et al., 1981). There may be species 
differences in the potency of these peptides. In this regard both 
j- andJ_MSH have been shown to have mitogenic effects in foetal rat, 
rabbit, sheep and human adrenal tissue; for example, Challis et al., 
1977 showed that in rabbit foetal tissue there was an increased 
sensitivity to C- MSH when the foetal adrenal was not responsive to 
ACTH, which gradually declined as ACTH responsiveness increased. 
These changes were paralleled by a changing content of MSH in the 
pituitary as described above. 
d-LPH, 
which is derived from LPH, is 
also thought to have aldosterone stimulating properties. It is 
derived from the r')-MSH sequence as opposed to the P-endorph in 
sequence, which in the rat has no stimulatory effect. 
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4.1.5 Sodium Status 
A correlation between Na+ status and aldosterone secretion was first 
observed by Leutscher and Axeirad 1954 and is now well established in 
a variety of animals. How Na+ acts to alter aldosterone secretion 
has not been completely elucidated. In vivo studies have shown in 
man, dog, sheep and rat a parallel activation of the RAS system 
during Na+ depletion and the opposite eff eat during Na+ loading 
(Douglas et al 1978b, Aguliera et al., 1978a, Blair-West et al., 
1963, Davis 1968) and as indicated above there is also an 
interrelationship between Na+ status and K+ concentration. Williams 
et al., 1971 tried to isolate the effects of Na+ ion changes from K"' 
changes in the blood and study the effects of these changes on the 
response to All and ACTH infusions in man. It was suggested that 
Na* principally controls and maximises the sensitivity of the adrenal 
response to All and ACTH and more recently Dawson-Hughes 1981 
demonstrated, again in man that the plasma aldosterone response to 
All, was steeper in low Na+ status compared to the effects of 
prolonged low dose infusions of All, in concordance with the earlier 
work by Oelkers et al., 1975; thus, indicating that in addition to 
the change in sensitivity to All, Na+ per se has a potentiating 
effect. 
Although All does have an important role in Na+ status there are 
reports of an increase in aldosterone levels in low Na+ conditions 
without an increase in renin and All e. g. in the nephrectomised rat 
and dog studies (McCaa et al., 1974, Pratt et al., 1981). 
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Aguilera 1980 also showed that in low Na* status (4 days), plasma 
aldosterone, side chain cleavage enzyme activity, 18-hydroxylase 
activity and All receptor number in the rat model, were more markedly 
increased than circulating All levels alone in normal Na* balance, 
indicating a potentiating effect of Naf on all these parameters. 
Hypophysectomised- nephrectomised dogs on low Na' diets, did not have 
a compensatory increase in plasma aldosterone compared to 
nephrectomised dogs with intact pituitary glands ( McCaa et al., 
1974). It has also been inferred by studies done in man, that Na+ 
per se or factor(s) activated in low Na+ status (possibly pituitary), 
may interact with the RAS system in increasing the respone to All 
infusions. Oelkers and coworkers (Oelkers et al., 1975) and Dluhy 
(1972), showed that in man, prolonged low dose infusions of All in 
normal Na+ states , only partially reproduced the effects of bolus 
infusions of All in increasing the sensitivity of the plasma 
aldosterone response in low Na+ status. In clinical studies 
patients with panhypopituitarism were unable to increase plasma 
aldosterone on low sodium diets compared to control patients although 
the RAS system remained intact (Williams et al., 1971). This 
suggested that other factors as well as All are important in low 
sodium status. 
f 
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I. 2 OTHER POSSIBLE LOCAL AND HUMORAL FACTORS 
4.2.1 Aldosterone Stimulating Factor (ASF) 
Aldosterone Stimulating Factor (ASF) is a relatively newly identified 
glycopeptide of anterior pituitary origin. Originally it was 
isolated in human urine extracts (Sen et al., 1981a, ) and found to 
have potent aldosterone stimulating properties in vitro in a variety 
of species including rat (Sen et al 1981b), cat and rabbit. It may 
also be responsible for the potentiating effects of low sodium in 
nephrectomised dogs and rats with an intact pituitary (McCaa et 
a11974, Palmore et al., 1969 see above). 
In the clinical syndrome, idiopathic hyperaldosteronism (IHA) a 
tentative role for ASF has also been suggested; Biglieri et al-9 
1984 suggested that the increased responsiveness and thus elevated 
levels of aldosterone could be related to an increase in ASF in the 
pars intermedia. Patients with IHA had elevated. ASF levels compared 
to control and adrenal hyperplasic patients . 
4.2.2 Atrial Natriuretio Factor (ANF) 
Early work by Anderson et al" 1959 pointed to an inhibitory effeet 
of atrial extracts on aldosterone secretion in the dog. More 
recently, Atarashi et a1,, 1984 using rat atrial extracts, showed that 
the extract did indeed inhibit basal aldosterone secretion in in 
vitro rat adrenal cells and further, the dose respone to All or ACTH 
was inhibited. The granularity of the atrium decreases in salt 
loading and increases after adrenalectomy, indicative of possible 
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interaction between aldosterone levels i. e. increased release and 
inhibition of aldosterone secretion in the volume expanded/salt 
loaded state , and the converse in the salt depleted /low volume 
state, which would support the inhibitory in vitro findings. Maki et 
al., 1984 deduced the. amino acid sequence of the atrial natriuertic 
factor using complementary DNA (cDNA) techniques; the precursor 
peptide consists of 128 amino acids. The molecule is trypsin 
sensitive, since treatment with the enzyme abolishes it's inhibitory 
effects. 
There are two peptides,. Atriopeptin I and Atriopeptin II of 21 and 23 
amino acids respectively,. which are derived from the precursor 
molecule 20,000-30,000 kDa. Chartier et al., 1984 and Maki et al., 
1984 both showed that synthetic ANF. (Arg101-Tyr126) later, called ANF 
48-73, were the important regions of the peptide in producing 
inhibitory effects on the dose response to All, K+ and ACTH,, in rat 
zona glomerulosa cells. Studies of isolated bovine adrenal cells 
and superfused adrenal glands have shown no effect of ANF on basal 
aldosterone production, and only a slight inhibition of the All dose 
response (Frisina et a1", 1986 ) Like other studies, these 
conflicting results may be a consequence of species differences 
and/or the cell system used to investigate the effects. In the 
pathophysiological state, an interesting observation has most 
recently been made by Cappueio et al,, 1986 who demonstrated that in 
normal subjects loaded with high salt, and then administered a 
mineralcorticoid analogue, f ludrocortisone, sodium retention 
81 
increases in the first 24 hours after administration of the steroid. 
Thereafter, the 'escape' phenomena in which Na+ excretion equals Na+ 
intake despite high mineralcorticoid plasma concentrations over the 
same time period, is associated with an increase in circulating ANF 
levels. They suggested that ANF may be important in augmenting this 
natriuretlo 'escape' effect both in this experimental model and in 
patients with hyperaldosteronism where the escape effect is relevant. 
ANF receptors'have been identified in crude rat adrenal capsular 
preparations with a high binding affinity KA 0.1nM and low capacity, 
comparable to those found in the vasculature (Schiffrin 1985). 
Similarly, ANF binding sites have been found in bovine adrenal zona 
r 
glomerulosa cells (DeLean et al., ' 19814a). ' Despite ANF's non- 
specific inhibitory effects on stimulated aldosterone secretion, it 
could not be displaced by other peptides such as-AII from its binding 
site, or by several calcium receptor blockers, indicating that it 
does not act via a non-specific calcium channel to block stimulated 
steroidogenesis. 
4.2.3 Oxytocin (OXT) and Vasopressin(LVP) 
Ang et al., 1984 after having discovered oxytocin and AVP in the 
intermedio-lateral grey columns of the spinal cord in humans decided 
to look for these compounds in the adrenal medullary tissue of rat, 
man and human phaeochromocytoma tissue. The intermedio-lateral 
grey columns are the site of location for pre- ganglionic neurons in 
the sympathetic nervous system, including the adrenal medulla so the 
possibility existed that these peptides were neurotransmitters for 
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any post-ganglionic connections to the medulla. By the use of 
several techniques including radioimmunoassy (RIA), high performance 
chromatography (HPLC) and histochemistry, Ang was able to measure 
large quantities of both OXT and AVP in the adrenal. Oxytocin 
appears to occur in larger amounts with concentrations in the range 
19.9-162.2pg/g compared to AVP of 9.8-103pg/g" Both values are 
markedly greater than the corresponding free plasma levels measured 
of 1.3-3. lpg/ml for OXT, and 1.9-3.8pg/ml for AVP, suggestive of an 
endogenous source for both substances within the adrenal gland. 
Nicholson et al", 1984 found by RIA measurement similar ratios of 
both compounds in human foetal adrenal tissue. Swansons group 
(1980), suggested that there may be a neuroendocrine link between the 
paraventricular nuclei of the hypothalamic region, and the adrenal 
i. e. possible afferent and efferent nerve fibres. Ang and 
coworkers working on this assumption and the role of OXT and AVP in 
this connection, performed electrolytic lesioning to the 
paraventricular nucleus (PVN) area in rats but this did not change 
the existing concentrations of the peptides in the adrenal. By 
another approach, Nussey et al., 1984 looked at the concentrations of 
AVP in the plasma, pituitary , adrenal and the hypothalamus of normal 
and Brattleboro rats. These rats are genetically different in that 
they do not have AVP in the hypothalamus and thus, are unable to 
conserve water. Despite this defect, it was found that both types 
of rat had approximately the same amounts of AVP in the adrenal, thus 
there appears to be a dissociation of PVN and adrenal contents of 
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AVP, which would argue against a neuroendocrine connection for this 
peptide at least. The possibility therefore exists of endogenous 
synthesis and inter-relationships with the cortex and medulla. In 
this regard, there have been suggestions that both peptides may 
influence the secretion of catecholamines from the medulla and 
therefore affect the secretions of the corticosteroids (see section 
on catecho lamines). AVP can influence the metabolic turnover of 
norepinephrine, and oxytocin directly depresses the activity of pre- 
ganglionic sympathetic neurons in the spinal cord. As well as these 
interactions, specific binding sites for AVP have been located in a 
crude capsular membrane preparation in the rat (Balla et al. ' 1985). 
These receptors have high affinity and low capacity and correlating 
with this, isolated perfused zona glomerulosa cells treated with 
increasing doses of AVP (10-8M-10-6M) synthesised more aldosterone 
over a2 hour period, although similar concentrations of AVP in a 
static system had no effect (Payet et al., 1982). In 1984, Payet 
suggested that AVP in the long term, may act as a local growth factor 
since similar results were found using cultured zona glomerulosa 
cells, and so the possibility remains that one or both peptides may 
have multiple functions in the maintenance of growth in the cortical 
regions and the modulation of cateoholamines and steroid interactions 
in the medullary regions (see also functional zonation of the adrenal 
gland). 
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42.4 Cateeholamines 
The adrenal medulla contains large quantities of epinephrine within 
its chromaffin granules, and smaller amounts of norepinephrine. 
Norepinephrine is commonly associated with the post- ganglionic 
neurotransmitter in the sympathetic nervous system although both 
amines have wide neurotransmitter functions. Indeed, histochemieal 
studies in both normal and transplanted sheep adrenals, have shown 
sparse post-ganglionic aminergic innervation which enters the adrenal 
gland with the supplying arteries which may represent another 
potential source of catecholamines in the gland. Within the 
adrenal gland, the cateeholamines exert a regulatory influence on 
steroid biosynthesis and in particular, the secretion of 
glueocortieoids. In the emergency state, catecholamines increase 
the synthesis and release of glucocorticoids from the zona 
fascieulata and the close interaction of the cortical and medullary 
zones are thought to be facilitate this role. In the zona 
glomerulosa, both norepinephrine and several analogues including the 
isomers isoproterenol(-), alprenolol(-) and the (+) isomers at lower 
" potency, are able to stimulate aldosterone secretion with an increase 
in cyclic AMP levels (DeLean et al ", 1984b). These effects are 
mediated through P-1 receptor types as defined in vascular tissue, 
however binding sites have not been investigated to correlate with 
the steroid data. 
IV 
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4.2.5 Histamine 
Histamine was found to stimulate aldosterone secretion in 
hypophyseotomised-nephreotomised dogs by Aikawa et al., 1979, which 
provided some evidence that histamine may have a direct effect on the 
I 
adrenal gland. More recently, Edwards et al., 1980b performed in 
vitro and in vivo studies in the rat and man respectively. In 
their in vitro studies, using isolated, perfused rat zona glomerulosa 
cells, the effects of histamine antagonists, rather than the agonist 
itself, were investigated. Using the H2 antagonists, eimetidine 
and ranitidine, they were able to elevate aldosterone basal 
production and selectively block the aldosterone response to All. 
The H1 receptor antagonist, chlorphenhydramine, enhanced the 
aldosterone response to ACTH and All. In vivo treatment of subjects 
with the H2 antagonist eimetidine, blocked the aldosterone response 
to furosemide without affecting plasma renin levels (PRA). Both 
types of study suggest the possible existence of a type H2 receptor 
interaction with All receptors in the zona glomerulosa cells. 
4.2.6 Prostaglandins 
Prostaglandins are a series of lipid based compounds of ubiquitous 
nature. They are sub-divided into a several types. 
Flack et Al., 1969 were the first workers to show a stimulatory 
effect on aldosterone secretion in vitro using rat zona glomerulosa 
cells and type E1, E2 and F1c( -prostaglandins. However, Spat et a1, 
1975 was only able to show a stimulatory effect of the type E 
prostaglandins in Na+ depleted rats. A role for prostaglandins in 
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the Na+ deplete state has been suggested by Morise et al., 1982 in 
which subjects infused with indomethaein and captopril, were 
compared with subjects treated with captopril alone in the Na+ 
deplete state; the former group did not show an exaggerated response 
to ACTH compared with the control or captopril group. Thus, they 
postulated that prostaglandins may mediate in part, the increased 
responsiveness of the adrenal to ACTH in the sodium deplete state. 
However the results of prostaglandins do not always follow a logical 
pattern and indomethacin has also been shown to block the effects of 
All in vitro. Recent reports have also claimed a role for type A 
prostaglandins in aldosterone secretion possibly augmenting the 
increased responsiveness of glomerulosa cells in the sodium deficient 
state. 
4.2.7 Somatostatin 
Immunohistochemical studies have shown that somatostatin exists 
within the zona glomerulosa and Aguilera (Aguilera et a1", 1982) has 
recently reported the existence of somatostatin binding sites in the 
rat glomerulosa cells. Somatostatin inhibits aldosterone secretion 
in rat adrenals but not in the dog, and receptor sites have not been 
found in this species or in human and monkey tissue. Thus, like 
other stimuli the effects are species dependent. Aguilera and 
others have argued that it is the release of dopamine, which under 
certain physiological conditions stimulates the release of local 
stores of somatostatin in the adrenal cortex and may be the primary 
regulator of somatostatin release. 
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4.2.8 Dopamine 
The dopamine antagonist, Metoolopramide (MCP), has been shown to 
enhance aldosterone secretion in vivo in man (Edwards et al., 1980a, 
Carey et al., 1976,1980, Norbiata et al., 1977, Brown et al., 
1977) on normal sodium diets without concomittant increases in PRA, 
ACTH or plasma K+ and this led investigators to postulate that 
aldosterone is under maximum tonic inhibition by dopamine in the 
normal sodium state. Edwards (Edwards et al., 1980a) using infusions 
of dopamine in an in vitro rat cell system, showed that the 
stimulatory effects of MCP were specifically blocked by dopamine, 
whereas the All stimulated aldosterone response was not. However, 
since these earlier studies, there seems tobe convincing-evidence 
that dopamine may interact with All , in differing Na+ states. 
Aguilera et al., 1984, infused All with (MCP) in rats on high Na+ 
diets and showed an increase in the sensitivity of the aldosterone 
response to All in, this situation, comparable to aldosterone levels 
found on normal salt intake. Thus, MCP appeared to derepress the 
possible dopaminergic inhibitory effects existent in the sodium 
replete state. Gordon et al., 1983, was able to show a similar 
derepression in humans. Conversely, infusions of dopamine in human 
subjects, together with All, prevented the increase in sensitivity to 
All normally seen in low Naf status (Edwards et al. 21975, Aguilera et 
al., 1984). In keeping with its possible physiological role during 
changes in sodium status, Alexander et Al., 1974, found that urinary 
dopamine excretion increased in sodium repletion within minutes of an 
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increase in extracellular volume and Carey It a_ 1., 1981, found a 
decrease in plasma and urinary dopamine in sodium depletion. 
Dopamine receptors have been found in rat (Dunn at al., 1981) tissue, 
and have even been subclassified as type D2 in rat and D1 in calf 
adrenal tissue (Bevilaequa at al", 1982). More recent studies using 
specific dopamine antagonists have been carried out by Missale et 
al., 1985,1986 in which the rat dopamine receptor types have been 
classified as DA1 and DA2 as opposed to type D1 and D2 receptors 
found in the brain. Both adrenal DA receptors are cyclic AMP linked, 
DA1, stimulating aldosterone and DA2, inhibiting aldosterone 
synthesis. DA2 receptors have therefore been assigned an important 
Physiological role in the adrenal cortex since dopamine inhibits 
aldosterone release in some experimental studies, both in vivo and in 
i` o. The origin of this dopamine is still highly speculative. 
Edwards (1980a) direct studies on zona glomerulosa cells and the 
studies by Wilson at al. 1983, in which ganglionic blockade of the 
autonomic nervous system did not prevent the direct effects of MCP 
infusions in man, suggest that in these species at least, dopamine is 
locally active. ' Indeed dopamine has been localised in the adrenal 
chromaffin granules of several species including the rat (Racz et 
al., 1974, McCarty 1984, Hannah et al., 1984), although it is also 
postulated that dopamine is not endogenous and is rather taken up and 
deconjugated of its sulphate moiety from the circulation (Van Loom 
1980). 
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4.2.9 Serotonin (5H? ) 
Like potassium, 5HT specifically stimulates aldosterone biosynthesis 
in the zone glomerulosa. Rosenkrantz in 1960, was the first to 
investigate the effects of exogenous 5HT on steroidogenesis using 
rabbit adrenal slices. His work included reports on specific 
structural requirements for the 5-OH group in aldosterone secretion. 
Structure-activity relationships have since been carried out by 
Muller et al.., 1968 and Al-Dujaili et al., 1981a. Muller showed that 
5HT is a potent stimulus in rat adrenal cells but the potency is 
species dependent. The, physiological importance of 5HT as a possible 
humoral agent in aldosterone biosynthesis was also studied by Muller 
t al., 1967 using isolated rat adrenal cell incubates. Rat serum 
induced aldosterone release, which could be inhibited by the 5HT. 
antagonist, methysergide. In earlier work by Bakker et al., 1960, 
rat serum was able, _to stimulate aldosterone release 
but the effects 
were not completely blocked by dihydroergotamine, and it was not 
thought-that the full effeet was 5HT mediated. Similarly, 
Mendelsohn et al, 1981 showed a similar effect of human serum on 
isolated rat glomerulosa cells but the effects were greater than 
those due to 5HT. Groups such as Haning et al., 1970; Albano et 
al., 1974; Tait et al., 1972,1975; Bing and Schulster et al., 1977 
and Shaikh et al., 1984,1986, have shown significant stimulatory 
effects in isolated zona glomerulosa cells. Early in vivo effects 
were less convincing and failure to produce significant effects on 
aldosterone release were attributed to uptake into blood platelets. 
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Since then direct stimulatory effects in both man and the rat have 
been reported Mantero et al., 1979, Al-Dujaili et al., 1980). 
Indirect evidence with important implications were reported by 
Maestri et al., 1985 . In this study, infusions of MCP, known to 
stimulate aldosterone secretion (see above), was infused after prior 
treatment three hours before, with a specific 5HT antagonist, 
pizotifen. The reasoning behind this protocol being that if MCP is 
acting as a 5HT agonist rather than a dopaminergic antagonistic to 
stimulate aldosterone release, this would be blocked by the 5HT 
antagonist. Aldosterone alone was blocked, whilst the effects of 
MCP on prolactin release were intact. '' The possible serotonergic 
effects of another dopamine agonist, bromocriptine, was studied in 
superfused isolated rat adrenal cells by Edwards et al.,, 1979 who 
showed that the dose response to 5HT and All could be blocked by this 
drug, suggesting therefore, that the effects in part of previous 
dopamine related drug studies may be accounted for by the 5HT 
involvement. A less clear cut but still significant result on the 
effects of ketanserin, a 5HT type 2 receptor antagonist was made by 
Mantero et aL, 1985, in which plasma aldosterone levels in patients 
with idiopathic aldosteronism were reduced by administration of this 
drug (see also Introduction). 
The case of hypersecretion of aldosterone in man in idiopathic 
aldosteronism is an interesting one. Originally it was 
subclassified with Conn's syndrome in which there is hypersecretion 
of aldosterone as well as adrenal hyperplasia. However, in 
91 
idopathio hyperaldosterism (IHA) there is hypokaleamia, and no 
significant variance in sodium concentrations in the whole body or 
plasma , unlike Conn's syndrome. Padfield et al.,. 1981, Griffing 
et a1., 1985, and others, have pointed out that IHA is better 
categorised into a continuum of the essential hypertensives in which 
there are low resin levels and an increased sensitivity in response 
to All and ACTH infusions in human subjects. 
Gross et al., 1981 and Mantero et al., 1985, using cyproheptadine and 
ketanserin, were able to show a drop in aldosterone levels in IHA, 
indicating some serotonergic involvement. Shenker et al. " 1985 
using peripheral blockers of the conversion of 5-hydroxytryptophan 
to 5-hydroxytryptamine, demonstrated a central involvement in man, of 
5HT and/or its precursor, in stimulating aldosterone release. The 
essential amino acid tryptophan itself or conversion to 5HT, was 
shown by Modlinger et al., 1979 to increase aldosterone, renin and 
cortisol secretion, thereby perhaps increasing stimulatory activity 
of ACTH-like peptides from regions such as the pars intermedia. 
Indeed, Jones and co-workers (Jones et al., 1977) showed that 5HT 
co-incubated with rat hypothalamic tissue could selectively stimulate 
the release of CRF, suggestive of a possible central involvement of 
5HT in adrenal steroid secretions. Corticotrophin-releasing factor, 
is involved in release of the large precursor molecule POMC, and has 
also been shown to be released by administration of 5HT precursors 
including 5HTP in vivo in the rat (Petraglia 1984), and this in turn 
increased the release of POMC peptides into the general circulation 
92 
within two hours of administration of 5HTP. The effects of 5HTP 
could be inhibited by the 5HT antagonist, methysergide, and lend 
credence to the hypothesis that 5HT may have an indirect regulatory 
effect through pituitary factors, in increasing aldosterone secretion 
(Petraglia et al., 1984). Thus, 5HT may have both central and 
peripheral involvement in aldosterone secretion and part of this work 
goes some way in determining its role in aldosterone control and 
secretion. 
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Chapter 5 
RECEPTORS AND MESSENGER LINKS FOR STIMULI OF STEROIDOGENESIS 
MECHANISMS OF ACTION OF ALL STIMULI IN STEROIDOGENESIS 
5.1 ACTS 
Schulster and Schwyzer (1980) reviewed the effects of ACTH and 
derivatives and concluded the sequence 1-39, in the ACTH peptide, can 
be divided into particular functional regions which may vary in 
different cell types. However it is the N-terminal amino acid 
sequence 1-24 which contains all the biological activity and within 
this subdivision sequence 1-4 is the potentiator sequence, 5-9 the 
message sequence which stimulates cAMP and steroidogenesis, and 11-23 
the address sequence. ACTH acts on plasma membrane surface 
receptors exemplified by studies using ACTH molecules that were 
chemically linked to inert polymers thereby'precluding entry into the 
cells (Grahame-Smith 1967), but still induced steroidogenesis. Lee 
et al., 1980, and Bristow et al., 1980 examined the effects of ACTH 
peptide fragments and antagonists including the use of a biologically 
inactive ACTH fragment, corticotropin inhibiting fragment (CIP)- 7-38 
ACTH (Lee et al., 1980) which inhibited the steroid response at doses 
dissociated with the inhibition of CAMP. ' Bristow (1980) showed that 
ACTH 1-39 stimulated steroid and cAMP production , whereas ACTH 5-24 
stimulated steroid output independent of cAMP. Further to this 
work, Bristow demonstrated a difference in inhibitory constants for 
the ACTH antagonist, ACTH 6-24 for ACTH 1-39 binding compared to ACTH 
5-24 binding, and suggested that two receptors for ACTH exist. 
However, Buckley et al., 1981 suggested the existence of one type of 
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receptor with calcium and CAMP playing interrelating roles in 
steroidogenesis ; Sehulster and Schwyzer (1980) postulated that CAMP 
at basal or even elevated levels needed to be 'guided' into 
physiologically important compartments for eliciting steroidogenesis. 
Thus, despite the early studies by Grahame-Smith (1967) indicating a 
role for cAMP in steroidogenesis, its primary importance as messenger 
in steroidogenesis has been questioned. Despite conceptual arguments 
that cAMP is in fact compartmentalised and that intracellular 
measurements would not indicate a change at lower ACTH doses, Tait et 
al., 1980 and others, have argued that another second messenger is 
involved. A major candidate for this role is undoubtedly Cat+. 
Birmingham (1953) was the first to propose that extracellular Ca2+ 
was needed for ACTH- stimulated steroidogenesis and others have 
substantiated this. Podesta et al., 1980 showed that Ca2+ alone 
under certain experimental conditions could mimic the effects of ACTH 
in stimulating steroidogenesis, however the Ca2+ ionophore A23187 
only weakly increases steroidogenesis indicating that other mediators 
besides Ca2+ may be important. In this regard Shima et al., 1979 
using fasciculata cells, showed that ACTH stimulated cAMP at greater 
levels in the presence of higher extracellular Cat+. It has been 
suggested that extracellular Ca2+ is important in the coupling of 
ACTH to cAMP formation, since at low Ca2+ concentrations the maximal 
response to ACTH was reduced and the ED50 for ACTH was increased 
(Fakunding et al., 1979). This was in contrast to the effects of 
Ca2+ on the ED50 for cholera toxin or 5HT stimulated steroidogenesis 
0 
95 
Fig 5.1 Stimulation of Phospholipid Metabolism 
I Phospholipids 
Phospholipase A2 
I Arachidonic Acid 
Lipoxygenase Cycloxygenase 
pathway pathway 
PGG2 -=-º PG1 
Leukotrienes 
F PGH2 ----` Thromboxane A2 (TBXA 2) 
PGE2 PGD2 PGF2a 
.......................................................... a 
Arachidonic Acid 
`_ Second messenger 
lonophoretic PGI2?? -º cAMP (3rd messenger) 
effects 
(Ca 2+ mobilisation) 
96 
which did not change (see below). In contrast, Shima et al., 1979 
suggested that intracellular Ca2+ was important in coupling the ACTH- 
cAMP-aldosterone output. An important role for extracellular Ca2+ 
was discovered by Cheitlin et al., 1985 for association and increased 
occupancy of ACTH receptors. 
The phospholipase-prostaglandin system may also be important in 
mediating the steroidogenic effects of ACTH. ACTH induces a Ca 
2+ 
dependent increase in phospho lipase A2 activity and prostaglandin 
synthesis formed from the precursor, arachidonic acid in the 
cyclooxygenase pathway. The Prostaglandins include PGF2 < and 
PGE2 both of which have been isolated in the perfusate of ACTH 
stimulated cat and rat adrenals or cells respectively (Laychock and 
Rubin, 1977). Arachidonic acid and/it's metabolites can either mimic 
or act as negative modulators of a primary stimulus. The other 
products of arachidonic acid metabolism are formed through the 
lipoxygenase pathway and are called the leukotrienes (see Fig. 5.1). 
Unlike the prostaglandins, they are potent ionophores and could be 
involved in mobilising intracellular Ca2+ stores in ACTH stimulated 
steroidogenesis. Indeed, products of arachidonic acid metabolism, 
and particularly the leukotrienes, have been implicated in the 
control of ACTH-stimulated steroidogenesis in the rat model (Jones et 
;. al", 1986). 
Saruta and Kaplan (1972) reported that prostaglandins require Ca2+ 
for steroid production, and aldosterone biosynthesis was increased by 
prostaglandins; Morise et al., 1982 showed that prostaglandins play 
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a role in ACTH stimulated steroidogenesis in humans in low salt 
status. Cyclic AMP is also increased in response to PGA1, PGF1 and 
PGF2, and provided Ca2+ is present, these prostaglandins increase 
cholesterol side-chain cleavage. The B series prostaglandins, have 
similar effects as the E series at lower doses, but it is well 
recognised that different doses have different effects. Rubin et 
al., 1977 had observed that PGE2 could induce an increase in cAMP 
and cGMP in bovine adrenal cells and that the cGMP preceded the cAMP. 
This in turn preceded PGE2 formation, which is Ca2+ dependent because 
phospholipase A2 activity requires Cat+. There is also evidence that 
phospholipase A2 and phospholipase C activity may be indirectly 
linked since metabolites of phospholipid turnover, stimulate 
phosphoinositol (PI- general abbreviation) hydrolysis and 
reacylation; conversely, diacylglcerol a product of PI hydrolysis, is 
rich in arachidonic acid and is a precursor for arachidonic breakdown 
products, obtained through phospholipase A2 activity. 
The possible importance of this process lies in the hypothesis that 
arachidonic acid and reacylation may be important in altering 
membrane lipid dimensions and thus, affect internal Ca2+ 
mobilisation and/or adenylate cycalse activity in stimulus-secretion. 
Phospholipase C is also activated by Cad and is responsible for 
removing the polar head group from a phospholipid and thus increases 
phosphatidic acid, which Farese et al., 1981,1983 in early studies, 
suggested as being important in steroidogenesis. Since then, new 
theories have been expounded, most notably by Rasmussen and Barrett 
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(1984) in which Ca2+ has been implicated in two important roles, one 
of which included PI hydrolysis and subsequent diacylglycerol and 
inositol triphosphate (InsP3) formation - see later sections. 
Phosphatidylinositol (PtdIns) and its phosphate derivatives, 
phosphoinositol 4,5 - biphosphate (PtdIns (1,5)P2) and 
phosphatidylinositol 4-phosphate (PtdIns 4P) are components of plasma 
membranes . and 
have a high level of turnover when stimulated by some 
extracel lular messengers. Although Ptdlns turnover may be closely 
linked to receptor occupancy, it may not be associated with receptor 
stimulation. Michell (1977) hypothesised, that PI may be responsible 
for Ca2+ gating, and Rasmussen and Barrett (1984) have already 
stated that Ca2+ messenger systems may involvePtdIns hydrolysis. 
The products of PI hydrolysis include diacylglycerol, which is rich 
in arachidonic acid and is thought to play an important role in 
mobilising intracellular pools of Ca2+ not bound to mitochondrial 
stores (see section on AID; and other metabolites include inositol 
triphosphate (InsP3) and less importantly inositol biphosphate 
(InsP2). InsP3 causes the release of Ca2+ from intracellular 
stores, in particular the endoplasmio reticulum where specific 
binding sites for InsP3 have been identified; diacylglycerol 
modulates C-kinase enzyme activity.,, The C-kinase forms a branch of 
the Cat+-linked stimulation response and includes a series of enzymes 
wholly dependent on Ca2+ for their, activity in eliciting a 
physiological response. Diacylglycerol may act as a fusogen in 
exocytotic processes (Fig 5.2) but in the steroid secreting cells 
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it's more important function may lie in its sensitization of protein 
kinase C to free Ca2+ levels in the cytosol, and this enzyme in turn 
is responsible for the phosphorylation of proteins (Takai et al., 
1985). Phosphorylation of diacylglcerol with production of 
phosphatidic acid has also been postulated to act as a endogenous 
ionophore, and thus-alter membrane permeability to calcium. In 
contrast, prostaglandins produced from phospholipid breakdown, 
stimulateadenylate cyclase and do not have ionophoretic 
characteristics. It is more than likely that the endogenous levels of 
prostaglandins and/or phosphatidic acid, reflect a situation where 
they interact with other messengers in potentiating a response. The 
other branch of-the Ca2+ chain requires Ca2± to. modulate and activate 
Cat+-calmodulin dependent phosphodiesterase activity. 
5.2ANGIOTENSIN II (AII) 
The intracellular, mechanisms which mediate the effects of All are 
uncertain, although Albano et al., 1974, suggested, that All 
stimulated cAMP production in the zona glomerulosa cells of the rat. 
Later work discussed by Tait et al., 1980, suggested that the effects 
of All on cAMP were probably a result of impurities in the 
preparartion rather than a direct result of All. In Tait's studies 
(Tait et al., 1974,1975,1980), cAMP did not change at all doses of 
All used (10-10 M- 10-7 M). Other groups, (Shima et al., 1978, 
Fujita et al., 1979), were not able to show an increase in cAMP 
levels in either, the rat or dog zona faseiculata or zona glomerulosa, 
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over a range of doses 10 -11 M- 10 -5 M even in the presence of the 
phosphodiesterase inhibitor, theophylline. In Shima's study, levels 
of cAMP were reported to decrease in response to an increased 
phosphodiesterase activity. Calcium has been postulated as the 
most important, if not sole regulator, in All steroid production. 
Shims et al., 1978 showed that in isolated rat cell preparations, 
decreasing the extracellular Ca2+ concentration or introducing a Ca2+ 
antagonist such as lanthanum, verapamil or tetracaine, blocked the 
response to AII. Fakunding et al., 1979, further showed that the 
decrease in extracellular Ca2+ decreased the maximal output to All 
stimulation, without affecting the ED50 response and the same was 
seen for potassium and 5HT stimulated steroidogenesis (discussed 
below). All binding was also not affected by Ca2+ in contrast to 
ACTH receptor binding (see above). Braley et al., 1984, using an 
intracellular calcium dye QUIN 2, was able to show a parallel 
increase in fluorescence of the dye with increasing intracellular 
Ca2+ concentrations, together with an increase in All stimulated 
steroidogenesis. There has been speculation as to whether All 
increases steroidogenesis by an increase in Ca2+ influx, or efflux, 
caused by intracellular Ca2+ redistribution. Williams et al., 1981, 
showed that pre-incubation of rat zona glomerulosa cells with 
45Ca 
followed by stimulation with All, increased the eff lux of Cat+, which 
would tend to suggest that All is responsible for a redistribution of 
Ca2+ within the cell. In contrast however, Elliott et al., 1981, 
observed an decrease in 
45Ca influx into bovine adrenal zona 
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glomerulosa cells, but an immediate increase (2 min) in Ca2+ levels 
intracellularly, parallel with an increase in aldosterone secretion. 
Thus, to include all the accumulated data on Ca2+ mobilisation would 
be to include the hypothesis that All receptor interaction controls 
the movement of both intra- and extracellular Ca2+ in the zona 
glomerulosa cells. It has already been seen that All stimulates 
phosphodiesterase activity, possibly the reason for the lowered 
levels of cAMP observed in Fujita's study (Fujiita et al 1979), and 
this enzyme activity modulation has also been related to an 
association of a Ca2+ binding protein, calmodulin, that acts as an 
intracellular Ca2+ receptor. It is thus conceivable that All 
receptor interaction could increase calmodulin- Ca2+ binding, and 
this in turn could modulate Ca2+ dependent forms of phosphodiesterase 
activity (Koletsky et al., 1983). Indeed, calcium-calmodulin 
dependent phosphodiesterase is known to exist in the adrenal and is 
activated by increases in free cytosolic calcium. Hence, the levels 
of Ca2+ and cAMP could be critical and determined in All stimulated 
steroidogenesis, by the tuning up of Ca2+ mechanisms and the tuning 
down of cAMP mechanisms. Most recently studies carried out by 
Kojima et al., (1984) demonstrated the importance of Ca2+ in 
eliciting the two phased aldosterone response (described above 
Rasmussen (1984)), in perifused bovine zona glomerulosa cells treated 
with All. They found that the aldosterone response could be divided 
into an initial transient phase component that was specifically 
dependent on the increase in free cytosolic calcium induced by 
initial hormone receptor 
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interaction; the same acute response could be induced by addition of 
the Ca2+ ionophore, A23187 instead of All. However, the initial 
interaction of All with its receptor induced changes in PI hydrolysis 
caused by the activation of phospholipase C through extracelluar Ca2+ 
entry into the cell. An increase in PtdIns(1,5)P2 turnover oceured 
with the resultant increase in InsP3, which is important in inducing 
the release of Ca2+ from non-mitochondrial pools. As stated before,, 
increases in free cytosolic Ca2+ are required for the initial 
calmodulin dependent transient phase of the response. The prolonged 
Cat+-dependent phase is dependent on the production of diacylglycerol 
and InsP3 which in turn modulate and sensitize the C-kinase enzyme 
(present in the cell cytosol), to cytosolic Cat+, both in the initial 
transient phase of the response when intracellular Ca2+ levels are 
increased and later when the levels of Ca2+ reach a maximum and then 
begin to decline, but the enzyme remains sensitive and active even at 
the lower concentrations of Cat+, thus inducing the prolonged AII- 
induced steroidogenic response phase. Confirmation of this latter 
effect was established by looking at the effects of the compound, 12- 
0-tetradecanoyl phorbol 13- acetate (TPA) which when added to 
perifused adrenal cells alone, induced the sustained phase of the All 
response curve. TPA is thought to act specifically on the C-kinase 
branch of the Ca2+ response curve (see Kojima 1984) in the same way 
as InsP3 and diacylglycerol, sensitizing the enzyme to cytosolic 
Cat+. 
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5.3 POTASSIUM W) 
Early in vitro experiments showed that K+ stimulated steroidogenesis 
included an increase in cAMP levels, and this occurred at higher 
doses e. g. at 3- 6mMK+ (Boyd at al., 1976. ); 3.6-6.4 mMK+ (Albano et 
al., 1974); 3-8.4 mMK+ (Tait at al., 1980) and the latter group did 
not observe an increase in cAMP levels at other doses of K+. Tait 
at al., 1972 also showed that cells incubated in the presence of a 
high dose of CAMP, and increasing doses of K+, showed an additive 
effect of K+ with cAMP on steroidogenesis, although this was not 
apparent at doses greater than 8 mMK+. They suggested that at lower 
doses of K+, steroidogenesis is mediated by a cAMP independent 
mechanism, and at 8 mMK+, cAMP is the common mechanism of action. In 
contrast, Fakunding It al., 1979, and Fujiita et al., 1979, using 
isolated zona glomerulosa cells, did not detect an alteration in cAMP 
levels in response to increasing K+ stimulated steroidogenesis. 
Further, changing the extracellular concentrations of Ca2+ affected 
the maximal response to K+ and All without affecting the ED50 of 
stimulated steroid production. It was also observed in Fujita's 
experiments, that there was a lack of additivity in steroid output 
when cells were incubated with K+ and All together and both sets of 
observations suggested, that both stimuli share a common mechanism of 
action involving Cat+. Mackie et al., 1978, had observed an 
increase in Ca2+ eff lux with increasing doses of extracellular K+, 
although in similar experiments using prelabelled calcium (45 Ca2+) 
undertaken by Williams et al., 1981, an increase in 
45 Ca2+ efflux in 
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zona glomerulosa cells was not observed in K+ stimulated cells. 
Despite the early attempts to include an important role for 
intracellular K+ in steroidogenesis for some if not all stimuli, 
(Dluhy et al., 1972., Mendelsohnn et al 1975), later studies by 
Mendelsohnn et al., 1981 using isolated rat cells and measuring 
intracellular K+ after stimulation, have not proved succesful in 
furthering this hypothesis. 
The role of phosphinositol hydrolysis, or the PI response (see above) 
has received increasing credence as a modulator in All and K+ 
stimulated steroidogenesis. Indeed, Farese (1981)demonstrated that 
both stimuli increased the incorporation of 32 P phosphate into 
phosphatidic acid and phosphoinositol. It was postulated that both 
stimuli increase PI hydrolsis but All stimulated sterodogenesis was 
more resistant to EGTA treatment than K+ stimulated steroidogenesis, 
which tended to suggest differing mechanisms of action. More recent 
evidence has supported this theory as-Kojima (1985) demonstrated 
using bovine adrenal zona glomerulosa cells perifused with 8mMK+. In 
these studies it was seen that intracellular Ca2+ levels increased 
upon stimulation with 8mMK+, causing a transient phase aldosterone 
response which was further modulated and sustained by an increase of 
cAMP levels rather than InsP3 or diacylglycerol seen for AII- 
stimulated steroidogenesis. Thus, in this case only the calmodulin- 
dependent branch of the Ca2+ chain was involved in the initial phase, 
with cAMP playing a modulatory role in the latter sustained phase of 
the steroid response. 
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5.4 SEROTONIN AND RECEPTOR TYPES 
The physiological role of 5HT and the existence of multiple receptor 
sites are controversial but need to be explained in some capacity to 
allow'further-understanding of a possible receptor-mediated 
steroidogenie response in the zona glomerulosa. 
A wealth of`both pharmacological and physiological data has 
accumulated that points to the existence of multiple 5HT receptor 
sites, which are discussed below. 
In brain tissue, `5HT has been identified as a neurotransmitter and 
the anatomy of the major serotonergic pathways established. With the 
advent of label led molecules , L3 H]-5HT and L3 H]-LSD 
in the first 
instance, have been used to differentiate 5HT receptor sites. 
Binding studies have been performed using a series of agonists or 
antagonists for displacing the labelled molecule, in order to measure 
the KI values, or the concentration of the drugs required to reduce 
the maximal effect of the agonist by 50%. 'This has produced a series 
of standardised values in brain tissue, that characterise the 
receptor type, and can be employed to identify other 5HT binding 
sites in various tissues, since these values are constant and 
independent of the tissue type. The terminology of serotonin-S1 or 
5HT1 binding sites was introduced by Peroutka and Snyder in 1979, and 
are' preferentially labelled by (3H)-5HT and (3H)-LSD. They bind 5HT 
at nanomolar concentrations; exhibiting a Kd in the nanomolar range. 
Type 1 receptors have higher affinities for indole agonists, compared 
with type 2 receptors (described below), and' lower affinities (in the 
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micromolar range) for classical 5HT antagonists. In recent studies 
employing labelled ligands, neurolepties, ? -blocking agents and 
antidepressants, Nelson (Nelson et al., 1980a), proposed that type 
1 5HT sites labelled with [3H]-5HT were in fact an average measure of 
[3H]-5HT to ,a series of type 1 receptors. He proposed that 5HT1A 
binding sites exist, which bind spiroperidol and [3 H]-5-HT. Hoyer 
in 1985, further proposed the existence of three pharmacologically 
different 5HT1 recognition sites: 5HT1A which show high affinity for 
8OHDPAT and spiroperidol; 5HT1B which shows high affinity for RU 
24969 andf-blockers; 5HT1C which is also labelled with [3H]- 
mesulergine and is particularly concentrated in the choroid plexus of 
the rat. and pig brain. In the latter case, these receptors are 
closely analogous to type. 2 receptors in that they too, are labelled 
with [3H]-mesulergine, but 5HT has a higher affinity for type 1 
receptors, and type 2 receptors are differentially labelled with 
[3H]-ketanserin. In general, type 1 receptors appear to predominate 
in all brain regions with the exception of the cerebral cortex where 
the same numbers of type 1 and 2receptors are found. Type 2 
receptors are labelled with [125 I]-LSD and [3 H]-spiperone. 
(Peroutka and Snyder et al., 1979), but with the arrival of [3H]- 
ketanserin, more specific labelling and binding to 5HT2 receptors 
has become possible (Leysen et al 1981). Further, all known 5HT 
antagonists (cyproheptadine, cinanserin, mianserin, ketanserin, 
methysergide, metergoline... ) bind with nanomolar concentration to 
these receptor sites, whereas the 5HT agonists bind with micromolar 
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affinity, and other neurotransmitters such as dopamine, gamma-amino 
butyric acid GABA, noradrenaline, histamine and acetylcholine, 
virtually do not bind to this site. The highest levels of type 2 
receptors are localised in the mammalian cerebral cortex and caudate. 
Various behavioral models using small animals, have indicated that 
the binding affinities for the compounds used, in displacing 
ketanserin and other type 2 agonists from 5HT2 receptors, are in 
close agreement. with the values obtained in inhibiting tryptamine and 
5HT induced clonic seizures of the forepaws in rats, or mesulergine 
induced head twitching in rats (Niemegeers et al., 1983). Type 2 
receptors are thought to mediate the centrally localised functions. 
It is important to mention that receptor binding studies should 
correlate with physiological observationsas seen above; further, a 
change in receptor number and/or sensitivity would concede a 
physiological role and in this instance, administration of 
antidepressants in rats carried out by Peroutka et al., 1980,. 
indicated a reduction in 5HT2 receptor binding as well as reduced 
density of. sites. Chronic treatment of rats with tricyclic 
antidepressants, such as amitrityline, which inhibits 5HT and 
noradrenaline reuptake-into nerve terminals, was found to reduce 5HT2 
receptor sites, but this down regulation follows a slow time course. 
(2 - 3weeks), which, may match the. delayed onset of the therapeutic 
efficacy of the drug in depressed patients. This has led to a 
tentative hypothesis for increased supersensitivity of 5HT2, receptors 
in depressed patients that may in part be responsible for their 
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symptoms. Conversely, lesioning of 5HT neurones and depletion of 5HT 
content, for example by intracerebral administration of the toxin 5,7 
dihydroxytryptamine into rats, produced supers ensitivity and 
increased binding of [3H]-5HT in rat brain membranes when 5HT levels 
were reduced (Nelson et al., 1978). This was related to an 
increase in the density of these receptors, thus a form of up 
regulation (as seen for All receptors and ACTH receptors) appears to 
exist for 5HT receptors. 
The effects of 5HT in the vasculature are complex; they include 
venular constriction, ateriolar dilatation, venous and arterial 
contraction of smooth muscle and thus the net effect in a given 
vasculature is determined by the balance between vasodilatation and 
vasoconstriction. In addition, 5HT has been shown to amplify the 
responses to other stimuli in the vasculature (see below). 
In vitro studies have demonstrated that there are marked differences 
in sensitivity in various vascular beds to 5HT, both within the same 
species and in differing species. As an example, Van Neuten et al., 
1981, showed that the ED50 values for 5HT in several canine vessels, 
ranged from 0.3nM in the basilar artery to 960nM in the gastrosplenic 
vein and in the rat aorta the ED50 was 6000nM, however the ED50 alone 
does not characterise the receptor type but rather the concentrations 
of antagonists and agonists required to displace the binding of 
labelled ligand, which under ideal conditions should correlate with 
the affinity constants of drug-induced physiological effects. 
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Serotonin induces contraction in several vascular beds including 
canine basilar arteries, rabbit aorta and femoral artery , rat caudal 
artery, cat tracheal and bronchial smooth muscle, and the perused 
hindquarter of the rat (Cheng et al., 1980., Peroutka et al., 1982, 
Cohen. et al., 1981, Stol lak et al., 1982., Van Neuten et al 
1981,1982a, 1982b., Chand 1981., Black et al 1981., Leysen 1982). In 
most vessels the constrictor effects can be antagonised by 5HT 
antagonists, which cause a parallel shift to the right in the dose 
response to 5HT, without affecting the maximal response; the 
antagonist ketanserin, has been shown to specifically block the 
contractile and vasodilatory ef£eats of 5HT-in a number of vascular 
beds despite differing sensitivities to 5HT (VanNeuten et al 1982a, 
1982b., 1983), in for example the rat caudal artery, and the arteries 
and veins of the dog and rabbit. Ketanserin blocks the effects at 
lower doses compared to methysergide, as seen in canine vasculature 
comparing the two drugs (Van Neuten 1981). Methysergide also has 
undesirable agonistic properties. Van Neuten showed that type 2 
receptors exist in the rat caudal artery and gastroplenic artery of 
the dog whereas in the cainine basilar and carotid artery the effects 
of. ketanserin antagonism were not as clear cut (Peroutka et al, 
1982)., 1 "1 - 
In, vascular tissue, it is generally agreed that 5HT interacts with 
type 2 receptors. In addition Van Neuten et al., 1981, observed 
that in rat caudal artery, 5HT. potentiates the response to low doses 
of norepinephrine induced contraction and that this could be 
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inhibited by ketanserin at low doses, indicating that type 2 
receptors are responsible for the amplification effect; in the rabbit 
femoral artery, 5HT amplifies the effects to other noradrenergic 
agents including All, histamine, and prostaglandin F2. c, < 
(Van 
Neuten et al 1982a) and this amplification effect was specifically 
inhibited by low doses of ketanserin and not affected by 
methysergide. Ketanserin inhibited the response at similar 
concentrations, regardless of the agonist used, which suggests that 
type 2. receptors are involved; in contrast, the rabbit ear artery 
constricts on. treatment with low doses of 5HT and norepinephrine, but 
the effect is, blocked by phentolamine, an 0 antagonist, indicating an 
interaction of 5HT with preceptors in some vasculature beds, 
including canine saphenous vessels (Black et al., 1981. ) 
In regard to 5HTs interaction with o(-receptors, Fozard (Fozard et 
al ", 1983b), has argued; that. the antihypertensive effects of 
ketanserin are due to it's interaction with o(Ireeeptors , however 
even at low intravenous, doses of. 10mg/ml Wenting (Wenting et al., 
1984), and others were able to show an attenuation of high blood 
pressure with patients on ketanserin. treatment and with efferent 
sympathetic lesions, that excluded the 0(-components of 
vasoconstriction. It is conceivable that 5HT interacts with both 
type 2 receptors and p(-receptors to augment the hypertensive state, 
but may also beýspecies dependent.. 
Other types of 5HT receptors that do not fit neatly into an 
identified receptor type include the pre-synaptic 5HT receptor 
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effects, which include an inhibition of norepinephrine release from 
postganglionic noradrenergio nerves. This pre-junctional effect of 
5HT is different from the receptor types classified, but may also be 
present in rabbit basilar artery and rat vas deferens (Hay et al., 
1982). ''Other types of serotonergic interactions with tryptaminergic 
specific receptors, have been characterised in brain tissue using 
[3H]- tryptamineeas ligand (Cascio and Kellar 1982), which allow 5HT 
stimulated effects; similarly in the rat Fundus, tryptamine and a 
number of other indoleamines, have been shown to exert their effects 
through serotoninergic receptors overlapping p_ receptor types, e. g. 
the sensitivity to tryptamine can be maintained in the rat fundus 
even when the response to 5HT is blocked by phenoxybenzamine, a non- 
competitive antagonist (Cohen et al. ', 1985); other reported 
indoleamine interactions with possible physiological relevance are N- 
Acetyl 5HT which interacts with 5HT receptors. This amine can also 
be detected in large amounts in brain tissue (Niles et al., '1983). 
Other'indoleamines that show high potency in the vasculature such as 
5-methoxytryptamine, and also in adrenal steroidogenesis (Muller 
1970., Al-Dujaili 1982), may also interact with uncharacterised 5HT 
receptors, or with type 1 or 2'reeeptors; however, - the field remains 
unexplored as yet. 
5.5 5HT RECEPTOR 'MECHANISMS OF STIMULATION: ADRENAL AND OTHER TISSUES 
In relation to 5HT stimulated steroidogenesis, 5HT receptor sites in 
the adrenal have so far, not been extensively, investigated. Albano 
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et al. 71974 showed however, that at 
high doses of 5HT, i. e. 10"4 M, an 
increase in cAMP was detected. Similarly, Tait et al., in 1975, 
noted an increase in cAMP with higher doses of SHT, although the 
steroid output was appreciable at the lower doses of 5HT (10-8 M) 
when CAMP was not significantly elevated. A noteworthy observation 
made by the Taits (1975), was that incubating cells with a high dose 
of exogenous cAMP and adding increasing doses of 5HT (10-9M -10'4 M), 
caused potentiation of the steroid response at 10-9 M and appeared 
to be maximal at all other doses with cAMP present. In this 
respect, lower doses of 5HT may stimulate steroidogenesis without the 
involvement of CAMP. Over a dose range of 10-8 M-10-5 M 5HT, Fujita 
(Fujitaet al., 1979) also observed an increase in cAMP levels. 
Further, Wiliams 1981 noted in studying Ca2+ efflux in zona 
glomerulosa cells stimulated by ACTH, All, potassium and 5HT, that 
5HT did not cause Ca2+ efflux in contrast to All, which suggested 
that 5HT mediated steroidogenesis did not markedly elicit steroid 
secretion by mobilising intracellular [Ca2+i. Fakunding (1979) was 
able to demonstrate in isolated rat and dog zona glomerulosa cells, 
that altering extracellular Ca2+ concentrations affected the maximal 
response to All, K+ and 5HT. stimulated steroidogenesis without 
affecting the ED50. Further, Ganguly (1985) also demonstrated an 
inhibition of the steroid response to 5HT with verapamil, again 
indicating an important role*for Cat+. It may be that Ca2+ in this 
case is specifically required for the initial calmodulin_dependent 
phase of the response, since it is already known that both ACTH- and 
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K+- induced steroidogenesis includes this Ca2+ dependent phase as 
well as cAMP in the sustained steroid response phase (Kojima 1985). 
Thus5,5HT may also follow this mode of stimulating steroidogenesis 
although there may also be a clear dissociation between the two modes 
and could be interpreted to suggest several receptor types. The 
response could be linked to a heterogenous group of 5HT receptors 
present in the adrenal cortex some of which are cAMP linked and/or 
Ca2+ linked. 
V 
0 
The mechanisms of stimulation through different 5HT receptors has 
been investigated in several species and most commonly in brain 
tissue e. g. in rat hippocampus the 5HT1A receptor. has been linked to 
cAMP production with a rank order potency of 
5-carboxamidotryptamine > 80H-DPAT = 5HT (Royer 1985). Fillion 
(1978)-obtained 5HT stimulation of brain adenylate cyclase in the nm 
range; other evidence has suggested that 5HT receptors are linked to 
guanine nucleotides which often reflects an association with 
adenylate cyclase since GTP is capable of binding to two distinct 
proteins, Ns which stimulates adenylate cyelase, and Ni that inhibits 
the enzyme. Guanine nucleotides decrease the binding of [3H]-5HT to 
5HT1 receptor sites but not the binding of [3H]-spiroperidol to type 
2 receptors. However as often is the case, the results are not 
clear cut and Titeler (1984) showed that GTP reduced the binding of 
5HT agonists to [3H]-ketanserin type 2 receptor sites and postulated 
a modulatory role for GTP which was linked to adenylate cyclase 
activation. 
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Nelson (1980. ) was able to demonstrate in rat brain tissue, that 5HT 
receptors that bound [3H]-5HT could either be linked to adenylate 
cyclase or be completely dissociated from the complex. Enjalbert 
et al., 1978 also found adenylate cyclase linked 5HT receptors in 
brain regions of new born rats with a Ka = 1µM for CAMP production. 
However, 5HT1 receptors that are linked to adenylate cyclase have not 
been associated with any clear physiological role except perhaps in 
Peroutka's-study in which 5HT1 receptors identified by ligand 
binding studies, were associated with canine vasculature 
vasoconstrictions (Peroutka-et al., 1982); here the cAMP levels were 
not looked. at so it is not known whether this bears any relevance as 
a second messenger. 
Type 5HT2 receptors have been linked to a Cat+-PI role. For 
example, in platelets prelabelled with 32 P, stimulation of 
aggregation with 5HT produced-a parallel increase in 32 p, 
incorporation into phosphatidic acid formation. The Kd for 5HT 
binding to the 5HT2 receptor was found to be 3x10-7M comparable to a 
Ki of phosphatidic acid formation of 3x10-7M; the latter value was 
determined by comparing the order of potency of 5HT antagonists in 
inhibiting phosphatidic acid formation, to the potency of antagonists 
in inhibiting [3H]-ketanserin binding to type 2 receptors in rat 
brain prefrontal cortex tissue (de Courcelles et al., 1985). A 
similar coupling of PI hydrolysis to type 2 receptors, has been 
described in primary cultured embryonic rat frontal cortical cells 
(Geaney et-al ,, 1984). While it is tempting to assume that these 
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receptors are directly linked to PI hydrolysis, it must be borne in 
mind-that in platelets, ADP, epinephrine and the ionophore A23187, 
all stimulate PI hydrolsis, and can all be blocked with a 
cyclooxygenase inhibitor. These agents stimulate phospholipase A2 
activity and arachidonic production. The metabolites of arachidonio 
acid stimulate PI turnover as diagrammed (Fig. 5.2) so it is possible 
that 5HT's stimulation of PI is an indirect effect of arachidonic 
acid metabolism. However, Conn et al., 's study 1986 in rat cerebral 
cortex showed that 5HT stimulated PI'turnover was not blocked by 
inclusion of cyclooxygenase inhibitors such'as indomethacin, or 
lipoxygenase inhibitors such as*BW755C, and followed a pharmacology 
of PI hydrolysis similar to-that in the rat aorta (Roth et al., 
1981{). Conn"concluded that 5HT could directly stimulate receptor 
mediated phosphoinositide hydrolysis. Indeed, diacylglycerol, a 
product of PI turnover is rieh in arachidonic acid and could provide 
a suitable substrate for leukotriene production rather than through a 
direct result of phospholipase A2-activation, since it is not fully 
established whether this- enzyme is directly activated by hormone 
interaction or indirectly through phospholipase C activation 
(Rasmussen and Barrett 1984). , In 'adrenal zona glomerulosa cells 
Farese (1981,1983) looked in particular at the effects of K+9 All and 
ACTH on PI turnover and in the limited studies with 5HT, they 
observed that 5HT, like All and K+, specifically increased the 
hydrolysis of phosphatidylinositol, which paralleled the increase in 
steroid output. These observations indicate a possible cAMP 
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independent role of receptor occupancy or one in which Cat+-PI 
mediated response are coupled to a CAMP response as indicated above. 
However, they do not prove that the PI hydrolysis per se is a 
prerequisite for steroid production. To date, the only direct 
linkage between PI hydrolysis and Ca2+ induced secretions for 5HT, 
has been seen in the salivary gland of the blow-fly (Berridge 1979). 
In experiments that involved reducing the PI content of the plasma 
membrane, the reduction in PI hydrolysis was associated with a 
reduced stimulation of salivary secretions. 
Prostacylin, a product of arachidonic acid metabolism via the 
cyelooxygenase pathway (see Fig. 5.1) has also been linked to type 2 
receptor stimulation. Coughlin (1984) looked at cultured bovine 
aortic smooth muscle cells, and showed doses of 10-7 M5HT-10-5 M 5HT 
caused an increase in prostacylin production in a dose dependent way 
which was Caz+ dependent. This would be the case in which 
phospholipid breakdown requires Ca2+ dependent phospholipase A2 
activity to produce arachidonic acid, the precursor of prostacylin. 
That similar receptors may exert their stimulatory effects on 
steroidogenesis is possible given that Ellis (1978) observed that cat 
adrenocortical cells could be stimulated to secrete steroid by 
increasing doses of prostacylin. ACTH is known to stimulate 
prostacylin production, so that a possible interaction between cAMP 
and prostacylin could exist. Prostacylin particularly at higher 
doses'(10-6M), can also increase cAMP levels, so whether it may act 
as' second messenger and cAMP as 'a third messenger in ACTH and indeed 
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in 5HT stimulated steroidogenesis, is speculative. 
5HT, receptors linked to Ca2+ channels have been described in the 
neurones of the species, A1 sia (Corrent et al., 1978., Pellmar et 
al., 1979). Serotonin induces a Ca2+ current which allows for 
neurotransmitter release at the post-synaptic nerve terminals. In 
other tissues where pre-synaptic 5HT receptors have been described 
(as above), - it is possible that 5HT is closely associated with a Ca2+ 
channel, in this regard PI hydrolysis may control Ca2+ gating as 
Michell(1977) has hypothesised. In the vas deferens, 5HT induces 
both phasic and rhythmic contractions of the vessel walls. The 
phasic component can be completely abolished by methysergide whereas 
the rhythmic component is blocked by Ca2+ channel blockers including 
nifedipine and verapamil, which might be associated with 5HT-Ca2+ 
channel interactions (Hay et al., 1982). 
In adrenocortical cells, Ganguly (1985) showed that verapamil, a 
slow Ca2+ channel blocker, inhibited 5HT stimulated steroidogenesis 
but whether the effects are due to a Ca2+-PIlinked receptor or Ca2+ 
channel per se with concomittant activation of Ca2+ influx, is not 
clear. However the overall conclusions appear to be that 5HT 
mediated steroidogenesis requires Ca2+ at some point beyond the 
initial binding site interaction, in order to modulate the magnitude 
of the response. Caution must also be made in using Ca2+ blockers 
in non-excitable tissues, as Rubin (1982) has indicated that the 
effects may be a result of local anaesthetic effects on the cell 
membrane and Ca2+ channel blockers in adrenal zona glomerulosa cells 
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have been shown to inhibit 5HT stimulated steroidogenesis. 
From the above evidence it would appear that the receptor-coupled 
mechanisms for 5HT are not clearly discernible. Indeed it is 
debatable that adenylate cyclase in the brain and possibly in the 
adrenal, at the lower concentrations of 5HT which stimulate 
steroidogenesis without affecting cAMP, has physiological relevance 
in the coupling response. This will be discussed more fully in the 
following chapters. 
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Chapter 6 
METHODOLOGY 
6.1 EXPERIMENTAL METHODS 
6.1.1 Preparation of Isolated Zona Glomerulosa Cells 
In all in vitro experiments female Wistar rats were used. 
Adult female rats of 180-200g were taken from cages containing a 
maximum of six rats per cage, and killed between 9.00a. m. -10.30a. m. 
by cervical dislocation. On average, eight rats were used for 
steroid experiments. An incision in the abdominal midline was made 
and the adrenal glands were quickly removed with surrounding fat and 
put into saline flasks placed on ice until digestion. 
6.1.2 Collagenase Digestion 
After trimming of adhering fat, each adrenal was placed in a petri 
dish with Whatman 5 hardened filter paper settled on the base of the 
dish, and soaked in ice cold saline. The adrenal was held firmly by 
a small pair of curved stainless steel forceps and partially cut 
along the middle with a sharp scalpel blade, until two hemispheres 
attached by a piece of uncut connective tissue was obtained. Using 
the back of the scalpel blade and holding the hemispheres cut-face 
downwards, the inner cortex and medulla were gently pushed out 
leaving the capsule and attached zona glomerulosa cells for further 
processing (Haning et al., 1970). 
All capsules were placed in ice cold saline until all the adrenals 
had been dissected and then, using a fine pair of forceps, all 
capsules were placed in a pre-warmed solution of collagenase 
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(Worthington) dissolved in 20g/l bovine serum albumin (2% BSA) Krebs 
Ringer Bicarbonate solution pH7.4. 
The composition of the Krebs-Ringer solution is shown Table 6: 1: 
Table 6.1 
------------------------------- ------------------------------------ 
Molarity Volume (mis) 
0.77M NaCl 81.4 
0.77M KC1 1.76 
0.55M CaC12 2.4 
0.77M KH2PO4 0.8 
0.77M MgS04 0.8 
0.154M 
--------------------------------------------- 
NaHCO3 
--- 
84.0 
------------ 
The solution was made up to a final volume of 520 mis with double 
distilled water (DDW); other total volumes were obtained by scaling 
the basic recipe. 
The solution. was gassed in a mixture of 95%CO2 /5%02 for 30 minutes 
and glucose (BDH Chemicals, Poole, Dorset. ) at a final concentration 
of 0.2% was gently dissolved into the solution. For the digestion 
step BSA (Fraction V, Miles Scientific, U. K. ) was added at a final 
concentration of 2% to Krebs and pre-warmed in a water bath at 370C. 
Crude collagenase at a final concentration of 2 mg/ml was added to 
Krebs solution (purified. forms have little effect on tissue 
digestion). 
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The whole capsules were placed in Krebs 2% BSA (0.2% glucose) and 
left in a shaking water bath 120Hz at 370C for thirty minutes. After 
this time the digestion mix was aspirated thirty times, using a5 ml 
pipette with the tip out to a diameter of approximately 1mm, to allow 
free dispersion of aspirate up and down the tip length. The cell 
suspension was then allowed to digest a further thirty minutes and 
resuspended again for a further thirty strokes. The cell suspension 
at this stage appeared homogeneous and was gently filtered through 
a' 1001= nylon gauze attached to the out end of a 5ml plastic syringe. 
The`cell suspension was filtered into equal volumes into 10ml plastic 
conical centrifuge tubes and after balancing, placed in the MSE 
coolspin centrifuge (Mistral model 1L) for 20 minutes at 400g and 
40C. This procedure was repeated three times with two washes of the 
cell pellets between spinning in Krebs-Ringer buffer (2% BSA), and 
after the final spin'the clear supernatant was discarded and the cell 
pellet resuspended in 5mis Earle's Medium M199 (M199 Flow 
Laboratories) without sodium bicarbonate (0.2% BSA, 0.2% Glucose) 
modified to a concentration of 3.6mmol K+/1 to give the same ionic 
concentration as the Krebs solution. The reason for using M199 was 
because experiments carried out in Krebs buffer (0.2% BSA) showed 
poor aldosterone responses when All was used as the stimulus. These 
observations have also been noted by other workers e. g. Campbell et 
al., (1982) showed that M199 increased both the basal and stimulated 
levels of aldosterone. Although in my experiments (and as reported 
by Tait et al., 1972,1980a and 1980b) it was found that All only 
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stimulated steroidogenesis in Krebs incubates containing 4% BSA, we 
did not continue with this regime because of the high cost of the 
albumin used for all the experiments; the high albumin concentration 
also caused loss of sensitivity in the direct steroid 
radioimmunoassays employed. The recipe used for reconstituting the 
M199 used in the studies was as follows. 
Medium 199 powder was dissolved in 100 mis of DDW and dispensed as 
aliquots into 10ml tubes. A working buffer solution was prepared 
with the following salts all of which were of Analar grade from BDH 
chemicals Ltd., Poole, Dorset, U. K. The ionic compostion of M199 is 
shown in Table 6: 2. 
To this was added 32.36 mis of DDW to make a working solution of 
75mis (3.6mM K'). Further increases in working volumes were made 
with the appropriate scaling. For experiments where different K+ 
concentrations were required the volume of NaCl was adjusted such 
that the total volume of (NaCl + KC1) was 20 mis as shown in Table 
6: 3. 
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Table 6: 2 
--------------------------------- 
Molarity 
----------------------------------- 
volume(mis) 
0.154M NaCl 20.00 
0.154M KH2PO4 0.11 
0.154M Na2HP04 0.135 
0.154M MgSO4 0.32 
0.154 NaHCO3 12.10 
0.11 CaC12 0.88 
--------------------------------- 
M199 
--------------- 
5.00 
------------------------ 
Table 6: 3 
----------------------------------------- 
Final K+ ( M] NaCl(mis) 
3.60 2000 
5.00 18.16 
8.40 16.92 
13.00 15.24 
15-00 14.5 
---------- 
KC1(m1s) 
1.83 
3.08 
u. 76 
5.50 
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6.1.3 Counting Cells in the Haemocytometer 
To a 100µ1 aliquot of cells a 1: 10 dilution of 4% Trypan blue was 
added i. e. 1ml and left to stand for 2 minutes to allow diffusion 
through the cells. `" 
A small amount of this suspension was placed at the edge of the cover 
slip adhering to an improved Neubauer haemocytometer, and allowed to 
spread by capillary action, ` across the counting chamber. The 
haemocytometer was viewed with a Nikon model type 104 optical 
microscope and glomerulosa cells-excluding Trypan blue (i. e. viable 
cells ) were counted. -All' cells within the four outside squares and 
the middle finely divided square were counted and the number of 
cells, multiplied up by the correction factor to a total volume of 
1ml. This number was then multiplied by the total volume of the 
original'cell suspension i. e. 
NUMBER OF CELLS = NUMBER IN COUNTS ,x 2000 x 5MLS (TOTAL VOLUME) 
6.1.4 Incubation of Cells 
In al 1"studies zona'fasciculata/reticularis cells accounted for less 
than ten percent contamination as previously seen by Haning (1970). 
The 5m1 cell suspension was placed in a plastic beaker and allowed to 
incubate in a shaking water bath at 370C and10%Trifor a total of 
thirty minutes. After this preincubation time the cell suspension 
was thoroughly mixed by swirling and several aspirations, using a 5m1 
plastic pipette, before being transferred to 10ml conical centrifuge 
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tubes in equally distributed volumes and spun down for a further 10 
minutes at 300g and 1°C. , The resultant supernatant was carefully 
aspirated off and the cell pellet gently resuspended in fresh M199 
(0.2 %BSA and 0.2% Glucose) to a total volume that gave 100,000 cells 
per L400µ1 aliquot. In all experiments an ice tray containing 
water/ice mixture was used to cool the incubation tubes prior to 
setting up the static incubates. All solutions and cell suspensions 
were also kept in the ice tray whilst taking aliquots. Initially a 
500µ1 aliquot of M199 (0.2% BSA) was pipetted into all incubation 
tubes followed by 1400µ1' of cells. All tubes were given a gentle 
shake and the incubates were then made up to a final volume of 1ml by 
the addition of 100µ1 of buffer/stimulus. In the case of drug 
antagonism studies, 1O0µ1 of antagonist was added to the 1400µ1 of 
cells with 1400µ1 of buffer, and pre-incubated for 15 minutes before 
further addition of 100µ1 of buffer/stimulus. All tubes were again 
gently shaken to allow complete dispersal and distribution of 
stimulus to the cell suspension. All solutions Of the stimuli were 
made up in' M199 (0.2% BSA), to a concentration 10 times greater than 
that: required in the final incubation, so that 100 pl added to a 
total volume of 1ml gave the required concentration. The incubation 
tubes were transferred from the ice bath to a shaking water bath 
operating at%OOcym, 
Aat 
370C and incubated for thirty minutes under a 
ventilation hood with 95% C02/5% 02" 
The incubation tubes were then removed from the water bath and placed 
directly on ice for 10mins to inhibit further steroid biosynthesis 
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before being transferred to pre-chilled centrifuge carriers at 40C. 
All tubes were centrifuged at 40C in the MSE centrifuge at 800g for 
20 minutes. The resultant supernatant was carefully decanted into 
clean test tubes (LP4), and frozen at -200C until assayed for steroid 
hormones. 
Preliminary experiments using 5HT as stimulus, showed that steroid 
output was linear with time for incubation times of 30 minutes to 2 
hours. 
6.2 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
HPLC was used to measure 5HT and its metabolites since it is one of 
the most precise methods for determining. biogenic amines in 
biological fluids and tissues (Sasa et al., 1977, Mefford 1981, 
Achilli et al., 1983). 
This method is sensitive to concentrations as low as 10- 
20pg/injection. The intra-assay coefficient of variation for the 
system described in this thesis has been determined as 2.1% 4 3.1% 
and the inter-assay coefficient of variation was 5.7% f 8.2 according 
to Gow et al., 1987. 
6.2.1 Reagents 
5-hydroxytryptamine creatinine sulphate and 5-hydroxyindole acetic 
acid were obtained from Sigma (Dorset, Poole. ) and internal standard 
N-W-methyltryptamine from Aldrich Chemicals. HPLC grade methanol and 
water for the mobile phase was purchased from Rathburn Chemicals 
Ltd., Walkerburn, Peebleshire, Scotland. Reagent grade sodium 
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dihydrogen orthophosphate (NaH2PO4) was obtained from BDH. The 
mobile phase consisted of a 3mM NaH2PO4 buffer containing 15-17.5% 
methanol, depending on resolution and retention time requirements 
of the, amines studied. The disodium salt of ethylene diamine 
tetraacetic acid (EDTA 1mM) was added to the mobile phase and 
purchased from BDH. Pairing ion agent (octane-l-sulphonic acid 
sodium salt) was from HPLC Technology Ltd. 
The final concentration of salts and solvents in 1 litre of the 
mobile phase are given in Table-6: 4. 
Table 6: u 
--------------------------------------------------------------------- 
WATER 850m15 
METHANOL 150m]s 
EDTA 400mg 
PIA 120mg 
NaH2P04 5.1kg 
The mobile phase was filtered and degassed by passing through a 0.21= 
Millipore'Durapore' filter (Waters, Millipore, Harrow, Middlesex) 
under reduced pressure. Standard solutions were prepared in a 
solution (pH 1.8) of 1.5% (0.15M) perchloric acid and 0.2mM cysteine 
(Sigma)-, and these were diluted to the desired concentration in the 
same solvent. 
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6.2.2Apparatus 
Liquid chromatography was. performed using a Waters M600A pump with a 
Waters U6K injector and 2m1 sample loop for injection into the 
system. -A pre-column 
(3.9mm x 2cm) of C18 Corasil was used 
(particle diameter 35-50µm) which consisted of C18 groups linked to 
particles of silica. It's function was to filter out large 
particles of contaminating matter which would have affected the 
analytical column, decreasing both it's resolution and it's lifetime. 
The analytical columns used were (1) 3.9mm x 30cm packed with C18 P 
Bondapak (particle diameter 10µm) from Waters Ltd., or (2) a 4.0mm x 
10cm column (Capital HPLC, Edinburgh, U. K. ) packed with Hypersil ODS 
(particle diameter 5µm) from Shandon Chemicals, Runcorn, Cheshire. 
Standard conditions were 1ml/minute flow rate at room temperature. 
Detection was accomplished using a Model LC-4A electrochemical 
detector (Bioanalytical Systems, West "'Lafayette, USA) using a 
working potential of+O. 7V with a 5nA full scale deflection for the 
oxidation of samples by glassy-carbon electrode. Peaks were 
plotted using a Waters data module, and quantitation of the amines 
present in blood and tissue samples were made by comparison of the 
peak heights of the samples to those given by standard 
concentrations, at the characteristic retention times for the amines. 
6.2.3 Sample Preparation 
In general, there are two methods of choice for pretreating samples 
prior to HPLC analysis (1) extraction of .. 
the components of interest 
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or (2) direct injection following deproteinisation. The latter 
method has been applied in preparing brain and adrenal homogenates 
(Blanchard, 1981, Kuriyama et al., 1984, Verhofstadt et al . 0983 ) 
and is by far the more rapid and simpler technique, especially in the 
handling of small tissue or fluid samples. 
6.2.4&drenal Sample Preparations 
Female, Wistar rats weighing 180-220g were obtained from the Animal 
Unit at the Western General Hospital, Edinburgh. All animals were 
fed normal rat chow and water ad libitum and were maintained on a 
12: 12hour light/dark cycle throughout the studies. The rats were 
always killed at the same time i. e. 9.30am -10.30am to reduce the 
variation in measurement of biogenic amines which are known to 
fluctuate during the day (Albrecht et al., 1956). 
Rats were sacrificed by cervical dislocation and the adrenals 
isolated and surrounding fat removed as described above. In some 
instances capsules were separated from the inner cortex and medulla 
and these as well as whole adrenals were assayed, or else frozen in 
polypropylene microcentrifuge tubes(1.5m1) at -700C. 
6.2. Tissue Homogenisation 
, ,, 
Tissue was weighed whilst still frozen and the appropriate volume of 
1.5% perchloric acid i. e. 100mg: lm1 acid, containing 2x10-6M internal 
standard (final concentration) to measure recovery of amines during 
the procedure, and 0.2 mM cysteine to prevent oxidation of the 
amines, was added to the samples. The samples were allowed to stand 
at 40C for 15 minutes before being processed in a motor driven 
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homogeniser (Jencons Scientific Ltd., Bedfordshire) with teflon 
pestle, for 2 minutes at maximum speed setting 10. The resultant 
homogenate was spun down in the Microfuge (model 154, Camlab, 
Cambridgeshire) at 15,000g for 15 minutes and 40C and the resultant 
supernatant carefully aspirated and samples of this injected into the 
HPLC column in 25µl aliquots. Where samples were not immediately 
assayed, these were frozen at -200C and usually assayed within a 
week, toreduce the risk of amine degradation. All tissue 
preparation steps werfe carried out on ice. All amine values on the 
column need to be corrected for the volume of acid the tissue is 
dissolved in; thus, 100 mg of tissue is routinely digested in 1 ml 
acid so that µM concentrations need to be converted to moles per pl 
to multiply up the concentration in x pi of tissue homogenate per x 
mg and thence per gram wet weight. 
6.2.6 Serum Samples 
A number of modified precipitation methods for prior removal of 
protein before loading onto the column, have been used (Semerdjian- 
Rouquier 1981, Blanchard et al., 1981) and modified versions include 
the one used below (Gow et al., 1987). Rats were anaethetised with 
ether and 1O0pl of blood collected by cardiac puncture into 
polypropylene conical microcentrifuge tubes containing 900µls of 
coagulant. 
The coagulant cocktail 'was a modified mixture from Engbaek et al., 
1982 and was prepared as described in table 6: 5. 
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In a total volume of 0.9mis used in sample preparations: 
Table 6: 5 
--------------------------------------------------------------------- 
0.1 Unit Thrombin/0.9 mis = 0.11 Units/ml(original stock) 
10 nmol Pargyline/0.9 mis 
1 nmol Chlorimipramine/0.9 mis = 
11.1 µM 
1.1 µM 
Thrombin augments platelet aggregation and stimulates the release of 
5HT from the platelets thus increasing the concentration of serum 
5HT. Pargyline inhibits monoamine oxidase activity and thus, the 
metabolism of 5HT which may occur in blood collections. 
Chlorimipramine, prevents the re-uptake of 5HT into platelets thus 
providing a more accurate measure of whole blood 5HT. 
Samples were left to stand at 40C for at least one hour, after which 
time the tubes were centrifuged at 10,000g and 40C for 15 minutes. 
The resultant clear supernatant was transferred to clean tubes before 
further processing. In a separate set of tubes was added 50 µl of 
1.5M perchlorie acid for the deproteinisation of serum, and 50 pls of 
M_jý)_methylserotonin dissolved in 0.15M perchlorie acid and added for 
marking recovery of the endogenous amines (Mais et al., 1981)' and 
finally, 400 µl of serum was added. The tubes were vortexed and left 
at 40C for 15 min after which, they were centrifuged for 30 min at 
40C and 10,000g. The resultant supernatant was collected and 25 41 
samples injected into the column. 
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Thus, all values obtained on the column need to be corrected by a 
factor of x12.5 to correct up for 1: 10 dilution of coagulant to blood 
in the first stages, and in deproteinisation 400 pl of sample in a 
total volume of 500 µl, i. e. 500/400 x 10 = 12.5. 
6.3 RADIOIMMUNOASSAY 
For all in vitro experiments with adrenocortical cells incubated in 
M199 (0.2% BSA), corticosterone and aldosterone were measured by 
direct radioimmunoassay of the medium using [1251]-corticosterone and 
E125I]-aldosterone respectively as radiolabels. 
6.3.1 Radioimmunoassay or Corticosterone and Aldosterone 
6.3.1.1 Preparation of [1251]-cortieosterone 
This was prepared by the coupling of corticosterone-3-(O- 
carboxymethyl) oxime to a previously labelled [125I]-histamine 
molecule (A1-Dujaili et al 1981b). 
6.3.1.2 Production of antisera 
Corticosterone-3-(O-carboxymethyl) oxime was coupled to bovine serum 
albumin and injected into New Zealand rabbits. The cross 
reactivities for the resultant antisera has already been described 
(Al-Dujaili et al., 1981b) and did not exceed 0.03% for 
11-Deoxycorticosterone the other major cross-reactant. 
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Fig 6.1 
Typical standard curve to corticosterone in RIA using charcoal 
separation method 
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6.3.1.3 Solutions and Steroid Standards 
A stock solution of corticosterone obtained from Sigma was dissolved 
in absolute ethanol x mg/ml and diluted out in M199 (0.2% BSA) 
iG., solution with 0.1% azide. 
Phosphate buffer 0.05 M pH 7.4 containing 0.1% BSA and 0.1% azide 
was used as diluent in the steroid assays. 
6.3.1.4 Dextran-coated charcoal 
This was prepared by making a2 litre solution as follows: 
activated charcoal (Sigma) 12.5g 
dextran (Pharmacia Fine chemicals, Upssala, Sweden) 1.25g 
both dissolved in 0.1M phosphate buffer and a prewarmed solution of 
gelatin in phosphate buffer (0.8g) was then added to a total volume 
of 2 litres. The resultant solution was chilled at 40C before use in 
assay seperations. 
6.3.2 Setting up Incubations 
The assay incubates both for aldosterone and corticosterone 
measurement were such, that the incubation volume contained : 25 µ1 
sample, 200 pl antibody/label mix in 0.05M phosphate buffer 
In the corticosterone assay the final antibody concentration was 
optimum for assay binding at 50%, at 1: 60K. The label solution gave 
counts in the range 3 000-5 000 opm in the final incubate volume. 
The lower level of sensitivity was at 0.5 ng/ml and the working range 
lay between 0.5-16 ng/ml (see Fig. 6.1). % 
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The interas say-coeffieient of variation at 0.5 ng/ml was 9.7%, 20.9% 
at 2 ng/ml, and 21.8% at 16 ng/ml. 
Tubes were vortexed and incubated at 40C overnight before charcoal 
seperation. Dextran-coated charcoal kept at 40C was added (volume 
0.6 mis) and tubes were centrifuged at 1,720g for 20 min at 40C. 
Tubes were aspirated and the charcoal pellet (free fractions), 
counted in the multiwell gamma counter (model LKB 1260 multigamma). 
Aldosterone levels in in vitro samples were measured in a similar 
direct radioimmunoassay procedure. The aldosterone antibody used was 
tested for cross reactivity and is tabulated below: - 
Table 6: 7 
STEROID % cross-reactivity of aldosterone antibody (pH 7.4) 
Aldosterone 100 
Pregnenolone <0.00002 
Corticosterone <0.00002 
17aOHProgesterone <0.00002 
Testosterone <0.00002 
Androstenedione <0.00002 
Oestradiol <0.00002 
Cholesterol <0.00002 
Cortisol <0.00002 
18OHDOC =<O. 00002 
DOC =<0.00002 
------------------------------------------------------------------------ 
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Fig 6.2 Typical standard curve to aldosterone In RIA 
using charcoal separation method 
The antibody was used at a final concentration of 1: 100K and was a 
4 
kind gift from Dr. F. A. O. Mendelsohnn. The antibody was raised in 
rabbits and Fig. 6.2 shows a typical standard curve for aldosterone 
in buffer pH 7.4 (0.2% BSA and 0.1% azide). The lower limit of 
detection for aldosterone was consistently around 50 pg/ml and the 
working range for steroid measurement lay between 50-3,200 pg/ml. 
The interassay-coefficient of variation was 4.4% at 50 pg/ml, 10.3% 
at 400 pg/ml, and 31.1% at 3,200 pg/ml. 
6.3.3.. Radioimmunoassay of Plasma Aldosterone and Corticosterone 
6.3.3.1 Plasma Aldosterone measurement 
Charcoal stripped serum from female Wistar rats was used in preparing 
aldosterone standards from a stock solution of 1mg/ml. Labelled 
[125I]-aldosterone was prepared by the chloramine-T method as 
described (Al-Dujaili and Edwards 1981b). Aldosterone antibody 
(S14-3) was prepared in sheep and used at a final concentration of 
1: 400K in the incubation samples. The plasma samples were prepared 
by collection. of whole blood into EDTA solution (see collection for 
PRA assay) and plasma samples were kept on ice before centrifugation. 
Plasma samples were centrifuged at 3,000g 40C for 20 minutes and the 
resultant plasma supernatant collected for direct assay or stored 
frozen at -200C until assay. 
A 20 pl sample of plasma or standard was added to polystyrene LP3 
tubes in duplicate and aliquots (480 µl) of an antibody/label mix 
(final dilution of antibody, 1: 400K) in phosphate /citrate buffer pH 
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4.0 (0.1% BSA and 0.1% azide) were added. The tubes were vortexed 
and incubated overnight at 40C before charcoal separation as 
described above. 
y Phosphate/citrate buffer pH 4 was prepared by mixing 15 parts Na2HPO 
(O. 5M)/citrate buffer(0.25 M) 35 parts as this was found to be the 
optimum pH for plasma aldosterone measurement (Al-Dujaili et al., 
1981c). 
6.3.3.2 Radioiumunoassay for plasma corticosterone 
Plasma corticosterone was measured by a direct radioimmunoassay of 
corticosterone (Al-Dujaili et al., 1981b). Blood samples were taken 
from EDTA treated samples in the measurement of PRA and/or All and 
plasma samples collected by high speed centrifugation at 40C as 
described above. Phosphate/citrate assay buffer (0.05 M, pH 4.0) was 
used in a total volume of 200 µl together with 50 pl plasma/standard 
samples. The final antibody dilution was as in the in vitro assay 
(1: 60K) using [1251]-labelled corticosterone at 3000cpm. 
6.4 Radioimnunoassay for cyclic AMP 
In measuring cAMP from in vitro samples, an aliquot of 500µ1 was 
treated on ice with 5µ1 of acetic acid (1: 4) and vortexed. 
Immediately afterwards, the acidified samples were acetylated with 
15µl of a freshly prepared mixture of acetic anhydride/triethylamine 
(1: 2). The acetylation reaction was carried out on ice and the 
vortexed samples were ready for assay. 
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Fig 6.3 
Typical standard curve to cyclic AMP In RIA using charcoal 
separation method 
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For radioimmunoassay, the cyclic AMP antibody was raised in rabbits 
following Harper and Brooker (1975) protocol. 
The incubates contained 25µls'sample, 250µlcitrate/phosphate buffer 
(pH 5.0) and antibody/label. The final antibody dilution was 1: 200K 
and the inter-assay coefficient of variation was less than 10% The 
working range lay between 15-500fm/tube (see Fig. 6.3). 
1- 
. Jý 
6.5 Assay for Plasma Benin Activity (PRA) 
Plasma renin activity is an indirect measure of All levels in the 
plasma and is often preferable to the measurement of All which has a 
short half life. 
below. 
6.5.1 Reagents 
Generation is achieved by the protocol described 
A 0.1M phosphate buffer solution containing 0.1% azide and 0.1% BSA 
was used in the assay procedure. An EDTA solution was prepared by 
dissolving 5g of the disodium salt in 50mis of distilled water at 
60OC9 and was used as a stock solution for the assay. In the 
collection of plasma samples 5g of EDTA salt were dissolved in 500m1 
of sterile saline at 600C (27'mM). BAL (British Anti-Lewisite - an 
angiotensin converting enzyme (ACE) inhibitor which prevents AI 
conversion to AII) was made up in the fume cupboard using 15ml 
arachis oil + 2,3-dimercapto-propran-l-ol(242 µl) + benzyl benzoate 
(535 µl) and kept frozen until assays were' set up. A solution of 8- 
hydroxyquinoline`(660 mg) was dissolved in 10 mis distilled water and 
kept at 4DC. Both this compound and'EDTA are used to prevent 
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conversion of AI to All by by extraneous peptidases present in the 
plasma. 
6.5.2 Treatment of Plasma Samples 
Rat blood samples were pipetted into polypropylene conical 
microcentrifuge tubes on ice, such that a final concentration of 1: 10 
was made relative to the addition of EDTA (27 mM) Samples were then 
centrifuged at 40C at 3000g for 60 minutes and the resultant 
supernatant frozen at -200C until assay. 
Generation of AI - Two sets of tubes, one set kept on ice 
throughout, and another set incubated at 370C were prepared by adding 
500 pl to one set of tubes containing. a 30 pl mixture of BAL, 8-OH 
Quinoline and EDTA at 14QC. The mixture was vortexed and to this was 
added 500 µl of 0.1 M phosphate buffer and vortexed again. Out of a 
total volume of 1.03 mis, 400 µl was pipetted into the other set of 
F 
empty tubes placed on ice. Both sets of tubes, i. e. 370C and 40C, 
were incubated for a total time of 120 minutes after which time all 
tubes were kept on ice. 
6.6 RADIOIMMUNOASSAY OF Al GENERATED IN SAMPLES 
The assay mixture contained 25 µl (sample/standard)in duplicate, 200 
Pi *Ab/label mix in phosphate buffer. 
The mixture was°vortexed, and incubated overnight at 40C and 
separated by dextran coated charcoal as described above, followed by 
counting in the multiwell gamma counter. * The antibody (R2B5) was 
prepared at a final concentration of 1: 60K and the label diluted to 
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give approximately 3000opm/tube. PRA values were calculated by 
subtracting counts from tubes maintained on ice from values of Al 
obtained at 370C" The final value was divided by the time of 
generation for AI to give values in x ng/ml/hr. 
6.6.1 Plasma All Aasaa 
6.6.1.1Reagents 
The peptidase inhibitor solution was prepared using 4.65g EDTA 
(chelator of Cat+) in 100ml distilled water with addition of 0.458 o- 
phenanthroline dissolved in 1ml ethanol. The working assay buffer 
was prepared by addition of 1.518 TRIS + 250ml water (distilled), and 
0.1% BSA with 0.1% azide. 
6.6.1.2Blood Collection 
A sample of blood was collected into polypropylene microcentrifuge 
tubes containing°a volume of inhibitor such that the blood: inhibitor 
ratio was 9: 1 and in rat blood collections this was 1.8 mis: 0.2 mis 
inhibitor. ' The blood sample mixture was collected on ice and 
centrifuged at 15,000g for 30 mins at 40C. The resultant plasma 
supernatant was collected and stored frozen at -200C until assay. 
6.6.1.3Preparation for All Separation from Plasma Samples 
Columns of C18 sep-pak cartridges were used in the separation of All 
and related peptides from plasma samples. C18 cartridges consist of 
hydrophobic moieties bound to a column of silica particles and this 
allows adsorption of peptides and small molecules with the elution of 
plasma proteins. The benefits of this separation are two-fold in 
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that it also enables plasma samples of All to be concentrated. A 
total volume of 5m1 methanol was passed through the columns followed 
twice by 5m1 of distilled water, after which the plasma sample was 
passed through. Bound peptides were then eluted by passing a final 
wash of 2.2 mis 80% methanol: 20% water over the column. The eluate 
was collected into glass 12 x 75mm tubes (Corning GlassWorks, 
Corning, USA) and dried under 95%CO2: 5%02 at 35OC-'400C. When dried 
0.5 mis of TRIS buffer was added to each tube and assayed. 
6.6.2Assay Procedure 
50 µl of sample/standard was added to 200 pl* Antibody/label mix 
(* Antibody R6B4 1: 300K final dilution. and 3000 cpm per incubate). 
The standard curve range lay between 0.02-10.24 ng/ml (double 
dilutions). 
The assay incubates were left overnight at 40C after which samples 
were seperated, by charcoal seperation as above and the pellets were 
counted using a multiwell gamma counter for [1251]-AII measurement. 
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Chapter 7 
THE EFFECTS OF 5HT ANTAGONISTS ON THE STEROID RESPONSE IN THE ZONA 
- GLOMERULOSA - 
7.1 DRUG ANTAGONISM 
The purpose of these studies was to attempt to determine more fully 
the direct effects of 5HT antagonists on 5HT stimulated steroid 
output, in particular aldosterone, in the rat zona glomerulosa cells 
incubated in vitro. 
In initial experiments the dose response to 5HT in isolated zona 
glomerulosa cells was assessed by measuring the output of CAMP, 
corticosterone and aldosterone over a thirty minute incubation 
period. In the first instance, only two 5HT antagonists were tested 
for their antiserotonergic properties in the adrenal. 
7.2 DRUGS USED IN STUDIES 
7.2.1 Ketanserin 
Ketanserin was described as a potent type 5HT2 receptor antagonist in 
rat cerebral cortex binding studies by Leysen et al 1981. It has a 
x1000 fold difference in affinity for 5HT1 and 5HT2 receptors. The 
Ki for 5HT2 = 2.7nM in vaseulature, whilst the Ki for 5HT1 = 2700nM. 
The reciprocal of Ki is a measure of the binding affinity for the 
drug, thus the smaller the Ki value, the greater the binding 
affinity. 
In vascular tissue containing 5HT1 receptors, such as the canine 
basilar artery, ketanserin and methysergide (below) are non- 
competitive inhibitors of 5HT. Ketanserin in this case, only has 
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Fig 7.1 Molecular structure of drugs used 
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inhibitory effects at concentrations greater than 10-6M. In vessels 
containing 5HT2 receptors such as rabbit and rat aorta, both 
antagonists are competitive, i. e. the antagonism is surmountable at 
higher concentrations of the agonist (Peroutka et al 1984). At 
concentrations greater than 10-5M, ketanserin interacts with o(1 and 
histamine receptors (Leysen et al 1981). 
Ketanserin (see Fig. 7.1) was obtained from Janssen Pharmaceuticals in 
ampoules containing 5mg/ml. The molecular weight of the tartrate = 
545.5, which has a solubility in water (pH3.4) = 2.4g/100mis. 
7.2.2 Methysergide 
Methysergide was purchased from Sandoz pharmaceuticals as a white 
crystalline solid (Deseril) the hydrogen maleate salt C25H31N306 m. wt 
169.5. 
The natural compound is one of a family of ergot alkaloids. An 
alkaloid is an organic compound of basic character containing 
cyclical nitrogen-carbon bonds i. e. pyrole, pyridine or pyrolidine 
structures. Ergot is used to describe a subclass of alkaloid 
compounds derived from a parasitic fungus called ergot, which grows 
on cereals and especially rye grass. Methysergide is a chemically 
synthesised compound and like all ergot alkaloids, is an amide of 
lysergic acid (Fig. 7.1(b)). 
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Fig 7.2 Effects of ketanserin and methysergide 
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7.3 STEROID AND cAMP RESPONSE TO 5HT STIMULATION 
In the in vitro experiments cAMP, corticosterone and aldosterone 
output varied for 100,000 cells incubates, and this has been widely 
reported and interpreted to mean that during cell preparation and 
aliquotting, cell receptor damage by collagenase digestion, as well as 
cell dispersion during digestion, may affect the sensitivity and 
responsiveness of the adrenocortical cells (Vinson et al 1985). 
Therefore all pooled results were normalised with respect to basal 
value and results plotted as a percentage of the basal values (Tait 
et al 1976,1980a, 1980b); individual experiments were plotted for 
secretions per 105 cells (Aguilera et a11978a, 1978b). 
7.4 RESULTS 
7.4.1 The cAMP, Aldosterone and Corticosterone Output with 5HT 
Figure 7.2 shows the aldosterone output (pg/ml/105 cells) and the 
dose response curves to ketanserin (10-10M-10-6M) and methysergide. 
In both instances, the 5HT antagonists have no significant effect on 
basal steroid output in the zona glomerulosa cells. 
Figure 7.3 shows the effects of ketanserin (10-7M) on the dose 
response curve to 5HT (10-9M-10-6M), measuring corticosterone and 
aldosterone output. Ketanserin at this dose, did not inhibit either 
the corticosterone or the aldosterone output induced by 5HT, but 
there was a slight potentiating effect of the drug on both steroids, 
particularly at higher doses of 5HT. 
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Fig 7.3 Dose response to 5HT ±ketanserin 10'7 M 
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Figure 7.4 shows the percentage above basal values for corticosterone 
and aldosterone with increasing doses of 5HT in two experiments in 
triplicate incubations. Methysergide (10-7M) tended to inhibit the 
dose response curve in a competitive way but this was not 
statistically significant at this dose. 
In Fig. 7.5 (A), (B) and (C) are shown the percentage increases in 
cAMP, corticosterone and aldosterone respectively, for two 
experiments. Cyclic AMP levels were markedly elevated by 230% above 
basal, only at 10-6M5HT. In contrast, corticosterone and aldosterone 
output was markedly elevated at 10-8M 5HT reaching a maximal of 220% 
at 10-6M5HT. 
7.4.2 Effects of Ketanserin 
However, as further experiments showed, steroid output was not always 
matched by an increase in cAMP levels. An example of this is shown 
in Figs 7.6 (A), (B) and (C). Cyclic AMP levels were not elevated at 
any doses of 5HT whereas corticosterone and aldosterone were 
significantly increased in this experiment at 10-9 M5HT. In the same 
experiment, ketanserin (10-6 M) inhibited aldosterone and 
corticosterone output at 10-8 M and 10'7 M 5HT. Discreprancies 
occured in ketanserin's inhibitory effects on corticosterone at 10-6 
M5HT without affecting aldosterone at the same concentration; 
conversely, ketanserin blocked aldosterone output at 10' 
9 M5HT and 
not corticosterone output. This was a common finding in all 
experiments measuring the inhibitory effects on both corticosterone 
and aldosterone but because aldosterone is produced solely by the 
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Fig 7.5 cAMP, corticosterone and aldosterone output with 5HT stimulation 
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Fig 7.7 6 Effect of 10 M Ketanserin on cAMP, corticosterone and aldosterone 
output with 5HT stimulation 
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zona glomerulosa, this was considered the more important parameter to 
use in measuring the potency of the 5HT antagonists. 
In Fig. 7.7 (A) cAMP levels were elevated at all doses of 5HT greater 
than 10-9 M and the percentage values closely paralled corticosterone 
output at 10-8 M-10-6 M5HT. Ketanserin significantly inhibited 
cAMP production at 10-8 M-10-7 M5HT. The aldosterone percentage 
increase in the control incubates were markedly greater than the cAMP 
response curve and inhibition by ketanserin was significant but not 
as great as cAMP inhibition. 
As stated in Chapter 5, ketanserin at doses >=10-5 M in vascular and 
brain tissue, has affinity for 0(1 receptor sites. In the 
experiments shown in Figs. 7.8 and 7.9 the effects of phentolamine (a 
non-specific antagonist) and prazosin (an 0ý1 antagonist) at 10-6 M, 
were assessed for their inhibitory effects on 5HT stimulated 
steroidogenesis in the zona glomerulosa. 
7.4.3 "EFFECTS OF ALPHA ANTAGONISTS 
Phentolamine 
The drug was purchased from Ciba Laboratories in ampoules containing 
10mg/ml. The molecular weight = 377.5 and the structure is shown in 
Fig. 7.1(c). Stock solutions were prepared by adding 25µl of the drug 
to 6.6mis of incubation buffer. = 1mM stock. 
Prazosin 
The drug was purchased from Pfizer Ltd., as the white crystalline 
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hydrochloride salt (HYPOVASE) m. wt C19 H22 C1N5 04* and dissolved in 
DMSO at a final concentration of 0.01% in the incubation medium. 
As in the antiserotonergic drug experiments, cells were incubated 
with the drugs alone for 15 mins before addition of the agonist. 
Figures 7.8 (A), (B) and (C) show the dose response to 5HT i 
prazosin, for cAMP, corticosterone and aldosterone in two pooled 
experiments with data normalised. As previously seen , cAMP levels 
were only elevated at 10-6M 5HT, whereas corticosterone and 
aldosterone output were elevated at 10-8M5HT. Preincubation with 
prazosin (10-6M) did not significantly affect basal and stimulated 
corticosterone and aldosterone, but cAMP levels though depressed 
with prazosin present, were not significantly depressed (Students 
paired t-test p<0.05). 
Figure 7.9 shows the results from one experiment done in triplicate 
in the presence of 10-6M phentolamine. In Fig. 7.9(A) cAMP levels 
were significantly elevated at 10-7M - 10-6M 5HT. The results with 
phentolamine suggested no inhibition of cAMP output compared-to 
unstimulated outputs with increasing doses of 5HT in the control 
curve. In Fig. 7.9 (B) and (C), both corticosterone and aldosterone 
were significantly elevated at all doses of 5HT; phentolamine did 
not inhibit these responses. However, the cAMP curve did not 
parallel the steroid response curves in the control experiment. 
7.1.4 Effects of Methysergide 
Methysergide was preincubated with the cells at 10-6 M for 15 mans 
before addition of 5HT to the cells. 
In Fig. 7.10 (A) CAMP levels were significantly elevated at 10-7 M 
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Fig 7.8 Effect of 106M prazosin on 
cAMP, corticosterone and aldosterone output with 5HT stimulation 
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and 10-6 M 5HT and in (B) and (C) corticosterone and aldosterone 
respectively, were increased at 10-8 M 5HT. Methysergide was more 
potent than ketanserin in inhibiting the CAMP, corticosterone and 
aldosterone output at all doses of 5HT. Methysergide inhibited CAMP 
production at all doses of 5HT that stimulated its production. 
Figure 7.11(A) shows that 5HT stimulates cAMP at lower doses, 
-.. _.. suggestive of closer coupling in this experiment, although the 
percentage increase in cAMP was not as great as the increase in 
steroid output. The same' observation was made in other experiments. 
I 
The ED50 i. e. the dose of 5HT that stimulates 50% of the maximal 
response, for cAMP was on average 10'7 M compared to an 
ED50 of 10-8 M for corticosterone and aldosterone secretion. 
In Fig. 7.12(A) methysergide (10-6M) did not inhibit cAMP at 10-6M 
5HT although B output was depressed in a non-competitive way and 
aldosterone was significantly decreased, since increasing doses of 
5HT did not overcome the inhibition. 
7.5 DISCUSSION 
7.5.1 Effects of Ketanserin 
From the ketanserin data, the lack of inhibition with the alpha 
antagonists (phentolamine and prazosin) tends to suggest that 5HT is 
not interacting with o(receptors but rather the effects of ketanserin 
are due to its antiserotonergic properties. 
In the ketanserin experiments, cAMP was not always increased 
although steroid was significantly elevated. However, ketanserin 
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Fig 7.11 
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blocked steroid production and when cAMP was increased, also 
inhibited its production. There appears to be a clear dissociation 
between 5HT's effect on stimulating steroid secretion and CAMP 
production. Its stimulation of cAMP appears to be a loosely coupled 
event, more apparent at higher doses of 5HT i. e. 10-6M (e. g. Fig. 7.5) 
but is not a prerequisite in the production of steroid (e. g. Fig. 7.6). 
As previously stated, ketanserin interacts with type 5HT2 receptors, 
which are not thought to be linked to adenylate cyclase. However 
Conn (1986) suggested that 5HT2 receptor binding of 5HT may require 
GTP, which suggested some adenylate cyelase interaction. If 5HT is 
interacting with an adrenal 5HT receptor, it appears to be loosely 
coupled to adenylate cyclase, which may be 'channeled' into steroid 
production (Sehulster et a1:, 1980) or equally the possibility exists 
that 5HT spare receptors may exist which at increasing doses of 5HT 
(notably 10'6 M), may be activated, and together may augment 
adenylate cyclase activation as described for ACTH receptors (Buckley 
et al., 1981). The possiblity exists that 5HT stimulates steroid 
through Ca2+ mediation as well as/or in preference to cAMP 
production, and is blocked by ketanserin. In this regard, 5HT 
stimulated steroidogenesis appears to fit into the receptor model of 
control of cellular function termed 'monodireetional control' (Takai 
et al., 1985) in that the stimulus, in this case 5HT, elicits 
production of several second messengers e. g. Ca2+ and cAMP that are 
stimulated independently and act as positive modulators of the 
stimulated response (see Rasmussen and Barrett 1984) although in this 
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case, cAMP may not be of great importance since cAMP did not always 
follow steroid inhibition. The other mode of control is termed 
bidirectional eontrol'in that the second messenger modulates the 
activity in a negative way, of other potential messengers. As 
discussed in the chapter on 5HT receptors, 5HT2 receptors are likely 
candidates for a prostacylin mediated increase in steroid secretion. 
However, in brain and vascular tissues, ketanserin is a more potent 
competitive inhibitor at lower concentrations (nM range) than was 
seen in these studies. Additionally, ketanserin did not appear to 
inhibit steroid production by 5HT in a competitive way, so the 
likelihood that type 5HT2 receptors exist in the 
adrenal tissue is remote (see later for specificity effects). 
7.5.2 Effects of Methysergide 
In the experiments with methysergide at 10"6 M, -CAMP was not always 
inhibited, although the antagonist always significantly inhibited 
steroid production. Here again the antagonist inhibits 5HT mediated 
steroidogenesis but cAMP does not appear to be-an essential second 
messenger in. steroid secretion. As indicated earlier, methysergide 
at, the lower dose of 10-7 M in Ew o pooled experiments, did not 
significantly, (Students paired t-test p<0.05) inhibit 
corticosterone or aldosterone secretion (Fig. 7.1). Again, the dose 
of-antagonist used is in the range described for interaction with 
type 5HT1 receptors. At this,. point , it may be appropriate to 
mention that agonists including the indoleamines, are more potent at 
interacting with type 5HT1 receptors, which also have lower affinity 
for 5HT antagonists. In Chapter 5, it was shown that 5HT had a potent 
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effect - ED50 approximately 5x 10-9 M- on aldosterone 
biosynthesis 
(Tait 1975). The evidence tends to favour a type 5HT1 subtype, 
which may coincidentally associate with adenylate cyolase but even 
without cAMP involvement, still elicit a 5HT stimulated steroid 
response. Nelson (1980), found that in brain tissue, 5HT antagonists 
were potent at displacing [3H]-5HT from 5HT binding sites and had 
little or no effect in inhibiting 5HT stimulated cAMP production. 
They also found that 5HT had a Kd 1-2nM in terms of binding , whereas 
5HT stimulated cAMP production had aK (apparent) 0.5µM-1µM. It was 
suggested that 5HT could bind to a heterogenous set of receptors some 
of which are coupled'to cAMP production. The. stimulatory effects of 
indolamines agonists were also investigated, including bufotenine 
and 5- methoxy-N, N-dimethyltryptamine , which displaces 
[3H]-5HT from 
brain membranes and activates adenylate eyclase in contrast to 
piperazine type compounds which only affect [3H]-5HT binding. This 
suggests structural differences in the adenylate cyolase receptor 
compared to the [3H]-5HT binding site. Shah (1979) demonstrated that 
5HT over a concentration range ýof 10-7M - 10-3M could specifically 
stimulate cAMP production in rat renal cortex. Serotonin has also 
been shown to stimulate CAMP in vascular endothelial tissues and 
insect salivary glands (Shama et al., 1979., Berridge et al., 1979). 
However, in other tissues, e. g. bronchial smooth muscle, platelets, 
uterine and mammalian umbilical artery, 5HT increases cGMP without 
affecting cAMP levels. In these studies, only cAMP was looked at so 
the possible involvement of other messengers e. g. Cat+, PI and eGMP, 
could not be discerned. Fozard (1983a) discussed the anomalies in 
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5HT receptor identification and possible association with CAMP 
formation. It was shown that type 5HT1 receptors have sometimes been 
linked with adenylate cyclase but have met with doubts as raised 
above. There have been claims that 5HT1 recognition sites have 
similar properties to the 5HT inhibitory autoreceptor located on 
presynaptic 5HT neurone sites, since metitepine is an effective 
antagonist at the autoreceptor and displaces [3H]-5HT with a similar 
potency. Methysergide however has no effect at the autoreceptor even 
at µM concentrations, yet displaces [3H]-5HT from its binding site 
with an IC50 of 62nM. Similarly, metergoline, another 5HT 
antagonist, has no effect on the autoreceptor. As revealed in 
recent studies in binding properties of several 5HT agonists and 
antagonists, the 5HT1 receptor represents a multiple class of binding 
sites, all of which bind [3H]-5HT and interact with indole agonists, 
but may not all mediate their physiological effects through the 
generation of cAMP. The same could apply in these initial studies in 
the adrenal cortex, although extensive pharmacological studies with 
many agonists and antagonists would be needed in further 
investigations. 
7.6 SPECIFITY OF 5HT ANTAGONISTS 
Further antagonism studies to characterise a 5HT receptor in the 
adrenal, as described in other tissues using a range of doses to the 
antagonist'or several antagonists, was not attempted at this stage 
since the specificity of the antagonism was sought. Dose response 
curves to ACTH, All and K+ in the presence of the antagonists 
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methysergide and ketanserin (10-6M), were carried out using M199 
(0.2%BSA and 0.2% glucose). Only corticosterone and aldosterone were 
measured by RIA as described previously. 
7.6.1 RESULTS 
7.6.2 Effects of Ketanserin on the Dose Response Curve to ACTH 
Figure 7.13 shows that ketanserin had no effect on corticosterone and 
aldosterone output in ACTH stimulated steroidogenesis in the same 
experiments in which ketanserin significantly inhibited aldosterone 
output at 10-9M and 10-8 M 5HT-stimulated steroidogenesis. 
7.6.3 Ketanserin in K+-stimulated Steroidogenesis_ 
Figure 7.14 shows that all doses of K+, ketanserin did not inhibit 
steroid output, although 5HT-stimulated corticosterone output was 
significantly inhibited at 10-9M - 10-7M and aldosterone output was 
inhibited at all doses of 5HT (p < 0.05). 
7.6.4 Ketanserin in AII-stimulated Steroidogenesis 
Figure 7.15 shows that ketanserin significantly inhibited the All 
stimulated aldosterone response at 10-8 M (p>0.05) and at all doses 
greater than 10-11M All, ketanserin significantly inhibited 
corticosterone output. In the same experiments, ketanserin inhibited 
5HT stimulated aldosterone output only at 10-8M - 10'7M 5HT. In a 
number of other experiments, ketanserin inhibited the All response 
curve at higher All concentrations and only affected the lower doses 
of 5HT-stimulated steroidogenesis (e. g. Figs 7.14 and 7.15). 
r, ---- 
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7.6.5 Effects of Hethysergide on the Dose Response Curve to ACTH 
Figure 7.16 shows the pooled data from two experiments for ACTH and ' 
5HT stimulated steroidogenesis. At all doses of 5HT, methysergide 
significantly inhibited both corticosterone and aldosterone output. 
For ACTH, corticosterone was significantly inhibited at 3x10-12M 
ACTH, 3x10-10M and 3x10-9M, although the percentage inhibitory effect 
at the highest dose of ACTH was not as great as for 5HT at 10-6M 
(ACTH stimulated corticosterone was reduced by approximately 33% 
compared to 50% for 10-6M 5HT). The aldosterone response was not 
significantly inhibited although the levels of significance and the 
large SEMs for each dose of ACTH may have disguised the inhibition as 
the graph clearly shows a tendency towards inhibition. 
7.6.6 Methysergide in K2. -stimulated steroidogenesis 
Figure 7.17 shows the typical dose response curve to K+ in M199 
(0.2%BSA). Fakunding (1979) had shown the response to K+ as 
plateauing at 8mMK+ and upwards. Individual experiments appeared to 
show this, although pooled data for the aldosterone resonse curve was 
more in keeping with the biphasic response curve described by the 
Taits (1980a and b). At all doses, methysergide (10-6M) did not 
affect K+ stimulated steroid output whereas 5HT-stimulated 
steroidogenesis was inhibited at all doses with methysergide. 
7.6.7 Effects of Methysergide on AII-stimulated Steroidogenesis 
In a typical experiment, methysergide significantly inhibited 
aldosterone output in AII-stimulated cells at the higher doses of 
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10-9M and 10-8M All (Fig. 7.18); corticosterone output was inhibited 
at the lower doses of All (10-10M - 10-9M) and 5HT-stimulated 
steroidogenesis was significantly inhibited at all doses. 
7.6.8 DISCUSSION 
Methysergide in vitro inhibited 5HT stimulated steroid production to 
almost basal levels in all the experiments. The effects did not 
appear to be a associated with a dose dependent inhibition as the 5HT 
concentration was increased. In Shah's (1979) study using rat renal 
cortical tissue stimulated with 10-4M 5HT, elevated cAMP levels were 
inhibited by methysergide. However a very high dose (10-4M) of 
antagonist was used and inhibition of cAMP may have been a result of 
interaction with dopamine receptors linked to the inhibition of 
adenylate cyclase i. e. D2 receptors (Missale et al., 1986) since 
dopamine receptors have been studied, in for example, the rat kidney 
(Felder 1984). Methysergide like several ergot derivatives, has 
dopaminergic agonistic properties, particularly at higher 
concentrations (Muller 1977). In an in vivo study undertaken by 
Krulich et al., (1978), infusions of 10mg/kg of methysergide (i. p. ) 
into rats, inhibited the release of prolactin and could be overcome 
by pretreatment with a dopamine antagonist; Krulich (1981), proposed 
that at high doses, i. e. greater than 0.1mg/kg methysergide, the drug 
was acting as a dopamine agonist, whereas at lower doses it showed 
serotonergic antagonistic properties. Similarly the antagonist 
inhibited ACTH and All stimulated steroidogenesis, although K+ 
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stimulated aldosterone secretion was not affected. This is in 
contrast to Mendelsohn's study with methysergide in which the drug 
inhibited K+ stimulated aldosterone output at 5mMK+ (Mendelsohn 
1981). The lack of inhibition in K+ stimulated cells would argue 
against the notion that methysergide at 10-6M has a toxic effect on 
the steroid secretions of the zona glomerulosa. Although dopamine 
has been associated with a tonic influence on basal aldosterone 
output (Carey et Al., 1982), methysergide if it does exhibit 
dopaminergic properties in these experiments, does not significantly 
inhibit basal aldosterone secretion as Fig. 7.2 shows. However 
several groups have reported that dopamine inhibits All stimulated 
aldosterone secretion both in vivo, and in vitro in rat, cow and 
human studies (McKenna et al., 1979., Birkhauser et al., 1979",, 
Edwards et al., 1975,1980a., Aguilera et al., 1984), so that 
methysergide's dopamimetic properties could be responsible for 
affecting the All stimulated secretions. Carey (1982) had suggested 
that in vivo in man, dopaminergic inhibition of aldosterone was 
independent of All and ACTH. Serotonin and dopamine are reported to 
have close interactions in several systems including brain striatal 
regions, which have close links (Lamberts et al., 1978); in other 
studies carried out with the dopamine antagonist metoclopropamide, in 
perfused rat adrenal cell columns, Edwards (1980a) , indicated that 
the potentiation of All stimulated steroidogenesis could be a result 
of its serotonergic agonistic properties and suggested that the two 
receptors might be closely coupled. In another in vitro study 
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using isolated rat adrenals in a static system Lauer (1982) tested 
the effects of metoclopramide on All, ACTH and K+ stimulated 
steroidogenesis. In this study a dose of MCP as low as 3x10-10M, 
significantly inhibited basal aldosterone secretion, which was ruled 
out as being a toxic effect. Further, the drug inhibited All 
stimulated steroid output in a dose dependent way over an All 
concentration of 2.4 x 10-10M -2.4 x 10-8M; at 3.5 x 10-11 M ACTH 
aldosterone output was significantly inhibited although 
corticosterone was not, nor was the corticosterone output affected by 
MCP in ACTH stimulated fasciculata cells; 5.9mM K+ stimulated steroid 
output was also significantly inhibited. Lauer argued that MCP in 
this-in vitro system, is acting at both 5HT and dopamine receptors, 
and its dopaminergic versus serotonergic antagonistic properties, are 
determined-'by the the relative concentrations of the amines within 
the tissue. To substantiate this hypothesis, incubating the cells 
under the same conditions with exogenous dopamine and MCP at 
increasing doses, produced an increase in aldosterone secretion in 
keeping with its dopamine antagonistic properties , so that assuming 
the cells have greater amounts of 5HT than dopamine; the antagonism 
to 5HT predominates. Despite the difficulty in understanding this 
concept in relation to drug antagonism, by a similar hypothesis, 
methysergide may be acting as a dopamine agonist and thus be 
responsible for the All and ACTH inhibitory effects., The lack of 
effect on K+ may be peculiar to this drug. In a similar in vitro 
study coordinated by Campbells group in 1981, increasing doses of MCP 
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(10-10M-- 10-5M) were coincubated with All, ACTH, K+ and 5HT. 
Unlike Lauer's group who used a MCP concentration of 3x 10-4M MCP, 
Campbell argued that this concentration and higher, had inhibitory 
effects on basal aldosterone and corticosterone output. Thus, they 
used a dose of 10-8M - 10-5M and found an inhibitory effect on All 
stimulated steroid secretion; there was a slight inhibition of ACTH 
stimulated steroidogenesis and no effect on K+ stimulated 
steroidogenes. This is more in keeping with the results found here 
with methysergide, although in Campbell's work dose response curves 
to All and ACTH in the presence of MCP, were not shown. However 
dose response curves to'5HT with two doses of MCP, 10-6M - 10-5M, 
showed competitive inhibition characteristics which they interpreted 
as MCP's serotonergic antagonistic proprties. The intepretation was 
based on diagrammatical representation of the competetion curves and 
analysis using the Schild plot method. This cannot be accurately 
determined using two antagonistic concentrations alone, and is 
therefore not a convincing intepretation of MCP's apparent 
competitive antiserotonergic properties; indeed, the fact that MCP 
also inhibits the All and ACTH response curves, would either suggest 
that the-drug is not a' clean' drug for intepretating receptor 
effects or that both 5HT and/or dopamine, have close interactions 
with receptors for the other adrenal zona glomerulosa stimuli and in 
this regard, methysergide may also be included in this effect. It 
has already, been indicated, in a previous chapter that dopamine and 
5HT modulate the response of basal and All stimulated 
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steroidogenesis, moreover, dopamine has been found in relatively high 
concentrations within rat and bovine cortical tissue (Hannah et al., 
1984., Racz et al., 984) and concentrations of 5HT within the 
adrenal have been measured in appreciable quantities as shown in 
Chapter 8. 
In in' vivo experiments, Birkhaüser (1979) showed that bromocriptine, 
a dopamine agonist with antiserotonergic properties also, modulated 
the plasma aldosterone response to infusions of All and ACTH and 
Edwards (1975) showed that bromocriptine reduced the aldosterone 
response to furosemide in man, suggesting a dopaminergic inhibition; 
Sowers et al., 1980 showed that in vivo' infusions of MCP directly 
stimulated plasma aldosterone'secret ion which was` independent of PRA, 
ACTH and this was considered to be due to its anti-dopaminergic 
properties at the level of the adrenal cortex; Maestri et al., 1985 
recently showed that MCP in vivo increased prolactin and plasma 
aldosterone levels independent of PRA and ACTH. However they argued 
that in this case, MCP was exerting a serotoninergic stimulatory 
effect as well as an antidopaminergic effect, and infusions of 
pizotifen ,a 5HT antagonist, reduced the plasma aldosterone increase 
to MCP, without affecting plasma prolactin levels in response to MCP. 
Methysergide, like MCP is- not a 'clean' drug and like all ergot 
derivatives, has dopamimetic effects"at high doses (Muller et al., 
1977)'and can displace binding of [3H]-dopamine and [3H]-spiroperidol 
from calf 'striatal membrane binding'' sites (Creese et al., 1976). 
However the in vitro and in vivo effects are complicated and 
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sometimes conflicting, but tend to suggest that there are close 
interactions between serotonergic and dopaminergic mechanisms in the 
control of aldosterone. 
That ketanserin inhibited the 5HT- and AII-stimulated steroid 
response without affecting basal concentrations at 10-6M, is more in 
keeping with a serotonergic interaction with All stimulated 
steroidogenesis. Leysen (1981), had shown in brain tissue that 
ketanserin has a very low potency for dopamine receptors i. e. 100 
times less than for 5HT2 receptors so the likelihood of dopaminergic 
interactions is remote in this instance. Hoyer (1985) described 
[3H]-5HT, recognition sites into subclasses 5HT1a, 5HT1b and 5HT1c. 
[3H]-5HT has complex binding to all 5HT1 receptors but they are 
distinguished by their ability to displace neuroleptics, agonists and 
P-blockers. In the case of 5HT1a sites, these have high affinity for 
the neuroleptic spiroperidol and 8-hydroxy-2 (di-n-propylamino) 
tetralin (80H-DPAT), and are in high concentration in rat and pig 
brain cortex and also have very low affinity for the 5HT antagonists 
methysergide, mesulergine and ketanserin. Recently however, these 
recognition sites have been correlated with adenylate cyclase 
activity (Kalkmau 1985 cited in Hoyer's study 1985). 5HT1b 
recognition sites have low affinity for spiroperidol, the new indole 
agonist. RU 24969, and selectively bind P-blockers such as (-) [1251 
iodocyanopindolol [125I] CYP in the presence of 30µM isoprenaline; 
they are now thought to be the subtypes of recognition sites that 
Fozard (1983a) described responsible for hyperlocomotory function in 
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rats treated with 5HT. The 5HT1b recognition site also has low 
affinity for ketanserin and is thought to be functionally related to 
the 5HT autoreceptor described in canine saphenous veins, which 
inhibits the release of [3H]-epinephrine after electrical 
stimulation. 5HT1c sites have high affinity for 5HT antagonists 
including pizotifen and [3H]-mesulergine; ketanserin shows relatively 
weak potency compared to its antagonism on 5HT2 receptors. The 
overall data from correlating binding affinities of the agonists and 
antagonists to labelled 5HT recognition subtypes, tends to suggest 
that for example, 5HT which in these steroid experiments stimulates 
steroid production at approximately 2-5x 10-9M 5HT, corresponds to 
a pKd figure of between 8-9. Similarly , the pKd values for 
significantly inhibiting 5HT stimulated steroidogenesis'of 
approximately 6, for both methysergide and ketanserin, would 
correspond with values for displacement binding to 5HT1a recognition 
sites _(see 
Hoyer et al., 1985). 5HT1a sites are thought to be 
associated with adenylate cyclase activation, which would be in 
keeping with the stimulation of cAMP in the steroid experiments. 
However, the ED50 for stimulation of cAMP, approximated between 10-8M 
- 10-7M 5HT, which is an order of magnitude greater than for 5HT 
stiumlated steroidogenesis. Ketanserin, although only weakly 
antagonistic, was more inhibitory at the lower doses of 5HT, around 
10-9M - 10-8M, at levels at which cAMP was infrequently or not at 
all increased. Therefore the possiblity exists that ketanserin is 
interacting with a subclass of 5HT1c recognition sites, which may 
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also be involved in stimulated steroidogenesis and also respond to 
5HT agonists, as seen in the indoleamine studies (Chapter 9). In 
Maestri's in vivo study (1985), inhibition of plasma aldosterone 
increase with pizotifen, could be due to interaction with 5HT1c 
recognition sites at the adrenal cortex but this is still highly 
speculative. In the rat fundus, 5HT agonists stimulate contraction 
and bind to 5HT1c recognition sites. The second messenger involved 
in recognition site coupling for the subclasses type lb and 1c, have 
not been elucidated but are apparently dissociated from adenylate 
cyclase action; since type 2 receptor mediated responses have 
already been extensively associated with several messengers including 
prostacylin, calcium and/or PI (see Serotonin Receptors, Section 5.4, 
Chapter 5), it is conceivable that 5HT1c receptors may also share 
similar second messenger modes of stimulation. The investigations 
are limited and further studies using a series of agonists displaced 
with an antagonist, in a physiological measured response system, as 
well as displacement studies for determining binding affinities of 
agonists and antagonists in the adrenal compared with brain regions, 
which have already been characterised for their recognition sites, 
need to be done before 5HT receptors (if they exist in the cortex) 
can be fully chäraeterised in relation to the dose related response 
curve, consistently obtained in vitro in the rat zona glomerulosa. 
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Chapter 8 
SEROTONIN IN THE ADRENAL GLAND 
8.1 SEROTONIN IN THE ADRENAL GLAND 
The origin of serotonin in the adrenal gland is not known. There 
exists the possibility that it is due to platelet release and is thus 
blood-borne (Osim et al., 1983). In the experiments and results 
described below adrenal 5HT was measured by HPLC before and after 
perfusion of the rat adrenal in situ with saline and simultaneous 
serum 5HT levels were also measured. 
8.2 PREPARATION OF ADRENALS FOR 5HT DETERMINATION BY HPLC 
Female Wistar rats of approximately the same age (8 weeks) and weight 
(100-120g) were ether anaesthetised and all the experiments were 
performed at the same time of day (9-10.30 a. m. ) to reduce any 
possible diurnal variation in 5HT levels (Albrecht et al., 1956). 
Perfusion was performed by prior ligation of the ascending aorta and 
below the renal artery and vein bifurcation in the descending aorta. 
A small clip was placed anterior to a fine tube inserted into the 
renal artery to prevent blood flow from the aorta into the kidney and 
adrenal. The tube was held in place by a tight thread and 
connected to a 100ml plastic syringe containing ice cold saline which 
was gently pushed out into the renal and adrenal vasculature. Upon 
perfusion and within 2-5 minutes the adrenal and kidney became 
blanched, and the adrenals were rapidly removed and placed in plastic 
sealed tubes on dry ice before being stored at -700C if they were not 
assayed on the same day. In the control experiments rats were 
anaesthetised and the adrenals were removed and assayed in the same 
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Comparison of Adrenal Serotonin Content 
In 
Perfused v Non-perfused Adrenals (meant 
SD ± SEM) 
Table 8.1 
Perfused Capsular [5HT]pg/g wet wt. [5HIAA]pg/g wet wt. Adrenal tissue 
0.3 0.18 
0.54 0.07 
0.35 0.14 
(3) (3) 
0.39±0.1 ±0.07 1 0.13±0.045±0.03 
() in parenthesis is number of experiments 
Non-perfused 
Capsular Adrenal 
tissue 
[5HT] ug/g wet wt. [5HIAA] ug/g wet wt. 
0.3 0.07 
0.5 0.04 
0.35 0.07 
(3) (3) 
0.38 ± 0.08 ± 0.06 0.06 ± 0.014 ± 0.01 
Statistics with Students paired t- test - no significant 
difference in perfused vs non-perfused capsular tissue. 
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way. Before homogenisation, adrenals were placed on ice and capsular 
portions separated from the rest of the adrenal to assay both 
portions separately. 
The preparation and assay of 5HT for adrenals and whole blood were as 
described in chapter 5. 
8.3 RESULTS 
8.3.1 Capsular Region 
Serotonin and its metabolite, 5HIAA were measured in the capsular 
portions as shown in Table 8.1.5HT levels averaged 0.39 + 0.1 f 
0.07 (S. D., S. E. M. ) pg/g wet weight in perfused and non-perfused 
adrenals and 5HIAA levels were sligh'ti. y but not significantly higher 
in the perfused capsules at 0.13 µg/g wet weight compared to 
0.06 pg /g wet weight in the non-perfused capsules. 
8.3.2 Decapsulated Adrenal 
Table 8.2 shows 5HT levels in the non-perfused decapsulated adrenals 
at 2.24 3 0.9 µg/g wet weight compared to levels of 1.67 f 0.24 µg/g 
wet weight in the perfused decapsulated portions after perfusion, 
which was not significantly different. Similarly, 5HIAA levels 
(Table 8.2) did not change significantly. 
8.3.3 5HT Serum Levels 
Serum 5HT levels were measured and are shown in Table 8.3. The 
values averaged Zinmol/ml which is approximately equivalent to 
0.7 µg/g wet weight. 
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5HT Concentration in Decapsular Adrenals : Perfused v Non-perfused 
(mean ± SD ± SEM) 
Table 8.2 
Perfused 
Decapsular 
Adrenals 
Non-perfused 
Decapsulated 
Adrenals 
[5HT] Iig/g wet wt. [SHIAA] iig/g wet wt. 
1.6 0.06 
1.43 0.08 
2.0 - 
1.67±0.24±0.17 0.07±0.01 
[5HT] ug/g wet wt. [5HIAA] ug/g wet wt. 
2.25 0.06 
1.13 0.06 
3.35 - 
2.24 ± 0.9 ± 0.64 0.06 
Perfused adrenal 5HT 
(by Students unpaired 
content decreased by 
t-test, this was not 
approximately 25% 
significant) . 
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Serum 5HT Levels 
Table 8.3 
Rat {5HT} µmol/I 
1 8.01 
2 2.89 
3 4.83 
4 3.71 
5 5.20 
6 1.98 
Mean 4.43 ± 1.93 
(± SD ± SEM) ± 0.87 
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8.4 DISCUSSION 
The results above suggest that most of the 5HT resides within the 
decapsulated portion of the adrenal gland. Unfortunately, it was 
not possible to further localise this to cortical as opposed to 
medullary regions. In perfusing the adrenals one might expect that 
removal of blood would reduce adrenal 5HT content. Although there 
was a hint of this, 5HT levels within the decapsulated adrenal were 
still considerably higher per unit wet weight than that measured per 
ml or per gram in whole blood in which platelets had been disrupted 
to release all bound stores of 5HT. Capsular tissue contained only 
approximately 25% of the concentration of 5HT in the inner adrenal 
and closely matched blood levels, which may suggest that disruption 
of contaminating platelets during homogenisation could have been 
responsible for the capsular levels measured. However, prior 
perfusion did not reduce the concentrations measured which would tend 
to indicate that significant levels of 5HT are present in the 
capsular regions of the adrenal cortex. As discussed in Chapter 9, 
it would appear that exogenous 5HT can be stored in the inner 
cortical regions. 
After the early separation and extraction methods for identifying 5HT 
pioneered by Vanable et al., 1963, it became possible to measure 5HT 
in organs previously not thought to contain any, and Snyder (1965) 
detected 5HT in the adrenal gland at " 0.45° µg/g wet weight levels. At 
around this time Potter and Axelrod(1963) localised 5HT , after 
exogenous administation of [1'C]-5HT, in the chromaffin granules, 
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using sucrose differential centrifugation. More recent methods using 
HPLC for measuring small amounts of tissue SHT, have estimated levels 
of 1.4 - 1.5 µg/g wet weight in the whole adrenal (Kuriyama et al., 
1984.9 Verhofstadt et al., 1983). Further, it has been proposed by 
Kuriyama's group that this endogenous 5HT is located in the 
adrenaline containing chromaffin granules rather than the 
noradrenaline containing granules. Exogenous administered 5HT by 
Bertler et al., in 1960, into rats showed that this too was taken up 
by the chromaffin granules. Biochemical determinations correlated 
with immunohistochemical staining studies by Holzwarth (1983) and 
Verhofstadt (1983), within the medullary region of the rat, although 
Petrovic (1984) could not localise it by histochemistry in this 
species (see also Chapter 11). Blood levels of 5HT were determined 
in dogs by Humphreys as early as 1954, who estimated values of 
0.4 µg/109 of 5HT in platelets, whilst Erspamer reported 5HT levels 
in rat serum of 0.57-µg/ml, which closely parallels these 
determinations. So far then, it is more than probable that 5HT is an 
endogenous amine in rat-adrenals, but where this arises, i. e. from 
blood, and is taken up into chromaffin granules and stored, or taken 
up into catecholaminergie nerve endings, thus displacing endogenous 
catecholamine stores present in the adrenal cortex (Kleitman et al., 
1985 see Nerve Innervation section) or is locally present within 
contaminating mast cells, which in the rat and mouse store and take 
up 5HT from the circulation, to be released during physiologically 
controlled mechanisms, is not known. 
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8.5 
: HANIPULATION OF ENDOGENOUS 
5HT LEVELS 
One way of looking at the physiological importance of 5HT in the 
control of aldosterone secretion at the level of the adrenal cortex, 
is to alter the endogenous levels. Serotonin levels can be increased 
by the administration of precursors such as tryptophan and 
5-hydroxytryptophan in vivo, or can be decreased by drugs that 
release endogenous stores, or alternatively by administration of 
drugs that inhibit 5HT biosynthesis. In a series of studies blood 
levels of 5HT in rats, were depleted or elevated by administration 
of pharmacological agents, and the in vitro response to 5HT and All 
was analysed. Angiotensin II was looked at in the first instance 
because 5HT antagonists were shown to be potent inhibitors of the 
aldosterone response to All. 
8.5.1 PCPA Administration 
Parachlorophenylalanine (PCPA) is a neutral amino acid derivative 
that in vivo is a non-competitive inhibitor of tryptophan 
hydroxylase. Koe (1966) showed that a single dose of PCPA in rats 
caused a marked and relatively selective depletion of 5HT in the 
brain (although it is also a potent inhibitor of peripheral 5HT 
biosynthesis). PCPA causes a relatively rapid depletion of 5HT 
within 24 hours which remains depressed for approximately one week 
(Fuxe et al., 1971). The disadvantages of PCPA include: (1) high 
doses of the drug have to be given which may affect tissue uptake and 
utilisation of other amino acids; and (2) PCPA also depletes 
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eatecholamine. However, the time course for eatecholamine depletion 
is longer when compared to 5HT depletion so that a short time study 
of PCPA's effects reduces the catecholamine depletion effects of the 
drug, and thus its involvement in any intepretation of results. 
In preliminary experiments a time-course study of the effects of a 
single dose of PCPA (i. p. ) on peripheral stores of 5HT, (in 
particular in the adrenal gland) were estimated in male Wistar rats 
200-250g: serum 5HT levels were used as a marker of the change in 51T 
synthesis since platelets take up 5HT from biosynthetic sites such as 
the GI tract. 
8.5.2 Rat Cannulation and Infusion of PCPA (i.. ) 
Male Wistar rats were used in this series of experiments since being 
larger, it was easier to perform cannulation operations. Rats 
between'200-250g were anaesthetised using ether and a cannula was 
placed in the carotid artery and exteriorised at the back of the 
neck. 
After allowing a 48 hour recovery period, blood samples were 
collected on day 3 at 11.00 a. m. in all rats divided into control and 
PCPA/5HTP treated groups immediately before drug treatments, i. e. day 
3 values were pre-drug control values for each set of rats, measuring 
plasma corticosterone (B), aldosterone, PRA and 5HT as described in 
Chapter 6. On day 4,24 hours after the first drug administration, 
blood samples were taken from each set of rats, and immediately 
after, another dose of drug administered; on day 5 another 24 hours 
after the previous dose, and 48 hours after the first dose of drug, 
blood samples were again taken and the rats sacrificed by cervical 
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dislocation as described in Chapter 6. The steroidogenic 
responsiveness of cells obtained from PCPA/5HTP treated rats were 
monitored relative to control rats which were treated with saline, 
using All and 5HT as stimuli. 
8.5.3 5HTP Administration 
5-Hydroxtryptophan is regularly used for increasing 5HT levels and is 
the substrate for the enzyme aromatic-L-amino acid decarboxylase. 
This enzyme is ubiquitous and is not restricted to 5HT synthesising 
sites. Thus, 5HTP can be converted to 5HT in catecholaminergic 
neurones containing the enzyme, and deplete catecholamine stores as a 
result of deposition of 5HT. To reduce the non-specific uptake of 
5HTP into tissues, lower doses (20-100mg/kg) have been used 
(Osborne 1982) and in this study L-5HTP at a dose of 20mg/kg was 
administered (i. p. ) into cannulated male rats. 
8.5.4 5HTP Administration into Cannulated Rats 
Rats were cannulated as described above; control rats were injected 
with saline (i. p. ) on days 3 and 4 and 5HTP treated rats were 
injected at the same time with 20mg/kg of L-5HTP. Blood samples were 
collected at similar time intervals over 3 days as for 
the PCPA study, and on day 5 after blood samples were obtained, the 
rats were killed and adrenals isolated for in vitro experiments, 
measuring the aldosterone secretion in response to All and 5HT. 
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Serum 5HT Levels after Single Dose (i. p. ) 
of PCPA (320 mg/kg) - Time Study 
Table 8.4 
Day 1 2 6 8 
Control 4.60 5.00 1.50 2.20 
{5HT} 3.40 3.15 4.65 1.20 
µmol/I 3.40 2.02 
4.00 ± 0.60 3.85 ± 0.80 3-01 ±1.57 1.81 ± 0.43 Mean 
t 0.60 t 1. S9 t 0.31 
+ PCPA 1.00 1.90 0.87 4.20 
{5HT} 3.00 1.43 3.40 2.80 
µmol/l 1.54 2.70 4.35 
Mean ± SD 1.87 f 1.04 2.01 ± 0.60 2.13 ± 1.80 3.78 ± 0.80 
f SEM f 0.60 f 0.40 t 1.26 f 0.49 
Table 8.5 
Whole Adrenal 5HT Levels after Single Dose 
(i. p. ) PCPA (320 mg/kg) Time Study 
Day 1 2 6 8 
Control {51-IT} 0.79 0.67 0.88 13.00 
µg/g wet wt. 1.30 0.54 1.20 10.56 (whole 
adrenal) 
Mean 1.04 ± 0.25 0.60 ± 0.06 1.04 ± 0.16 11.78 ± 1.2 
+ PCPA {5HT} 0.47 0.37 0.74 2.20 
µg/g wet wt. 
(whole 0.40 0.40 0.35 1.23 
adrenal) 
Mean ± SD 0.43 ± 0.05 0.38 ± 0.02 0.54 ± 0.27 1.75 t 0,48 
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8.6 RESULTS 
8.6.1 PCPA Time Study 
Table 8.4 shows the concentration of 5HT in pmol/l in rat serum over 
8 days in control and PCPA-treated rats. On day 1 5HT levels 
approximated 4.0pmol/l in the control group compared to 1.87µmol/l in 
the PCPA group which showed a depressing trend although this did not 
reach a level of significance until day 2 (p< 0.05); on all following 
days 5HT levels in the PCPA and control groups were not significantly 
different. 
Table 8.5 shows the corresponding changes in 5HT levels in the whole 
adrenal over the same time period in the same group of rats. Here 
again there was a trend towards reduction in 5HT levels 24 hours 
after a single dose of PCPA from I. 01µg/ wet weight to 0.43µg/wet 
weight in the treated group although on this and day 2) the levels 
were not significantly different by statistical analysis. However, 
only a few rats were taken in this limited study and a greater 
number of measurements given more time might have delineated a 
clearer trend; there were also anomalies in the measurement of 5HT 
in the control adrenals compared to the PCPA treated rats on day 8. 
The levels were exceedingly high compared to the PCPA group and even 
in comparison to the other control data, levels of 5HT were very 
high. 
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8.6.2 DISCUSSION 
As mentioned earlier, brain 5HT levels are reduced within 24 hours 
and remain depressed for up to a week after a single dose of PCPA; in 
these studies it appears that there is a trend towards a close 
parallel in 5HT levels in serum and adrenals at 24 hours and 48 
hours, but 5HT levels return to control values more rapidly in the 
blood compared with the adrenal gland as indicated by percentage 
changes. For example, after day 6,5}IT levels in the serum in PCPA 
treated rats approached 2/3 the control levels, compared with 
approximately 1/2 5HT concentration in the PCPA treated adrenals 
after day 6, whereas after day 1 and day 2,5HT levels in both the 
adrenals and the blood respectively, approximated 1/2 the control 
value. Thus, over 24 hours and more significantly at 48 hours, 
serum levels may be a good indicator of what is happening at the 
level of the adrenal after a single dose of PCPA. However, there may 
be differential recovery of several 5HT synthesising organs within 
the rat after PCPA administration, thus after a maximum of 48 hours, 
some organs, such as the GI tract, may begin to recover and 
synthesise 5HT which would be reflected as an increase in 5HT storage 
in platelets. In contrast, synthesis of 5HT within the adrenal 
appears to show slower recovery after PCPA administration. This data 
would argue for a possible local synthesis of 5HT within the adrenal 
as well as/or blood contaminating 5HT levels. The previous results 
showed that perfusing capsular and decapsulated adrenals, did not 
completely remove 5HT. 
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PLASMA ALDOSTERONE AND CORTICOSTERONE VALUES 
IN ± PCPA TREATED RATS 
Table 8.6 
Plasma Aldosterone ng / 100 mis 
Days 3 4 5 
Control + PC PA Control + PCPA Control + PCPA 
17.86 59.8 17.86 214.3 17.85 58.9 
48.2 57.1 58.9 73.2 75.0 73.2 
58.0 32.1 13.4 38.4 223.0 54.4 
44.6 17.8 69.6 50.0 35.7 59.8 
80.35 20.5 141.1 53.6 29.5 - 
. 
75.0 - 25.8 - - - 
25.8 - - - - - 
49.9 ± 37.1 ± 54.4 ± 85.9 ± 76.2 ± 61.6 ± 
21.6 ± 17.3 ± 44.0 ± 65.0 ± 75.8 ± 6.9 ± 
8.9 8.7 21.6 33.0 38.0 4.04 
N. S. N. S. N. S. 
Plasma Corticosterone ng /mi 
Table 8.7 
Days 3* 4* 5 
Control + PC PA Control + PCPA Control + PCPA 
307 . 418 96 825 58 135 
289 446 638 563 536 1140 
590 206 690 552 500 820 
470 164 166 477 359 500 
329 37 599 602 582 - 
350 - 717 - - - 
345 - - - - - 
383 ± 254 ± 484 ± 603 ± 407 ± 649 ± 
100 ± 78 253 ± 119 ± 373 ± 373 ± 
41 114 60 215 215 
N. S. N. S. N. S. 
I 
Each value =1 rat 
* p<0.05 
8.7 IN VIVO EFFECTS OF PCPA AND 5HTP ON BLOOD PARAMETERS AND THE 
RESPONSIVENESS OF ZONA GLOMERULOSA CELLS TO All AND 5HT 
8.7.1 PCPA Treatment 
Tables 8.6 and 8.7 show the results of one PCPA experiment, although 
two similar experiments showed similar trends; PRA values were 
incomplete for all days on individual experiments and are thus not 
included in the final analysis. Plasma corticosterone and 
aldosterone were measured on days 3,4 and 5 and in all cases PCPA 
did not significantly alter the levels compared to control values or 
between the same group on different days except between day 3 and 4 
for the PCPA rats (p <0 . 05), where day 3 represents pre-drug plasma 
B values, and day 4, plasma B values 24 hours after the first dose of 
PCPA; plasma aldosterone was not significantly different in the same 
group. 
However, over the same time scale 5HT levels (Fig. 8.1) in the serum 
were significantly depressed (p < 0.001) by day 5 from 8.6µmoi/l to 
1.6µmo1/1 when the adrenals were used in in vitro studies. 
8.7.2 Responsiveness of Zona Glomerulosa Cells to All and 5HT in 
Control and PCPA Treated Rats 
As can be seen in Fig. 8.2, basal steroid output of aldosterone in 
control and PCPA-treated rats, were significantly different (p<0.05), 
with depressed steroid output in the PCPA'group compared to the 
control group. At all doses of stimulus, a steep dose response curve 
was achieved in the control group. In the PCPA group there is still 
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Fig 8.1 
Whole serum serotonin levels in ±PCPA treated rats 
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Fig 8.2 
Dose response curve to 5HT and All in control vs PCPA treated 
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Plasma PRA, Aldosterone & Corticosterone Values In ± 5HTP Treated Rats 
PRA ng/ml/hr 
Table 8.8 
Tat 
Tat 
Days 3 4 5 
Control +SHTP Control +SHTP Control +5HTP 
60.2 41.6 100.48 21.2 32.0 
60.2 41.6 34.0 30.0 28.0 7.8 
40.4 20.1 96.0 22.0 40.0 34.8 
40.4 80.4 24.0 1.6 52.0 - 
- 20.6 41.2 - 24.0 - 
- 70.9 10.6 - - - 
62.0 47.6 52.3 25.1 31.0 24.8 
±12.4 ± 6.22 ±35.0 ± 5.7 ±14.0 ±12.0 
± 7.4 ± 8.8 ±14.1 ± 3.3 ± 7.0 ± 8.6 
N. S. N: S. N. S. 
ale 8.9 Aldosterone , ng/100 mis 
Days 3 4 5 
-Control 
+SHTP Control +5HTP Control +SHTP 
17.8 38.4 80.35 60.7 48.2 58.9 
47.2 25.0 33.9 21.4 23.2 33.9 
19.6 . 214.0' 46.4 20.5 80.3 26.8 
- 18.75 25.0 - 77.7' - 
- 116.0 - - - - 
28.2 82.4 46.4 34.2 57.3 39.8 
±13.5 ±74.0 ±21.0 ±18.7 ±23.4 ±13.7 
± 9.5 ±37.0 ±12.0 ±13.0 ±13.5 ± 9.7 
N. S. N. S. N. S. 
Plasma Corticosterone ng/ml 
ale 8.10 
Days 3 4 
.5 
Control +SHTP Control +SHTP Control +SHTP 
430 612 182 560 91 248 
599 230 412 220 485 353 
858 647 248 99 248 509 
103 83 128 232 - - 
- 696 299 - - - 
- 504 - - - - 
462 495 277 254 370 259 
± 249 ± 316 ± 197 # 110 ± 131 ± 147 
± 102 ± 158 ± 99 ± 49 + 76 ± 65 
N. S. N. S. N. S. 
i 
1 
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a clear and significant dose response curve to each stimulus, however 
the absolute levels are significantly reduced at all doses compared 
to the control response. Although basal levels are depressed, the 
lowest dose for stimulating steroid output above basal levels, is not 
altered, i. e. the sensitivity by this definition, is not altered, 
but rather the responsiveness is reduced significantly at all doses. 
8.8.1 5HTP Treatment 
Tables 8.8,8.9 and 8.10 show plasma PRA, corticosterone and 
aldosterone respectively in control and 5HTP-treated rats on days 3, 
u and 5. Over the time period of blood sampling no significant 
changes occured in PRA, cörticosterone or aldosterone in the 5HTP 
treated rats compared to the control group. However, 5HT levels were 
significantly elevated (p < 0.05) in the serum by day 5 when in vitro 
experiments were performed (see Fig. 8.3). 
8.8.2 Responsiveness of Zona Glomerulosa Cells to All and 5HT in 
Control and 5HTP Treated Rats 
Figure 8.4 shows the dose response curves to All and 5HT and 
aldosterone output per 100,000 cells in one experiment representative 
of two other experiments showing similar results. The basal steroid 
output was not increased in the 5HTP group in this experiment 
although in both other experiments basal levels were increased 
relative to the control group. However, in these two experiments, 
serum 5HT levels were not significantly elevated by day 5 compared to 
the control group. In the data shown (Fig. 8.4 and Fig. 8.3) 5HT 
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Fig 8.3 
Whole serum serotonin levels ± 5HTP treated rats 
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Fig 8.4 
Dose response curve to 5HT and All in control vs 5 HTP treated 
rats in Isolated zona glomerulosa cells 
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serum'levels were increased by day 5, and the dose response curve was 
elevated at the higher doses of the stimuli, although the sensitivity 
of the response was not altered, the maximum responsiveness appeared 
to be increased by 5HTP treatment. 
8.9 DISCUSSION 
From the in vitro findings it would appear that depletion of 5HT in 
the whole animal causes a marked and reproducible depression of basal 
steroid output at the level of the adrenal. However in the case of 
the 5HTP experiments, although the responsiveness and sometimes basal 
steroid levels were increased by 5HTP treatment, serum 5HT levels did 
not always parallel these changes, thus changes in 5HT levels in the 
serum may be dissociated from the effects at the level of the 
adrenal. 
Blood samples were taken at 24 hour intervals prior to a dose of PCPA 
on the same day, so that plasma steroid measurements recorded the 
effects` of the previous dose of the drug 24 hours before. Thus, the 
chronic effects on these parameters indicated that 5HT depletion did 
not result in a reduction in plasma aldosterone levels in each group 
or relative to one another i. e. inter- and antra-groups, unlike the 
in vitro findings; interestingly after the first 24 hours of PCPA 
treatment, plasma corticosterone within the same group of rats on 
PCPA treatment, 'was elevated thus the drug may be acting on the 
higher centres, possibly affecting ACTH and other pituitary factors 
(see later) although the trend is in the opposite direction to the 
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work of Vernikos-Danellis (1973) and is not readily explicable. What 
is probably a more valid measure are the plasma values for each 
group of rats on a given day, and in this case, plasma parameters did 
not alter for any day. PCPA takes at least 24 hours to deplete 
5HT 
levels so that measurements over this time period are valid in 
indicating an effect of 5HT depletion as opposed to the injection of 
a drug per se. The in vitro experiments are unique in that they 
isolate the zona-glomerulosa cells from all circulating factors that 
together influence plasma aldosterone levels, so this allows one to 
look at-the effects of individual stimuli. In this case, if 5HT 
depletion is having an effect on aldosterone output in vivo, the 
effects are masked by other, factors which also regulate basal steroid 
output, such as All (Aguilera et-al 1978a and 1978b) in the rats= 
although pituitary factors especially in the sodium deplete state, 
are thought to exert an important regulatory influence (Palmore et 
al., -1970., Pratt et al., 1981, Brown et al., 1979., McCaa et al., 
197I., Dawson-Hughes et al., 1981). It is interesting however, that 
increasing 5HT levels increases basal output in some experiments and 
decreasing 5HT levels has the opposite effect, in that the levels of 
the indoleamineappear to exert a prominent 'tonic' influence on 
steroid output, either within the periphery or at higher centres and 
further, this tonic influence also modulates the dose response to All 
and 5HT in the, in vitro set up. 
This is similar to the in vitro and in vivo effects seen with 
dopamine, which has been regularly postulated as exerting a tonic 
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inhibitory influence both on basal and All stimulated steroidogenesis 
(Carey et al., 1982., Edwards et al., 1975,1980a., Noth et al., 
1980., Aguilera et al., 1981,1984., Lauer et al., 1982., McKenna et 
al., 1979). Indeed Aguilera has postulated that dopamine exerts a 
potent inhibitory effect on the dose response to All infusions in 
rats on high salt intake, which can be overcome with coinfusions of 
dopamine antagonist, metoclopropamide. In man, Drake et al., 1984, 
found that the plasma aldosterone response to All infusions in low 
salt-diet, -was also blunted by the administration of dopamine, which 
more directly involved dopamine in'modulating the response; the 
effects of dopamine could not be'seen in normal sodium status. It is 
conceivable that"the effects of dopamine'are closely interactable 
with a serotonergic tonic influence in differing salt status, i. e. in 
the high salt state, 5HT may be reduced or may not change (see 
Chapter 10), but be effectively reduced in relation to dopamine 
concentrations; the converse may hold for the low salt state (see 
Chapter 10). In the results obtained in vivo for PRA in 5HTP-treated 
rats, the effects of 5HT on the adrenal appeared to be independent of 
a renal influence in the chronic measurement; Nisbet (1987) however, 
showed that acute measurements of PRA and plasma aldosterone, after 
5HTP administration, revealed an increase in both parameters with 
increased 5HT serum levels. It has already been discovered that 
there are neural links between the hypothalamus and the kidney 
(Dempster et al., 1978) and 5HT within the brain has several putative 
functions as a neurotransmitter, both within the brain and also 
208 
possibly as a sympathetic neurotransmitter within the renal nerves. 
Petrovic showed that there existed large quantities of 5HT within the 
kidney although neural containment was not mentioned (Petrovie et 
al., 1984). However it has been shown by several groups that 5HT acts 
centrally to induce changes in PRA concentrations in the plasma. 
Zimmerman (1980), injected 5HTP into dogs to increase 51sT levels in 
the brain and periphery and by differential inhibition of the 
peripheral decarboxylase enzyme using carboxydopa, showed that PRA 
levels were significantly elevated 15 and 30 minutes after the 
injection of 5HTP whereas the PRA levels were not increased when 
brain decarboxylase was also inhibited with benserazide. These 
results do not rule out a peripheral effect of 5HT on PRA but rather 
suggest a more prominent role for 5HT within the brain controlling 
PRA, at least acutely. However, the lack of conclusive results for 
5HT precursors and depletors on PRA in this chronic study are in 
keeping with other studies. Maestri (1985), showed that plasma 
aldosterone was-increased without concomittant changes in PRA and 
potassium when MCP was administered and this could be reduced by 
administering the serotonin antagonist pizotifen, thus suggesting a 
tonic effect of 5HT on plasma aldosterone at least when measured in 
an acute study over an hour. Sowers et al., 1980 found similar 
effects with MCP in vivo but had postulated that this was a 
dopaminergic phenomenon. Similarly, direct infusions of 5HT into man 
suggested to Mantero and co-workers (1979), that 5HT can stimulate an 
acute increase in plasma aldosterone levels (over an hour) 
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independent of other factors including PRA and K+. Whether 5HT 
increases plasma aldosterone through a central and/or peripheral 
mechanism at the level of the adrenal is still not clarified. As 
indicated in other studies, 5HT exerts important neural influences on 
the secretion of hypothalamic and pituitary factors such as CRF, 
endorphin, fLPH, ACTH; these aldosterone stimulating factors and 
others such as oI -MSH, j_MSH, 
' 
-MSH and ASF, also exist within the 
pituitary and hypothalamic area, which is rich in serotonergic 
innervation (Petraglia et al., 1984) and may be subject to 
serotonergic control. The pituitary also contains 5HT containing 
cells and a decarboxylase capable of converting 5HTP to 5HT, so 
central 5HT may be involved in a paracrinal role in controlling 
pituitary-adrenal axis steroidogenesis. Shenker et al., -1985 showed 
that oral administration of 5HTP into humans increased plasma 
aldosterone levels but peripheral inhibition'of its conversion to 5HT 
did not alter the increase in-plasma aldosterone, which was ' 
independent of PRA, K+ or ACTH levels. ' They suggested a central 
serotonergic involvement in aldosterone secretion which may also be 
an important aetiological factor in the hypersecretion of aldosterone 
seen in primary aldosteronism. Gross -et al., 1981 had previously 
shown that cyproheptadine (a 5HT antagonist) given to 
hyperaldosteronism patients, reduced plasma aldosterone levels. In 
idiopathic hyperaldosteroinsim, the sensitivity to All and 
responsiveness is increased, and the extrapolation that this is due 
to higher 5HT concentration within the brain and/ or periphery, -coüld 
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account in part, for the some of the in vitro findings in this study 
when 5HTP increases plasma, and possibly adrenal levels of 5HT, and 
potentiated the response to All and 5HT at the higher doses. Indeed, 
a neural component has been postulated in controlling the sensitivity 
and pulsatility of corticosterone secretion at the adrenal with ACTH 
(Ottenweller et al., 1978,1982), so that a central neural 
serotonergic element which controls the 'tonic' aldosterone output, 
is a possible factor in aldosterone biosynthesis. Alternatively, 
diurnal disruption of ACTH known to occur with PCPA administration, 
with an increase in the a. m. low ACTH and prevention of the p. m. rise 
in ACTH secretion, may affect steroid biosynthesis and basal and 
stimulated -levels. Inýthis regard an important in vivo and in vitro 
study undertaken by Vernikos-Danellis's group in 1973 indicated that 
after a single dose or-two daily doses of PCPA in rats, the plasma 
corticosterone levels decreased and there was a parallel drop in in 
vitro corticosterone output in basal incubates as well as a reduced 
response to exogenous ACTH both in vivo and in vitro. Serotonin 
concentration within the brain was reduced to 20% the control values 
and there was an associated disruption in the circadian ACTH rhythym 
of-secretion. Thus, although the changes in 5HT within the brain 
appeared to be an important controlling factor in adrenal 
responsiveness, the effects were not specific for the zona 
glomerulosa and aldosterone biosynthesis, but rather an. ACTH- (and 
/or related-peptides of the precursor hormone POMC), related effect 
on adrenal status. The effects of a single dose of PCPA on diurnal 
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changes lasts for 48 hours although 5HT levels remain low, so there 
is a clear dissociation between the two effects. However in these 
studies, rats were sacrificed 24 hours after the last PCPA injection, 
so that diurnal changes may in part have been responsible for the 
observations. 
An effect of 5HTP administration in the opposite direction on diurnal 
rhythms was also observed by Popova et al., 1972, when they 
administered 5HTP to normal and hypophysectomised rats, in an attempt 
to localise the serotonergic effects to either peripheral or central 
mediated mechanisms. Hypophysectomy abolished the increase in plasma 
corticosterone seen in control rats after 5HTP administration, 
suggesting that the effect of 5HTP and 5HT are centrally mediated, at 
least in the control, of adrenal corticosterone biosynthesis; by 
another means of increasing local concentrations of 5HT, Fuller et 
al., 1980, administered a specific 5HT releasing drug from neurones, 
parachloroamphetamine (pCA) into conscious rats, and during the time 
study plasma corticosterone levels increased within an hour of the 
injection, returning to basal' values within-4 hours. Here again, it 
appears that 5HT generally has s-a stimulatory effect on corticosterone 
but this does not rule out the possiblity that 5HT can specifically 
stimulate aldosterone in the zona glomerulosa by a central and/or 
peripheral mechanism, which was not specifically looked for in the 
studies on diurnal ACTH regulation and its relation to corticosterone 
biosynthesis. -A possible peripheral component of 5HT's effects was 
suggested by Van de Kar et al., 1985 in which pCA, a drug that 
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releases 5HT stores, was administered to rats, and 2 hours later the 
rats were sacrificed and plasma corticosterone levels measured. By 
selective manipulations that included severing afferent connections 
to the hypothalamus from dorsal and medial raphe; mediobasal cuts in 
the hypothalamus which severed connection between the hypothalamus 
and pituitary; and hypophysectomy which removed pituitary influences, 
5HTP induced changes in plasma corticosterone secretion even after 
hypophysectomy and thus pituitary influence. 5HTP administration 
acutely increased plasma corticosterone slightly but significantly. 
Unfortunately in this study, plasma aldosterone levels were not 
measure, the inference made is that 5HT and/or it's precursor, may 
have a small but significant peripheral (and possibly direct) effect 
at the level of the adrenal cortex in altering steroid secretion. - 
Similarly, in the in vivo and in vitro results above, manipulation of 
5HT levels appear to alter adrenal reponsiveness, and the lack of 
effect on plasma aldosterone levels in vivo could be a result of a 
more acute effect not seen over this time-scale. In the early 
sections of this chapter, measurements of 5HT in the adrenal were 
given which by any standards is high in tissues with high established 
serotonergic content e. g. brain approximately 1.5-2µg/g wet weight in 
some regions, such as the dorsal and raphe nuclei (Osborne 1982), so 
the possibility exists that 5HT is a locally stored amine within the 
adrenal; further, the metabolism studies, (Section 9.3, Chapter 9), 
indicate some storage of exogenous 5HT within'the inner cortex and 
medulla. 'In addition therefore, 5HT may be taken up as an exogenous 
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source, from the circulating platelets and stored in the medulla 
/cortex in the same way that has already been postulated for dopamine 
in defining a paracrinal role influencing 'tonic', and All 
stimulated steroidogenesis. In other tissues, such as the 
hypothalamus, Jones (1977) showed that 5HT in a dose range of 
10-9M - 10-6M, could stimulate in a dose dependent way, the release 
of CRF and serotonergic innervation and control of CRF release is 
well established. That 5HT also stimulates steroidogenesis within 
this dose range in the adrenal cortex , could be extended to a 
serotonergic neural involvement here, but to date there is no 
evidence to suggest this. Serotonin concentrations may also regulate 
and/ or modulate other possible local regulators such as dopamine, 
which could play a more direct role in the effects seen here. Thus, 
in PCPA treated rats, decrease in 5HT levels within the adrenal may 
reduce "a possible fine control between dopamine and 5HT in 
controlling the release of somatostatin, which is known to inhibit 
plasma aldosterone secretion through well characterised receptors in 
the rat adrenal. Aguilera'(1981) had previously suggested a 
dopaminergic inhibition of aldosterone mediated through somatostatin 
release which could then interact with well characterised 
somatostatin receptors in reducing aldosterone biosynthesis. The 
possiblity exists of extending this fine control-of somatostatin 
regulation through 5HT-dopamine ratios, in that high SHT: DA ratios 
would inhibit its release and'vice versa for high DA: 5HT levels. 
Another serotonergie involvement in the control of othe regulatory 
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factors of aldosterone includes a modulatory role on p{-MSH release, 
particularly in low sodium status, or in the pathophysiological state 
of idiopathic hyperaldosteronism. In the latter instance, the 
aetiology includes enlargement of the pars intermedia, which contains 
several pituitary peptide fragments including o( -MSH; in low sodium 
too, Vinson, et al., 1980 indicated that c, -MSH levels are increased 
in low salt status. One could speculate that in both instances, an 
increase in serotonergic stimulation to the hypothalamic and 
pituitary regions could induce these changes in o/ MSH level which 
are known to stimulate aldosterone secretion in the low salt state 
(Whitehouse et al., 1982). That sodium per seýmay alter the 
sensitivity of, the adrenal to aldosterone stimulating factors 
including All, and in some reports, to ACTH (Oelkers 1974., Kinson et 
al.,, 1968) is recognised, but-that 5HT concentrations may be altered, 
or that sensitisation changed as a result of changes in 5HT levels is 
discussed more fully in Chapter 10. 
Other factors were described in the introductory chapters as 
modulating the steroid output both in vivo and in vitro. PCPA may 
have depleted to some extent cateeholamine levels within the 
medullary tissue and affected steroid biosynthesis; similarly in the 
case of 5HTP administration, newly synthesised 5HT can be achieved by 
displacement of *endogenous catecholamines within medullary granules 
and/or cateeholaminergic sympathetic neurones, so the possibility 
exists that 5HTP indirectly increases the local concentration of 
'catecholamines within the adrenal, which potentiates steroid 
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biosynthesis in a non-discriminate way. The salient feature of these 
studies lies in the observations that altering 5HT levels with these 
drugs, may affect plasma corticosterone, aldosterone and PRA acutely, 
but that the in vitro responsiveness of the zona glomerulosa cells is 
altered chronically, even when other parameters are not significantly 
changed within the two groups on the same day of sampling. Thus the 
events appear to be dissociable from the effects of other circulating 
factors including ACTH. The consequences of altered responsiveness 
and possibly sensitivityin vivo, could be investigated further, by 
infusion studies of All, ACTH and potassium and comparing the dose 
response of plasma aldosterone in PCPA/5HTP treated and control rats. 
Further studies of the effects of changing endogenous 5HT levels on 
the dose response to All infusions in altered salt diets may point to 
a possible modulatory role of 5HT and/ or dopamine in altering 
adrenal sensitivity. A peripheral involvement of 5HT levels in 
modulating plasma aldosterone levels could also be dissociated from 
central effects by using hypophyseotomised rats. That 5HT is 
intimately involved at some level in the 'tonic' control of 
aldosterone biosynthesis, and moreover, the likelihood of it's direct 
local stimulatory effect, is credible given the reproducible dose 
response curves with incubation of cells with exogenous 5HT within 
the physiological range 10-9M. 
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Chapter 9 
THE METABOLISM OF SEROTONIN IN THE ADRENAL 
9.1 METABOLISM OF SEROTONIN 
Although histochemical techniques are useful in indicating SHT 
storage, metabolic studies that follow the pathway of 5HT or its 
precursors 5-hydroxytryptophan (SHTP) or tryptophan, provide a 
dynamic picture of storage and turnover. One of the first studies 
undertaken to follow 5HT storage in the whole animal was done by 
Bertler et al., 1960 in which rabbits were injected i. v. with 5HTP 
and the amount of 5HT formed'in the adrenal medulla was measured by 
differential centrifugation.. Serotonin was localised in the medulla 
in concentrations of 1.4µg /adrenal pair and furthermore appeared 
within cytoplasmic granules rather than within the cytoplasm itself. 
It was suggested that in this species at least, the adrenals contain 
enzymes capable of converting 5HTP to 5HT. Further to these precursor 
studies Gershon et al., 1966, injected radioactive precursors [3H]- 
5HTP or [14C]-5HTP into mice, demonstrated by autoradiography 
'active' sites of 5HT turnover and this allowed for the measurement 
of tissue radioactivity, and chromatography of products formed. 
5-hydroxytryptophan differs from 5HT in that it penetrates the brain, 
liver, the gastrointestinal tract and any other organ that contains 
the enzyme aromatic amino acid decarboxylase. Moreover, the ability 
of cells to accumulate 5HT from 5HTP appears to be linked to the 
endogenous levels of 5HT. The relationship is reciprocal in that 
cells with large amounts of endogenous 5HT accumulate less amine, 
compared to those with lower amounts of endogenous 5HT. Gershon 
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(1966) found high concentrations of radioactive 5HTP in the adrenal 
which was rich in decarboxylase activity but poor in 51T content. 
Although there is evidence for storage of 5HT in the medulla 
(Holzwarth et al., 1983., Verhofstadt et al., 1983., Kuriyama et al., 
1984). In early studies, Gershon (1966) showed that there did not 
appear to be a rapid turnover of 5HT in the whole adrenal gland, with 
administered radioactive 5HT remaining in the gland for 72 hours. 
Furthermore, 90% of the [3H]-5HT remained in the adrenal compared to 
58% and 41% in the spleen and lung respectively. There were no 
detectable metabolites occurring in adrenal tissue compared to 13% 
and 14% metabolites in the spleen and lung respectively and in these 
studies, it appeared that the adrenal gland was capable of converting 
the maximal amount of precursor 5HTP to 5HT. Despite this evidence 
for precursor requirement for 5HT synthesis, 'it is not known how much 
circulating 5HTP is readily available for uptake. 
More recent in vitro studies were carried out by Trost et al.,, 1976 
in which decapsulated and capsular tissue from bovine adrenals were 
incubated at 370C in the presence of [3H]-5HT and the accumulation of 
[3H]-5HT and/or its metabolites measured by TLC and liquid.. 
scintillation counting. Trost's work indicated that [3H]-5HT was 
taken up, both by the capsular and decapsular tissue, and compared to 
other tissue fragments, the highest proportion of radioactivity was 
found in the capsular portion of the adrenal gland and the aorta with 
a 'ceiling' effect of accumulation in the aorta and the decapsular 
portions after 1 hour, suggestive of what Gershon had called !.. the 
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endogenous 5HT binding site pools. ' In contrast, 5HT accumulation 
continued to rise in the capsular portions during the second hour of 
incubation. In decapsulated tissue, [3H]-5HT was taken up 
independent of increasing concentration of the amine, until 
concentrations of 10-3M-10-2M were reached, whereas in the capsular 
portion tissue radioactivity fell with increasing [3H]-5HT; the 
capsular tissue converted 3-4 times more 5HT to 5HIAA per unit weight 
than the decapsular portions of tissue incubates. The fractional 
retention of radioactivity varied with incubation time and the 
initial 5HT concentration. From these studies it appeared that the 
capsular tissue did not store the amine. More recent studies by 
Holzwarth (1983) failed to identify any 5HT containing neurones, 
which also argued against 5HT storage in capsular and outer cortical 
tissue. However, 5HT has been measured in rat adrenal medullary 
tissue by HPLC (Verhofstadt et al., 1983., Kuriyama et al., 1984) and 
localised by immunohistochemistry techniques (Verhofstadt 1983., ) 
Vaccari et al., 1977 measured the levels of 
tryptophan hydroxylase, the rate limiting enzyme in 5HT biosynthesis 
and L-aromatic amino acid decarboxylase in several brain regions and 
the adrenal glands of male and female rats at different stages of 
development. In these studies it was found that in 60 day old adult 
rats tryptophan hydroxylase levels in the adrenal gland were 
0.43nmol/hr/g protein in females compared to 0.34nmol/hr/g protein in 
males. This compares to some regions of rat brains of similar age 
e. g. mesodiencephalon where the levels are 0.36nmol/hr/g protein in 
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females and 0.16nmol/hr/g protein in males. Furthermore L-aromatic 
amino acid decarboxylase in the adrenal occurs with values of 
18.312.6 µmol/hr/g protein in females compared to 29.2 µmol/hr/g 
protein in males. In the pons brainstem region where the activity of 
this enzyme is considered to be high, the values for female rats 
average 6.9 pmol/hr/g protein and 7.8 pmol/hr/g protein in male rats. 
Monoamine oxidase (MAO) is also found in the adrenal at levels of 
approximately 14.6 µmol/hr/g protein in both females and males. MAO 
activity can be found in both the adrenal medulla and the cortex and 
in studies carried out by Youdim in 1974 (cited in Youdim 1976) MAO 
activity was more concentrated in the cortical tissues of rat, pig 
and dog compared to medullary tissue. The presence of L-aromatic 
amino acid deearboxylase and monoamine oxidase (MAO) in the adrenal 
does not prove that 5HT acts there as a neurotransmitter, however the 
presence of the rate limiting enzyme, tryptophan hydroxylase, does 
suggest that de novo synthesis of 5HT in some region of the adrenal, 
more likely the medulla, does occur in some species including the 
rat. 
The purpose of the present studies was to continue the work of Trost 
in determining the metabolic fate of added radioactive [3H]-5HT in 
isolated cells from the inner decapsular and outer capsular regions 
of the rat adrenal. The advantage of using isolated cells in this 
work was the removal of connective tissue and associated mast cells 
that in the rat and mouse are capable of uptake of 5HT. Also, a 
direct comparison of the fate of 5HT in glomerulosa cells compared to 
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fasciculata/reticularis cells could be made although contaminating 
medullary tissue was also likely to be present in the latter case. 
Further, studies examined the steroidogenia potency of indoleamines 
and 5HT metabolites as possible stimulatory factors for 
steroidogenesis in the zona glomerulosa. 
9.2 STEROID RESPONSE OF GLOMERULOSA CELLS TO SOME INDOLEANINES 
Previous work by Al-Dujaili et al., 1982 using rat zona glomerulosa 
cells in a perfusion system showed that 5HT, 5-methoxytryptamine 
(5MT) and to a lesser extent 5-methoxytryptophol and melatonin were 
able to stimulate aldosterone secretion. 5-Methoxytryptamine 
appeared to be even more potent than 5HT in this respect. Muller in 
1970 was able to show a stimulatory effect of 5HT, 5MT and 
L-5-hydroxytryptophan in static incubates of adrenal slices, at 
doses of 10-6M for all but the latter compound which had a 
stimulatory effect only at 10-5M. 
9.2.1 The Effects of Indoleamines on Aldosterone Secretion 
Further to this work these amines as well as some metabolites of 5HT 
i. e. 5-hydroxyindoleacetic acid (5HIAA), N-Acetyl-5HT, 
5-hydroxytryptophol and other related indoleamines including 
5-methoxytryptophol and melatonin were all incubated at two doses, 
10-8M and 10-6M with isolated rat zona glomerulosa cells in the 
method described for cell incubations in Chapter 6. The rationale 
behind this study was: (1) to determine how specific 5HT stimulated 
steroidogenesis is in relation to other structure-related 
indoleamines and to define more clearly the structure-activity 
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requirements for this stimulation in the zona glomerulosa cells; (2) 
to see if the metabolite(s) or intermediates produced during 
monoamine oxidase activity on 5HT rather than the molecule itself is 
responsible for the steroidogenic response 
Between two to four experiments were done using female adult Wistar 
rats and 105 cells per incubate were prepared. Stock solutions of 
the indoleamines (10-3M) were prepared in saline or absolute alcohol 
and the final alcohol concentration never exceeded 0.1% in the cell 
incubates. Serial dilutions ten times greater than the final 
concentration in the incubation medium were made in Medium 199 (0.2% 
BSA). The steroid output varied between experiments (this is 
,. r 
possibly due to different sensitivity of receptors during enzyme 
digestion and preparatory treatment on different days). All results 
therefore are expressed as percentage values of aldosterone relative 
to the control in 'n' number of experiments. The results were 
analysed statistically using Student's unpaired t-test. 
r-` 
9.2.2 RESULTS 
Figure 9.1 shows the percentage above basal aldosterone output in 4 
experiments for two doses of indoleamines compared to the reference 
amine, 5HT at 10-8M and 10-6M in the zona glomerulosa preparation. 
5HT significantly enhanced the aldosterone output to 250% (p< 0.05) 
at 10-8M 5HT and 350% (p< 0.005) at 10-6M 5HT. 5-Methoxytryptamine 
approached the potency of 5HT in elevating aldosterone at 275% at 10- 
8M 
and > 300% at 10-6M. The indoleamines melatonin, SHTP, 5- 
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Fig 9.2 % Stimulation above basal of aldosterone with several indoleamines 
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methoxytryptophol and 5HIAA did not significantly stimulate 
ýt, 
aldosterone at either dose. N-Acetyl-5HT stimulated to 
approximately 150% aldosterone output at 10-6M (p < 0.05) and 
5-hydroxytryptophol stimulated aldosterone output to 175% at 10-8M, 
but this was not significant possibly because of the larger standard 
error bars in this experiment although the stimulation became 
significant at 10-6M at 150% above basal (p< 0.05). 
Figure 9.2 shows the results of 1 experiment. Tryptamine, 
5-methyltryptamine and N-methyltryptamine all significantly elevated 
aldosterone at both doses (10-8M-10-6M) (p<0.05). At the lower dose 
of 10-8M, N-methyltryptamine approached a similar potency to SHT. 
Tryptamine and 5-methyltryptamine were approximately equipotent and 
half as potent as 5HT or N-methyltryptamine. 
9.2.3 DISCUSSION 
From the graphs it can clearly be seen that the indoleamines 
with a free amino group at position C9 or with a methyl group 
attached to the nitrogen (N) atom (Fig. 9.3) are the most potent 
stimuli of aldosterone biosynthesis. Thus, increasing the basic 
character at this position and therefore the electron cloud 
negativity appears to be of primary importance in aldosterone 
secretion. Substitution as in 5MT and an unaltered amino portion, 
with a retaining of some of the basic character at this site, i. e. 
inclusion of an oxygen atom, does not alter the potency of 
indoleamine stimulated aldosterone production, and substitution with 
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a non-basic group such as 5-methyl 5HT, or indeed complete removal of 
the group at position C5, e. g. tryptamine, slightly reduces the 
potency of the stimulation. Thus, the indole moiety appears to be of 
primary, importance in stimulation of aldosterone secretion. 
Modification of this region e. g N- Acetyl-5HT or 5-hydroxytryptophol 
allows for slight stimulation possibly because of the presence of the 
other important 50H region, but the common feature of reduced basic 
character, reduces potency. In this respect, modification of this 
region too, (e. g. melatonin and 5-methoxytryptophol), has no 
stimulatory effect, unlike Al-Dujaili's findings, which employed a 
column perfusion system. 
The requirement of intact ethylamine structures in these studies 
would tend to suggest that if a 5HT type receptor exists within the 
zona glomerulosa, it requires this group for steroidogenesis as 
opposed to binding ehr se. Previously, it had been shown in 
studies by Niles et al., 1983, that the hydroxyl group possessed by 
5HT and N-Acetyl-5HT were essential for high affinity binding in the 
rat brain and since N-Acetyl-5HT interacted with the 5HT receptor, it 
was suggested that there was a close interaction on the same 5HT 
receptor; however it was shown by Cohen et al., 1985, that tryptamine 
could interact with 5HT receptors in the rat fundic region, so the 
conformational requirement for stimulating through 5HT receptor sites 
does not appear to be too rigid. In a series of binding studies 
for 5HT and its structural requirements in brain tissue, Bennett and 
Snyder 1976 showed that the key requirement for 5HT, high affinity 
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binding was the 5-hydroxy substituted indole moiety and this was 
supported by the studies of Allgren et al., 1985 using solubilised 
bovine cortical brain membranes. The latter group also observed that 
membranes specifically required potent interactions between 5-hydroxy 
and a free amino terminal group for high affinity binding and this 
was lost in solubilising the membranes. Allgren postulated that the 
5HT1 site may exist as a subunit complex containing separate amine 
and indole attachment sites. 
From the observations it could be suggested that a 5HT binding site 
with type 1 character may exist, and at higher concentrations of 5HT 
adenylate cyclase is increased as suggested for type 1 receptors; 
further investigation into the effects the stimulatory indoleamines 
have on cAMP levels and the use of more specific 5HT1 receptor 
antagonists are required to complete the picture of 5HT binding 
sites in the adrenal and the subclassification of a type 1 receptor. 
9.3 METABOLISM STU IRS 
9.3.1 Cell Preparation 
Isolated zona glomerulosa and decapsulated tissue for the preparation 
of zona fasciculata cells was prepared as explained in chapter 6. 
Tritiated 5HT was obtained from Amersham International plc., and had 
a specific activity of 77.3mCi/mg. The molecular weight of the 
creatinine salt was 405 and the radioactive concentration was 
1.0mCi/ml. 
The purity of the product was assessed by injecting a solution of 
1Oµ1 in 10ml of 0.15M perchioric acid onto the HPLC column and 
228 
measuring the counts in lm1/minute fractions in a beta counter in 
relation to the retention time for a 5HT standard solution. It was 
found to be approximately 98% pure. 
A stock solution of the label was made by addition of neat label, 
50µl to 10ml' of incubation buffer Medium 199 (0.2% BSA) containing 
10-5M cold 5HT. 
An aliquot of the stock solution , 100µ1 was added to 5m1 of cocktail 
Scintran to determine the counts and thus the original concentration 
of radioactive 5HT added to the incubates. 
106 opm were present in 100µ1 aliquot (original stock) 
This volume was added to 0.9m1 incubates thus = 106cpm/incubate 
The, beta counter used had a counting efficiency of 32% for 
3H thus - 
3.125 x 106. DPM, which corresponds to a concentration of 4.5 pmol/ml 
added to each tube. 
This amount of radioactivity was dissolved in a stock solution of- 
cold 10-5M 5HT in 0.2%BSA. 
9.3.2 Incubation of Cells 
In the control experiments isolated cells or medium alone, were pre- 
incubated for 15 minutes in M199 (0.2% BSA), whilst pargyline, added 
at a final concentration of 10-5M was added to additional aliquots of 
medium (f cells) for 15 minutes preincubation. After this period 
100 µl additions of mixed label + cold 5HT was added to all tubes and 
incubated for a further 30 minutes. All tubes were then briefly 
0 
placed on ice to stop the reactions and incubates centrifuged at 4C 
for 15minutes at 15,000g. 
229 
9.3.3 Cell Pellets and Medium Preparation for HPLC 
A 400 pl aliquot of the medium supernatant was pipetted into clean 
conical polypropylene tubes containing 50 pl 15% perehlorio acid and 
5041 internal standard for indoleamines ( N-W -methyl-5HT) as 
previously described in Chapter 6. 
After sample preparation a 25µl aliquot was injected onto the HPLC 
column and 1ml/min fractions collected in plastic scintillation tubes 
containing 5mls of cocktail Scintran for a total run time of 20 
minutes. Previous standards for 5HIAA, 5HT, N-methyl-5HT, N-Acetyl- 
5HT, 5-methoxytryptamine, 5,6-dihydroxytryptamine and 5,7- 
dihydroxytryptamine were injected onto the column to determine their 
retention times. 
All cpm fractions corresponding to the retention times of 5HT, 5HIAA 
and other possible metabolites, were integrated and subtracted from 
background counts. In the final calculation all cpm values in the 
medium were corrected up for total deproteinising volume of 4001il in 
500µl i. e. 5/4 and multiplied up by a factor of 1000µl/25 (injection 
volume) =x 40 
The remaining medium was discarded and the cell pellets washed twice 
in 500 µl of ice cold saline. Finally the cell pellets were 
deproteinised in 50 µl of 1.5% perchloric acid containing 1 µM 
internal standard and left to stand for 15 minutes at 40C before 
sonication for 10 seconds per tube at speed setting 6 on ice to 
completely disrupt the cells and thus release any stored labelled 
5HT. 
The cell homogenate was centrifuged for 15 minutes in a refrigerated 
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Experiment 1 
Table 9.1 
(A) 
3H5HT dpm 
Sample x106 MI 'I Number medium 
Glomerulosa Cells 
(B) 
3H5HIAA dpm 
x10 6 MI-1 
medium 
(C) 3H5HT dpm 
x10 
cell pellet 
(D) (E) 
3 H5HIAA dpm T count 
x 105 x 10 
cell pellet" dpm 
3 2.62 0.28 3,360 1,5.40 2.90 
4 2.54 0.195 2,520 1,800 2.75 
Table 9.2 
Fasciculata Cells 
3 
(A) 
3 
(B) (C) (D) 
H5HT dpm H5HIAA dpm 3 H5HT dpm 3 H5HIAA dpm 
Sample x106 mI x106 MI .1x 105 x10 5 
_ý Number medium medium cell pellet_' cell pellet 
(E) 
T count 
x 106 
dpm 
3 2.30 0.29 47,950 5,020 2.65 
4 2.52 0.32 45,630 8,400 2.91 
Samples 3&4a cells +3 H5HT + 10 6 M5HT cold. 
All dpm values in 3&4 are the mean of original counts - dpm 
values background counts. 
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microfuge, and a 2541 sample injected onto the HPLC column. 
Fractions were collected as for the medium, but the final cpms were 
corrected up to the total volume of the digest compared to the 
injected volume i. e. 
50/25µl =x 2/100,000 cells 
All values therefore in the tables are corrected for dilution factors 
and converted to DPM after preliminary determination of the counting 
i 
efficiency for the beta counter. 
9.3.4 Direct Radioimmunoassay of the Medium 
Aliquots of control and stimulated cell medium } 10'5M pargyline, 
were assayed for aldosterone secretion, as described in Chapter 6. 
9.4 RESULTS 
An example of the calculations are given for the first experiment. 
Tables 9.1 and 9.2 show the dpm values derived from correcting for 
dilution factors and recovery. Samples 3 and 4 in Table 9.1 show 
3' ,, the dpm values for 5HT and 5HIAA in zona glomerulosa cells and cell 
medium without pargyline. Similarly, Table 9.2 shows the dpm values 
^--- for zona fasciculata and inner cortical and medullary cells and 
I 
medium. Tables 9.3 and 9.4, samples 5 and 6 show the dpm values for 
5HT conversion to 5HIAA in medium alone. Thus these values and the 
subsequent calculation of percentage conversion of 5HT by air 
oxidation processes alone can be derived (see Table for calculation ) 
and the percentage value subtracted from those values derived from 
glomerulosa cells and inner cortical/medullary cells. 
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Experiment 1 
Table 9.3 
Recovery of 3H Counts -in Medium Alone 
3H5HT dpm 3 H5HIAA dpm 3 H5HT dpm 3 H5HIAA T counts 
Sample x 106 ml l x10 6 ml x 10 x 105 x 106 
Number medium medium cell pellet cell pellet dpm 
5 2.48 0.13 - - 2.61 
6 2.59 0.09 - - 2.68 
Table 9.4 
4 
Sample 
Number 
% total 
3H5HT 
used 
5 4.98 
6 3.35 
Mean±SD 4.16±0.8 
Samples 5&63 H5HT + 10 6 M5HT (cold) + medium. 
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Experiment 1 
Glomerulosa Cells 
Table 9.5 
Sample % total3 H5HT % converted 
Number used to 3 H5HIAA 
%3H5HT in 
cell pellet 
(x 105 cells) 
% total 3 H5HT 
in cell pellet 
(x 105 cells) 
3 
4 
5.32 
3.46 
95.80 
91.00 
1.20 
1.20 
0.12 
0.09 
4.39 ± 0.93. 93.4, ± 2.4 1.20 0.105 ± 0.015 
Fasciculata Cells 
Table 9.6 
% H5HT in % total 3H5HT 
Sample % total3 H5HT % converted cell pellet in cell pellet 
Number - used to 3 H5HIAA (x 10 
5 cells) (x 105 cells) 
3 10.00 81.80 13.70 1.90 
4 9.20 82.82 11.70 1.60 
9.6 ± 0.4 82.3 ± 0.5 12.7 1 1.00 1.75 ± 0.15 
% total 3H5HT used = (E) - (A) /(E) x T00 
% converted to 3H5HIAA s (B+D) / E-A x 100 
%3 H5HT in cell pellet = C/E-A x 100 
%3 H5HT (total) in cell pellet = C/E x 100 
Values in columns 1&2 are derived from subtracting % 
(mean) used in samples 5&6 (-) cells. 
3H5HT 
Table 9.5 shows the resultant percentage values from incubating zona 
glomerulosa cells at 370C for 30 minutes. Of all the [3H]-5HT 
available to the cells, only 5.32% and 3.46% in samples 3 and 4 
respectively, of the total, is used by the cells themselves. This 
approximates 4.4%, and approximately 93% of this is converted to the 
metabolite 5HIAA, specifically by the cells rather than the medium 
alone. Only approximately 1.2% of the total [3H]-5HT used, remains 
in the glomerulosa cells (capsular region) after 3 saline washes (see 
also Fig. 9.4). 
Table 9.6 shows that approximately twice as much of the total [3H]- 
5HT available is used by the inner adrenal i. e. 9.6% per same number 
of cells compared to the capsular region. Of this, 82.3% is 
converted to [3H]-5HIAA; approximately 13% of the total C3H]-5HT 
used, is retained in the cell pellet, considerably more than in the 
zona glomerulosa (Fig. 9.4). Thus, overall more 5HT is used by the 
inner adrenal cortex/medulla compared to the capsular region, and 
less is metabolised in inner zones relative to the zona glomerulosa. 
Hence, more 5HT appears to be 'retained' in the inner zones. 
The second metabolism experiment (Fig. 9.5) included the same 
protocol as the first but also included tubes incubated (= pargyline) 
in medium alone or in the presence of cells. Roughly the same 
amount of labelled 5HT was added to both zones of cells but the 
percentage values suggest that more 5HT is used by the inner cortex 
compared to the zona glomerulosa cells. Although there is not a 
significant difference in the corrected percentage conversion of 5HT 
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Pooled Data for 3 HSHT Metabolism in vitro 
In Isolated Cells at 37°C 
Table 9.7 
Glomerulosa Cells 
Sample % total 3H5HT % converted %3 H5HT cell 
used to 3 H5HIAA pellet 
% total 3 H5HT 
cell pellet 
Exp 1 
3 5.32 95.80 1.20 0.12 
4 3.46 91.00 1.20 0.09 
Exp 2 
3 3.11 77.10 0.98 0.07 
4 3.61 43.91 1.76 0.14 
mean ± SD 3.87 ± 0.85** 76.9 ± 20.3 1.28 ± 0.28* 0.10 ± 0.03 
± SEM ± 0.49 ± 11.71 ± 0.16 ± 0.015 
Table 9.8 
Fasciculata Cells 
Sample % total 
3 H5HT %3 converted %3 H5HT cell % total 3 H5HT 
used to H5HIAA pellet cell pellet 
Exp 1 
3 10.00 81.80 13.70 1.90 
4 9.20 82.82 11.70 1.60 
Exp 2 
3' 7.68 53.61 5.40 0.64 
4 10.41 41.81 8.70 1.29 
mean ± SD 9.32 t 1.04** 65.01 ± 17.80 9.87 ± 3.14* 1.36 ± 0.46 
± SEM ± 0.60 ± 10.30 ± 1.87 ± 0.27 
` p<0.02 
"" p<0.001 Students paired t-test. 
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to 5HIAA in the zona glomerulosa (60.51% 1 16.6) compared to the in 
the inner zones (47.7% -t 5.8) the trend in the two samples suggests 
greater monoamine oxidase activity in the outer zones as seen in the 
first experiment (see Figs 9.4 and 9.5). 
In percentage analysis the amount of [3H]-5HT used by the zona 
glomerulosa cells is not significantly different in either experiment 
without pargyline, though less is converted to 5HIAA in the second 
experiment (60.5%) compared to the first (93%). However from the 
results measuring 5HT retained in the cell pellets after 3 washes, 
the amount retained in the zona glomerulosa is approximately the same 
(see discussion). 
The pooled percentage data for the capsular and inner adrenal zones 
(Table 9.7 and 9.8 and Fig. 9.6) shows these results graphically. 
The overall percentage use of the total (3}I]-5HT available is 
approximately 2.5 times as great in the inner zones per 105 cells 
than in the zona glomerulosa cell preparation. The overall' 
percentage conversion of the total [3H]-5HT used is not significantly 
different in the two zones although there is a tendency for greater 
metabolism in the zona glomerulosa. Overall, significantly more 5HT 
is retained in the inner zones compared to the zona glomerulosa cells 
(p<O. 0,3. ) . 
In the second experiment (Fig. 9.5) a further set of tubes were 
incubated with/without pargyline (10-5M). The total amount of 5HT 
used in the zona glomerulosa is not significantly changed by the 
presence of pargyline; the amount converted to 5HIAA with pargyline 
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Fig 9.6 
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present is reduced from 60% to approximately 45% although 
statistically this was not significant. In the same experiment the 
raw data counts (cpm) for HPLC collected fractions in medium and 
cells + medium with pargyline present (Fig. 9.7 a and b) shows that 
pargyline removes the' 5HIAA peak ( retention time (Rt) 6.5 mins - 
broken line) from the medium incubated with cells present. The 
amount of 5HT retained in the washed cell pellet is not significantly 
different in the presence of pargyline. Figure 9.9 (b) shows that 
pargyline slightly reduces the low level of counts at the 5HIAA peak 
( Rt 5.4 minutes - closed circle). 
Inner zones incubated in the presence of pargyline use significantly 
more of the total [3H]-5HT available, i. e. 9.04% used (- pargyline) 
compared to 24% used (+ pargyline) see Figure 9.5. However, there 
is no significant difference in the amount converted to 5HIAA in the 
presence of pargyline. This percentage result is anomalous with the 
raw data epm values obtained for aliquots of medium, where the 5HIAA 
peak is removed in the presence of pargyline (Fig. 9.8 a and b). 
Considerably more 5HT appears to be retained in the cell pellet (- 
pargyline) i. e. 7% compared to only 2.15% (+ pargyline) - see 
Fig. 9.5. The results in raw counts (Fig. 9.9 (a)) also show a 
slight elevation of the 5HT peak in the presence of pargyline, which 
is contradictory to the final recovery and corrected dpm values 
calculated. The final analysis does however show a trend towards 
inhibiting 5HIAA formation, in the inner adrenal zones treated with 
pargyline, in the same way as the capsular data demonstrates. 
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Fig 9.9a 
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In experiment 1 the steroid output (Fig. 9.10) was also measured in 
both cell preparations. The inner zones showed no significant 
increase in either corticosterone or aldosterone in the presence of 
5HT; zona glomerulosa cells responded to 5HT with a significant 
increase in aldosterone. In the second experiment (Fig. 9.11), again, 
only the zona glomerulosa cells responded to 5HT; pargyline did not 
affect either cell type in increasing steroidogenesis, indeed there 
was a slight but significant depression in the stimulation of 
aldosterone in the presence of pargyline compared to control. 
9.5 DISCUSSION 
Serotonin metabolism is only partially inhibited by the monoamine 
oxidase inhibitor. This suggests several things: the inhibitor is 
not potent enough to inhibit all the MAO present at this dose 
(10-5M); or that the inhibitor is non-specific to Type A and Type B 
monoamine oxidase, so that at least some of the activity of one 
enzyme subtype still remains; Type A is present, since this 
specifically oxidizes 5HT, norepinephrine and epinephrine and 5HT is 
converted to 5HIAA in these studies. Type A monoamine oxidase is 
present specifically in intraneural locations and is found in 
sympathetic nerve endings. However, the lack of complete inhibition 
of 5HT metabolism, using pargyline, could also indicate the presence 
of Type B within the adrenal, the extra-neural subtype - particularly 
in the inner regions. Possibly of more importance, is the greater 
percentage use of 5HT and its larger concentration present in the 
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Fig 9.11 
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cell pellet of the fasciculata cells and contaminating medullary 
tissue, compared to the glomerulosa cells; there is however an 
anomaly in the amount of total 5HT used in the inner zone (+ 
pargyline), compared to lower amounts present in the control cell 
pellet (- pargyline) - this could be due to indiscriminate 'leakage' 
of 5HT from the washed cell pellet. However, 5HT can be stored or 
remain unmetabolised in the inner zones to a greater extent overall 
as shown in-the pooled results, 'with/without pargyline, compared to 
the glomerulosa cells. There remains the possiblity that 5HT is 
taken up by medullary ehromaffin granules possibly present in the 
inner cell preparation, or contaminating mast cells and platelets 
obviously present in larger amounts in the vascularized inner zones 
compared to the capsular zone., Livett et al. p-1984, -found that 
medullary rat adrenal tissue could be isolated and prepared in a 
similar procedure as employed for capsular cell preparations, 
although medullary tissue is more readily dispersed compared to 
cortical tissue. Thus it may be present, albeit in smaller 
quantity, in the cortical preparation. In the preparation of 
isolated capsular and decapsulated cells in the rat, Matsouka et al., 
1981b, referred to the medullary cell contamination within the 
decapsular cell preparation which was also prepared by collagenase 
dispersal. Winkler et al., 1986 described specific amine carrier 
systems present within isolated adrenal chromaffin granules, which 
are capable of taking up exogenous 5HT as previously reported by 
Bertler in in vivo rabbit studies, and by Potter and Axelrod in 
248 
centrifugal sucrose density gradient isolation of labelled 5HT in 
chromaffin granules. Another possibilty is that platelet 
contamination, particularly in the highly vascular inner zones, 
allowed for 5HT uptake into platelet uptake sites. Brain, 
medullary and platelet tissue all share a common mode of uptake for 
5HT as well as other biogenic amines. Medullary tissue is modified 
sympathetic neuronal tissue and together with sympathetic nerve fibre 
endings, which have already been described in sheep and rat adrenal 
inner cortex (Robinson et al., 1977., Kleitman et al., 1985), may 
account for the greater apparent storage of 5HT within this region. 
Of course the reasons remain speculative, since further work would be 
needed to clarify these findings, including the isolation of 
medullary cells and the measurement of monoamine oxidase activity 
independent of the adrenal cortex. - The important point to note 
however, is that the metabolism of 5HT, although nonspecific to the 
whole adrenal, is more marked in the glomerulosa zone where 5HT 
stimulates steroidogenesis; metabolism and/or storage are not the 
important factors in determining steroidogenic potency - this is also 
borne out in the indoleamine studies where 5HIAA did not stimulate 
aldosterone secretion. Thus, ýthis-rather suggests a specific, 
receptor mediated response, particular to the outer zona 
glomerulosa. 
The possibility exists of: 1) a neural innervatory component 
(possibly catecholaminergic as described above since 5HT nerve fibres 
were not visualised in the immunohistochemistry experiments) (see 
Chapter 11) existing in this region. Serotonin released from 
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platelets or mast cells (Osim et al., 1983., Green et al., 1962) 
possibly in the wake of a physiological stimuli such as stress, 
haemmorrhage, shock... as 5HT release has already been noted, e. g. 
when TSH (thyroid stimulating hormone) stimulates the release of mast 
cell constituents including 5HT (Green et al., 1962), may lead to 
displacement of catecholamines bound to nerve ending vesicles and 
affect a response including the stimulation of aldosterone secretion; 
2) alternatively 5HT could displace or be co-stored in medullary 
epinephrine containing granules, as Kuriyama (1984) described, 
within the inner zones. Thus, 5HT may play a subsidiary alternate 
neural and/or paracrinal role during increased sympathetic activity. 
Excess and non-bound exogenous'5HT, as appears to exist in the zona 
glomerulosa, could then be metabolised by endogenous monoamine Type 
A enzyme within this region and/or type B in the'inner regions. High 
levels of MAO Type A have been measured in whole adrenal tissue 
(Viveros et al., 1979) in adult rats, which would lend credence to 
this theory. However the lack of total inhibition of 5HT conversion 
to 5HIAA, particularly in the inner zones could also indicate 
different concentrations of this enzyme in the different regions or 
heterogenous subtypes of MAO as indicated above. Of further interest 
were the effects of inhibiting 5HT metabolism on the steroidogenic 
response in the glomerulosa cells. As the graphs show, in the zona 
fasciculata preparation, 5HT had no effect on steroid output as 
expected, whereas in the zona glomerulosa cells 5HT stimulated 
aldosterone secretion. However, the presence of pargyline did not 
enhance the steroid response to exogenous 5HT or even increase the 
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basal steroid levels in the control incubates. This at first would 
tend to suggest that an increase in 5HT levels presented to the 
adrenal in the presence of a MAOI did not potentiate the adrenal 
response to 5HT as might be expected in a neural innervatory 
situation, for example, when MAOI is added to synapses there is a 
potentiation of the nerve impulses due to increasing the local 
concentrations of neurotransmitter. There also exists the 
possibility that the large dose of non radioactive 5HT would blanket 
any potentiating effects that pargyline may exert on depleting 
metabolism; further, in this static cell system , it may not have 
been sensitive enough to detect changes in the potentiating effects 
of non-metabolised 5HT, although statistically, the small percentage 
drop in 5HT metabolism may also have been responsible for the lack of 
potentiation. Overall, the inner zones store and utilise more 5HT 
than the zona glomerulosa but the metabolism itself is not involved 
in eliciting the specific steroidogenic response. Pargyline, a non- 
specific inhibitor of monoamine oxidases tends to be more potent in 
inhibiting the conversion of 5HT to 5HIAA in the zona glomerulosa, 
although this does not reach statistical significance in the limited 
number of studies carried out during this time; more data needs to 
be collected to determine if indeed both types of monoamine are 
present in all zones of the rat adrenal, and whether Type A 
predominates in the zona glomerulosa with considerable amounts of 
Type B also present in the inner zone. The results, far from being 
conclusive, point towards a local and immediate receptor-mediated 
response at the level of the zona glomerulosa with the inner zones 
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serving a storage, and possibly local paracrinal role in regulating 
aldosterone secretion. 
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Chapter 10 
THE EFFECTS OF SALT DIET ON PLASMA 5HT AND ADRENAL 5HT LEVELS AND 
THE IN VITRO RESPONSIVENESS TO All AND 5HT IN THE ZONA GLOMERULOSA 
10.1.1 THE EFFECT OF SALT STATUS ON III IND 5HT DOSE RESPONSE 
CURVES IN ISOLATED ZONA GLOMERULOSA CELLS AND ON PLASMA 
CONCENTRATIONS OF ALDOSTERONE, PRA AND SERUM 5HT LEVELS 
Serotonin may exert its steroidogenic effects through specific 5HT 
receptors that are subject to changes in sensitivity during altered 
sodium status. Aguilera demonstrated changes in All receptor 
affinity and sensitivity, the latter extrapolated from a change in 
the magnitude of the steroid output obtained from rats on different 
sodium intake which paralleled changes in plasma aldosterone, All and 
PRA levels. In the present studies the effects of a similar time 
study of altered sodium diets on the 'sensitivity' (as defined as a 
measure of the quantitative measure of the aldosterone response) of 
isolated zona glomerulosa cells to All was studied to see if 
Aguilera's results could be reproduced, and further to determine 
whether the 5HT dose response curve was altered in any way with 
changing salt status. Serotonin levels in whole blood and in the 
adrenal gland were also measured to see if they altered as a 
consequence of a change in sodium intake. 
10.1.2 METHODS 
Female Wistar rats (100-150g) were placed in groups of six per cage 
and kept on wholemeal diets supplemented with 1% NaCl in the food in 
normal diets and water ad. libitum; low salt diet included wholemeal 
flour supplemented with 1% CaCO3 and water ad. libitum; whilst high 
salt diet included 1% NaCl in the food and 1% saline for drinking. 
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Fig 10.1 
Plasma aldosterone, PRA and All levels with normal, low and high salt diets 
(time study) 
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(Fattah et al 1977). The rats were fed normal diets for a control 4 
days before switching to the salt diet regimes for 36 hours, 4 days, 
1 week and 2 weeks. After these time intervals the rats were 
sacrificed for in vitro incubations of zona glomerulosa cells or 
r 
blood samples and whole adrenals collected for the measurements of 
plasma aldosterone, corticosterone, PRA, All and 5HT in whole blood 
and tissue (see Chapter 6 for methods). 
RESULTS 
10.1.3 Plasma Measurements after 36 hours 
After 36 hours PRA did not significantly change (Fig-10.1a) although 
plasma All and aldosterone paralleled each other in accordance with 
salt status (Figs. 10.1b and c). Thus, All and aldosterone were 
significantly increased in low sodium status and decreased in high 
sodium status with respect to the control group. Whole blood 5HT 
levels were not significantly different in either low or high sodium 
status with respect to control groups nor was 5HT levels 
significantly different in the low salt state compared to the high 
group (Fig. 10.2 and Table 10.1). The adrenal content of 5HT did not 
vary after 36 hours in both the decapsular and capsular portions of 
the adrenal glands (Tables 10.5 and 10.6). 
10.1.4 Plasma Heasurents after 4 days 
PRA values were increased slightly but not significantly on low salt 
diets and depressed though not significantly on high salt diets 
compared to control group (Fig. 10.1a). All levels did tend to 
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Fig 10.2 
Whole blood serotonin levels in normal, low and high salt diets: 
changes with time 
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Fig 10.3 
Serotonin levels In whole, capsular and decapsular adrenals on salt diets 
(time study) 
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normal low tmgh normal low high 
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Whole Blood Serotonin Values for Normal, Low & High 
Salt Diets : Time Study (mean ± SD ± SEM) 
Table 10.1 (36 hours Na diets) 
Normal umoles 5HT/i Low pmoles 5HT/l High pmoles 5HT/l 
5.0 2.6 5.7 
4.3 6.1 5.7 
7.2 4.0 7.8 
6.6 3.2 6.4 
4.3 6.25 6.4 
5.2 6.6 6.6 
(6) (6) (6) 
5.4±1.1 ± 0.5 4.8±1.5±0.7 6.2±0.8±0.36 
(4 days Na + diets) 
Table 10.2 
Normal pmoles SHT/I Low pmoles 5HT/I High umoies 5HT/I 
15.4 41.2 6.7 
40.8 37.8 13.6 
30.0 34.0 42.7 
6.4 2.5 12.5 
15.8 - 7.3 
(5) (4) (5) 
21.7 ± 13.6 ± 6.1 28.9. ± 17.8 ± 8.9 16.6 ± 14.9 ± 6.7 
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Whole Blood Serotonin Values For Normal, Low & High 
Salt Diets : Time Study (mean ± SD ± SEM) 
(1 week Naa diets) 
Tebie 10.3 
Normal umoles 5HT/I Low jtmoies 5HT/I High pmoles 5HT/l 
11.4 8.3 9.1 
6.0 9.35 10.6 
11.9 1.3 10.8 
14.7 8.5 9.6 
(4) (4) (4) 
11.0 ± 3.1 ± 1.7 9.8 ± 1.8 ± 0.6 10.0 ± 0.7 ± 0.4 
(2 weeks Nä diets) 
Tz ble 10.4 
Normal pmoles 5HT/I Low Nmoles 5HT/I High pmoles 5HT/I 
8.0 8.5 11.0 
8.2 6.5 9.6 
11.3 6.0 8.6 
5.4 6.1 16.4 
5.4 10.3 10.2 
9.6 11.8 10.5 
(6) (6) (6) 
7.9 ± 2: 1 ± 0.9 8.2 ± 2.2 ± 1.0 11.0 t 2.5 ± 1.11 
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SEROTONIN CONCENTRATIONS IN ADRENALS OF FEMALE 
RATS ON NORMAL, LOW & HIGH SALT DIETS: TIME STUDY 
CAPSULAR ADRENALS 
Table 10.5 (36 hours) 
Normal ug 5HT/g 
wet weight 
Low ug 5HT/g 
wet weight 
High ug 5HT/g 
wet weight 
0.14 0.023 0.211 
0.16 0.074 0.141 
0.22 0.24 0.105 
0.14 0.14 0.176 
0.123 0.056 0.035 
(5) (5) (5) 
0.156 ± 0.03 ± 0.016 0.106 ± 0.07 ± 0.038 0.134 ± 0.06 ± 0.03 
. 
DECAPSULATED ADRENALS 
Table 10.6 
Normal pg 5HT /g 
wet weight 
Low pg 5HT /g 
wet weight 
High pg SHT/g 
wet weight 
1.65 1.18 0.95 
1.1 1.26 1.13 
0.95 1.19 1.34 
1.02 0.98 1.00 
0.93 1.21 - 
- 2.18 - (5) (6) (4) 
1.13±0.26 1.33 ± 0.38 1.105±0.5 
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parallel this change with no significant difference in low salt 
compared to the control 4 days study. On high salt, All levels 
were significantly depressed relative to low salt (p< 0.05) but not 
different by statistical analysis (Students unpaired t-test) compared 
to normal salt status. However the large standard error of the mean 
was probably responsible for this result, although visually, there is 
a definite trend to decreased levels relative to the control group 
(Fig. 10.1b). Interestingly however, although PRA and All levels 
are not significantly altered on low salt relative to normal salt 
status, plasma aldosterone shows significant changes according to 
salt status at this time interval (Fig. 10.1c). This was paralled by a 
similar trend in whole blood 5HT levels with respect to control 
values (Fig-10.2 and Table 10.2) although this did not reach 
statistical significance; a similar trend was seen in whole adrenal 
5HT measurement although this was not statistically significant in 
the case of control vs low salt status (Fig. 10.3 and Table 10.7). 
10.1.5 Plasma Measurents after 1 week 
PRA, All and plasma aldosterone levels closely paralleled one another 
after 1 week salt diet changes (Fig. 10.1a, b and a). All 
parameters were significantly increased in low salt status relative 
to the control group and interestingly, high salt parameters were not 
significantly altered with respect to normal diets; they were 
however significantly lower in all eases, with respect to low salt 
status. This is in contrast to shorter time intervals in which high 
salt values are sometimes lowered with respect to the normal salt 
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WHOLE ADRENALS 
Table 10.7 (4 day Na+ diet) 
Normal pg[5HT]/ 
g. wet. weight 
Low pg[5HT]/ 
g,, wet weight 
High ug[5HT]/ 
g wet weight 
1.51 2.11 1.09 
1.44 1.53 1.51 
1.88 1.62 1.18 
1.58 1.53 1.34 
- - 1.18 
(4) (4) (5) 
1.6 ± 0.17 ± 0.09 1.69 ± 0.24 ± 0.14 1.26 ± 0.15 ± 0.07 
WHOLE ADRENALS 
Table 10.8 (1 week Na+ diet) 
Normal pg [5HT]/ 
g wet weight 
Low, Ng [5HT]/ 
g wet weight 
High pg [5HT] / 
g wet weight 
0.7 0.704 0.72 
0.63 0.95 1.00 
0.83 0.98 0.68 
1.02 0.79 97 
0.94 0.83 
(5) (5) t4) 
0.82 ± 0.14 ± 0.07 0.85 ± 0. ±0 ± 0.05 0.84 ± 0.14 ± 0.08 
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CAPSULAR ADRENALS 
Table 10.9 
(2 weeks) 
Normal ug 5HT/ 
g wet weight 
Low jig 5HT/g 
wet weight 
High pg 5HT/g 
wet weight 
0.45 0.422 0.67 
0.74 0.45 0.56 
0.56 0.53 0.405 
0.45 0.74 0.211 
(4) 
(6) `5) 
0.55 ± 0.12 ± 0.07 0.47±0.14± 0.49±0.17±0.08 
Table 10.10 DECAPULATED ADRENALS 
Normal pg 5HT. / 
g wet weight 
Low pg 5HT/g 
wet weight 
High pg 5HT/g 
wet weight 
1.04 1.72 1.95 
2.64 0.57 0.70 
0.77 0.67 1.57 
0.84 1.48 2.3 
0.98 1.62 1.3 
1.33 0.72 2.86 
(6) (6) (6) 
1.26 ± 0.6 ± 0.28 1.12 ± 0.49 ± 0.22 1.77 ± 0.69 ± 0.31 
() values in parenthesis indicate number of rats in study. 
Statistics by unpaired Students t- test p <0.05 level. 
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Fig 10.4a 
Aldosterone dose response curve to 5HT and All : 36 hour salt diet 
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diet values. 5HT levels 'were not significantly different after this 
time in serum (Fig. 10.2 and Table 10.3) or in the whole adrenal gland 
(Fig. 10.3 and Table 10.8) in high or low salt status. 
10.1.6 Plasma Measurements after 2 weeks 
PRA, All and aldosterone levels were significantly elevated in low 
sodium status with respect to control values but in the high salt 
state, they were not significantly different from control values 
(Fig. 10.1a, b and c). Whole blood 5HT levels were not significantly 
different in the low salt group compared to control values, and were 
just above the p<0.05 level of significance in the high salt group 
compared to the control group (see Fig. 10.2 and Table 10.4). 
Serotonin levels were not significantly different in any of the 
groups in the capsular and decapsulated portions of the adrenal 
gland (Fig. 10.3 and Tables 10.9 and 10.10). 
!_ 
10.2 IN VITRO RESULTS OF SALT DIETS 
10.2.1 'Dose Res ne Curves to 5HT and All (36 hours) 
In the first 36 hour experiment (Fig. 10.4a) the basal levels of 
aldosterone in vitro were altered by salt diet. The steroid output 
and sensitivity, as defined as a change in steroid output at a given 
dose, was increased for the dose response curve to All and 5HT on low 
salt diet and the maximal output was increased for All alone. 
Conversely, high salt diet reduced steroid output at all doses of 5HT 
and All. Point to point the steepness of the response curve was 
increased at the lowest dose of All and 5HT on low salt, compared to 
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control; in high salt diet, the steepness was reduced at the lowest 
dose of All and 5HT compared to control. The results were plotted as a 
percentage above basal, rather than percentage of the maximal 
response, since a plateauing of the response was not always achieved, 
demonstrates an increase of 230% aldosterone output in low salt 
status at the lowest dose of 5HT used (10-9M) compared to 180% output 
in normal and 100% on high salt diet. Looking at both this plot and 
Fig. 10.4a showing absolute outputs, it can be seen that the initial 
slope of the dose response curves are not superimposable but rather, 
on low salt at 10-9M 5HT, the sensitivity is increased relative to 
control and at the same lowest dose on high salt, the sensitivity is 
decreased. The magnitude of the absolute response is reduced* 
markedly at all doses of 5HT but the percentage levels above basal 
(Fig. 10.4b) approach low salt percentage levels, even at 10-7-10-6M 
5HT. As can be deduced therefore from this result, salt status at 36 
hours affects the sensitivity of the response at the lower levels of 
5HT and in the case of high salt status, at all doses of 5HT, but 
does not affect the magnitude of the response in absolute terms in 
low salt compared to control at higher doses of 5HT (10-7-10-6M). 
For the All dose response to changing salt, the steroid output was 
markedly elevated at all doses of All in low salt relative to normal 
salt diets, and only at the lower doses of All, was the magnitude of 
the response, both in absolute terms and in percentage terms, greater 
with respect to the control group (Fig. 10.4a and 10.4c). In high salt 
all doses of All did not elicit as great an absolute response as 
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Fig 10.4b 
% above basal aldosterone for 5HT stimulation : 36 hour salt diet 
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Fig 10.4c 
% above basal aldosterone for All stimulation : 36 hour salt diet 
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Table 10.11 
p-values for % 
: 36 hours salt 
Stimulus (M) 
5HT 
above basal aldosterone 
diet (1st experiment) 
10-9 Normal/Low NS 
Normal/High 0.05 
Low/High 0.003 
10-8 Normal/Low NS 
Normal/High NS 
Low/High 0.05 
10'7 Normal/Low 0.002 
Normal/High 0.002 
Low/High NS 
10-6 Normal/Low 0.0002 
Normal/High 0.005 
Low/High 0.05 
All L 
10-11 Normal/Low 0.005 
Normal/High NS 
Low/High 0.004 
10-10 Normal/Low NS 
Normal/High NS 
Low/High NS 
10'9 Normal/Low NS 
Normal/High NS 
Low/High NS 
10-8 Normal/Low 0.05 
Normal/High 0.05 
Low/High NS 
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Fig 10.5a 
Aldosterone dose response curve to 5HT and All : 36 hour salt diet 
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control when the curves were superimposed. In percentage terms 
(Fig. 
10.4c) the sensitivity to All was increased in low salt diet at 10-11M 
All whereas both in absolute terms and in percentage terms, there was 
no significant stimulation on high and control diets at 10-11M All. 
In the second experiment, (Fig. 10.5a) basal steroid output was again 
altered by sodium status as was the steroid output point to point 
along the respective dose response curves. However, for the 5HT 
dose response curve, low salt status did not significantly alter the 
sensitivity of the response with respect to control when the curves 
were superimposed, i. e. they did not show competitive curve 
characteristics at any dose. Indeed, the percentage increases 
tended to be lower on low salt compared to the control curve (Fig. 
10.5b) although this did not represent any significant difference 
(Table 10.12). In contrast, aldosterone output was decreased at all 
doses of 5HT on high salt compared to the control response, although 
by statistical analysis of percentage changes, this was not 
significantly depressed with respect to the control percentage 
values; only the responsiveness of the cells was changed by the salt 
regime. In this experiment the cells were all more responsive to 
All on all salt regimes, with 10-11M eliciting a steroid response. 
10 The magnitude of the responses to All at lower doses of All although 
in absolute terms varied with basal levels, upon superimposition, 
were not markedly different with respect to control, even in high 
salt diets, i. e. they were not competitive curves - indicative of a 
change in sensitivity, as defined as a change in ED50 by more 
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Fig 10.5b 
% above basal aldosterone for 5HT stimulation : 36 hour salt diet 
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Fig 10.5c 
% above basal aldosterone for All stimulation : 36 hour salt diet 
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Table 10.12 
p-values for % 
: 36 hours salt 
Stimulus (M) 
5HT 
above basal aldosterone 
diet (2nd experiment) 
10'9 Normal/Low NS 
Normal/High NS 
Low/High NS 
10-8 Normal/Low NS 
Normal/High NS 
Low/High 0.07 
10-7 Normal/Low 0.01 
Normal/High NS 
Low/High 0.02 
10'6 Normal/Low NS 
Normal/High 0.01 
Low/High NS 
All 
10-11 Normal/Low NS 
Normal/High NS 
Low/High NS 
10-10 Normal/Low NS 
Normal/High NS 
Low/High NS 
10'9 Normal/Low NS 
Normal/High 0.01 
Low/High 0.06 
10'8 Normal/Low NS 
Normal/High NS 
Low/High 0.06 
1' 
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Fig 10.6 a 
Aldosterone dose response curves to 5HT and All : 4day salt diet 
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rigorous curve-fitting computer analysis - this was not employed in 
these experimental studies. Only the absolute maximal output 
appeared to be altered by salt status. In both experiments the dose 
response to 5HT on high salt appeared to be attenuated more markedly 
than the dose response to All on high salt. 
10.2.2 Dose Response Curves to 5HT and All (u days) 
Figure 10.6a shows a representative dose response curve to All and 
5HT in one out of two experiments and in both cases, the basal 
aldosterone levels were altered with respect to salt status as had 
been seen at 36 hours. Thus, on low salt diets basal levels were 
significantly greater than control values, and depressed with respect 
to control in high salt diets. The absolute responses are altered 
with respect to salt status for both stimuli at all doses. Serotonin 
stimulated steroidogenesis at the lowest dose 10-9M 5HT on normal 
salt diet; the magnitude of the response in absolute terms was 
c. 
greater on low salt, thus indicating an increased sensitivity. 
However, on a percentage basis, this was not significantly different 
when compared to the control percentage increase (Fig. 10.6b and 
Table 10.13). Superimposing the high salt dose response curve to 5HT 
i. 
on the control curve, showed a reduced sensitivity as well as reduced 
responsiveness at all doses of 5HT-stimulated steroidogenesis. This 
was also reflected in reduced percentage increases of steroid output, 
particularly at lower doses of 5HT, which were significantly 
different compared to the control curve (Fig. 10.6b and Table 10.13). 
The increased responsiveness of the 5HT response in low salt, 
276 
Fig 10.6 b 
% above basal aldosterone for 5HT stimulation :4 days on salt diet 
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% above basal aldosterone for All stimulation :4 day salt diet 
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Table 10.13 
p-values for % above basal aldosterone 
:4 days salt diet 
Stimulus (M) 
5HT 
. 10'9 Normal/Low 
NS 
Normal/High NS 
Low/High 0.006 
10-8 Normal/Low NS 
Normal/High 0.001 
Low/High 0.02 
10-7 Normal/Low NS 
Normal/High 0.07 
Low/High NS 
10-6 Normal/Low NS 
Normal/High NS 
Low/High NS 
All 
10'11 Normal/Low NS 
Normal/High NS 
Low/High NS 
10-10 Normal/Low NS 
Normal/High NS 
Low/High NS 
10'9 Normal/Low NS 
Normal/High 0.06 
Low/High 0.03 
10-8 Normal/Low NS 
Normal/High 0.04 
Low/High 0.06 
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Fig 10.7a 
Aldosterone dose response curves to 5HT and All :1 week salt diet 
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resulted in an earlier plateauing of the dose response compared to 
both normal and high salt diets i. e. at 10-8M 5HT compared to 10-7M 
5HT on high and normal salt status. 
The All response curve changed in a similar fashion to the 5HT 
response curve although in this case, the sensitivity as defined in a 
change in the percentage increase at the lowest administered dose, 
did not alter even on high salt compared to control (Fig. 10.6c and 
Table 10.13) although here again, the responsiveness as measured in 
absolute terms was altered with respect to salt status. 
10.2.3 Dose Response Curves to 5HT and All (1 week) 
In both experiments showing the dose response curves to 5HT and All, 
basal aldosterone levels are significantly elevated on low salt diets 
' and depressed on high salt diets compared to control values. In the 
first experiment (Fig. 10.7a), the dose response curves for All and 
h 
5HT on high salt were depressed at all points along the dose response 
curve compared to the control curve; conversely, the dose response 
curves were slightly steeper at some points along the dose response 
curve in low salt status and were slightly steeper at the lowest dose 
of 5HT and AII. However, superimposition of the dose response curves 
for both All and 5HT in control salt diets onto low and high salt, 
showed that the maximal outputs altered in accordance with salt 
state, but that only the sensitivity to both stimuli was altered and 
reduced in high salt relative to the control response. In 
percentage terms (Fig. 10.7b) there was an increase in steroid output 
at 10-9M 5HT relative to the same dose on different salt diets, which 
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Table 10.14 
p-values for % above basal aldosterone 
:1 week salt diet (1st experiment) 
Stimulus (M) 
5H T 
10'9 Normal/Low 0.05 
Normal/High NS 
Low/High 0.05 
10"8 Normal/Low NS 
Normal/High NS 
Low/High 0.05 
10"7 Normal/Low 0.05 
Normal/High NS 
Low/High NS 
10-6 Normal/Low 0.05 
Normal/High 0.07 
Low/High 0.0002 
All 
10'11 Normal/Low NS 
Normal/High NS 
Low/High NS 
10'10 Normal/Low NS 
Normal/High NS 
Low/High NS 
10'9 Normal/Low NS 
Normal/High NS 
Low/High NS 
10-8 Normal/Low NS 
Normal/High NS 
Low/High 0.05 
284 
Fig 10.8a 
Aldosterone dose response curve to 5HT and All :I week salt diet 
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Table 10.15 
p-values for % above basal aldosterone 
:1 week salt diet (2nd experiment) 
Stimulus (M) 
5HT 
10'9 Normal/Low 0.008 
Normal/High 0.03 
Low/High NS 
10-8 Normal/Low 0.01 
Normal/High 0.01 
Low/High 0.0004 
10-7 Normal/Low 0.04 
Normal/High 0.03 
Low/High 0.06 
10'6 Normal/Low 0.05 
Normal/High 0.04. 
Low/High 0.01 
All 
10-11 Normal/Low 0.001 
Normal/High' 0.02 
Low/High NS 
10-10 Normal/Low 0.04 
Normal/High 0.04 
Low/High NS 
10'9 Normal/Low 0.02 
Normal/High 0.02 
Low/High 0.07' 
10'8 Normal/Low 0.05 
Normal/High, 0.04 
Low/High 0.01 
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was significantly different in low compared to control diets (Table 
10.14); however, looking more closely, only on high salt diet was the 
response at the lowest dose likely to be non-significant and thus of 
reduced sensitivity compared to the other diet regimes. The same 
analysis holds for the All response curves, with only high salt diet 
in absolute terms showing a reduced sensitivity (Fig. 10.7c); the 
percentage values relative to each salt diet, particularly looking at 
the lower doses of All, are not significantly different suggesting 
little change in responsiveness with respect to its own control. 
The. second one week experiment (Fig. 10.8a) is graphically similar to 
the first experiment (Fig. 10.7a) in that it shows a reproducible 
dose response to 5HT and All. Superimposing the curves on each salt 
regime over the control response, indicates that the sensitivity to 
both All and 5HT, is only affected and reduced in high salt compared 
to control; compounding this, the responsiveness with respect to its 
own control, is also depressed non-specifically in high salt for both 
AII- and 5HT-stimulated aldosterone production. In terms of 
percentage changes in both All and 5HT-stimulated steroidogenesis in 
low and high salt diets, both are markedly affected and reduced 
compared with their control basal values (Figs. 10.8b and c) and this 
shows up as a significant difference compared to the control 
percentage values (Table 10.15); conversely the high salt response in 
percentage terms is also significantly reduced with respect to the 
control percentage dose response curves (Table 10.15). The 
important factor which appears to determine the percentage above 
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Fig 10.9a 
Aldosterone dose response curves to 5HT and All :2 week salt diet 
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basal values in each diet, is the variability in the basal 
measurement i. e. the low salt diet measure of steroid has a larger 
standard error bar compared to the control curve value. In this 
second experiment, the basal values for control and high salt are not 
significantly different and the shape of the respective dose response 
curves for All and 5HT in each regime, indicate a compound change and 
reduction in sensitivity and responsiveness after 1 week high salt 
diet. Only the responsiveness is increased in the low salt regime. 
10.2.4 Dose Response Curves to 5HT and All (2 weeks) 
In the first experiment (Fig. 10.9a) the basal values are altered in 
relation to the salt regime. For both All and 5HT-stimulated 
steroidogenesis, there is stimulation at the lowest dose, on all 
regimes although this was not significant on high salt diets. 
However, as expected, the responsiveness is altered in parallel with 
t 
a change in salt diet. Superimposing the curves in each regime for 
a given stimulus shows a change in responsiveness only for low salt 
compared to control, after 2 weeks; conversely, the sensitivity as a 
measure of the magnitude of the response is reduced slightly for high 
salt in both AII- and 5HT-stimulated aldosterone production. The 
anomalies arise in interpreting the results in percentage terms for 
as Figure 10.9b shows, the percentage increase relative to its own 
basal is reduced in the low salt compared to the normal dose response 
curve and this shows up as a significant difference with respect to 
control as shown in Table 10.16. The same holds true for the All 
response curve; the high salt dose response curve compared to the 
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% above basal aldosterone for All stimulation :2 week salt 
diet 
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Table 10. 
p-values 
:2 weeks 
16 
for % above basal aldosterone 
salt diet (1st experiment) 
Stimulus (M) 
5HT 
10'9 Normal/Low 0.08 
Normal/High 0.08 
Low/High NS 
10"8 Normal/Low 0.005 
Normal/High 0.02 
Low/High 0.07 
10"7 Normal/Low 0.003 
Normal/High 0.015 
- Low/High 0.02 
10-6 Normal/Low 0.03 
Normal/High 0.03 
Low/High NS 
All 
10'11 Normal/Low 0.05 
Normal/High NS 
Low/High NS 
10'10 Normal/Low NS 
Normal/High NS 
Low/High NS 
10'9 , Normal/Low 0.008 
Normal/High NS 
Low/High NS 
10-8 Normal/Low 0.005 
Normal/High NS 
. Low/High 0.01, 
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Fig 10.1Oa 
Aldosterone dose response curves to 5HT and All :2 week salt diet 
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control curve is not significantly different. 
Figure 10.10a shows the second 2 week experiment with dramatic 
changes in basal steroid output according to salt status. Only in 
high salt does the sensitivity in terms of the absolute output 
reponse, decrease from 10-9M 5HT in control and low salt, to 10-8M 
SHT; the All response curve is reduced at all doses in the high salt 
situation. The percentage 5HT dose response for high salt is 
significantly reduced compared to control (p < 0.02) at 10-9M 5HT but 
not affected at any other dose except 10-6M 5HT; as indicated in an 
#-I earlier interpretation, this is possibly a result of the large 
standard error bar measure of basal steroid output; in contrast the 
greater precision in basal steroid measurement in high salt diet, 
gives more accurate and interpretable results where there is a 
significant reduction in the sensitivity and percentage above basal 
steroid output at 10-11M All in high salt compared to normal salt. 
status; there is no significant difference in the percentage above 
basal values at any other doses of stimuli, except at 10-8M All, in 
which case low salt diet has a lower percentage value (for the 
reasons above) than the control diet value at this dose. 
z 10.3 DISCUSSION 
Vinson et al., 1983 defined change in sensitivity as the lowest dose 
of stimuli required for stimulation and plotted steroid output as a 
percentage of maximal in studies on o(MSH stimulation. However the 
initial basis of these experiments was to give the same dose of 
stimulus to cell incubates in differing salt regimes and see how this 
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Table 10.17 
p-values for % above basal aldosterone 
:2 weeks salt diet (2nd experiment) 
Stimulus (M) 
5HT 
10'9 Normal/Low 0.02 
Normal/High 0.02 
Low/High NS 
10'8 Normal/Low NS 
Normal/High NS 
Low/High NS 
10'7 Normal/Low NS 
Normal/High NS 
Low/High 0.02 
10-6 Normal/Low 0.03 
Normal/High NS 
Low/High 0.004 
All 
10-11 Normal/Low 0.0004 
Normal/High NS 
Low/High NS 
10-10 Normal/Low NS 
Normal/High NS 
Low/High NS 
10'9 Normal/Low NS 
Normal/High NS 
Low/High NS 
10-8. Normal/Low 0.01 
Normal/High NS 
Low/High NS 
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affected the magnitude of the response, both in absolute terms as 
Aguilera (Aguilera et al., 1978b) had set up and in percentage above 
basal terms. 
In analysing both the in vivo and in vitro results, it can be seen 
that at 36 hours All levels were significantly altered in response to 
salt status together with parallel changes in plasma aldosterone 
levels. At this time whole blood 5HT and adrenal 5HT levels were 
not significantly altered. 
The basal plasma aldosterone level changes are also reflected in the 
in vitro experiments beginning at 36 hours. In both experiments at 
36 hours, basal steroid output altered significantly with respect to 
control output; this was in contrast to Aguilera's findings (Aguilera 
et al., 1978b) who showed that for the same number of cells per 
incubate the basal aldosterone outputs were not altered by salt diet. 
In these studies, superimposing the absolute output dose response 
curves (in particular in the first 36 hour experiment), showed that 
the 'sensitivity' as defined by Aguilera as a change in the magnitude 
of the response and ED50 was increased in low salt compared to 
control dose response both for All and SHT; the converse was true for 
high salt relative to control. However, in the second experiment 
the sensitivity was not markedly changed although absolute basal 
values were again different with salt diet. Interestingly, these 
values plotted as percentage changes showed that overall, the 
percentage output were not significantly altered by salt status. 
However as indicated in the results section, this percentage measure 
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relative to a similar dose of stimuli on another salt diet regime, on 
reflection, is probably not a true measure of changes in 
responsiveness, since it measures values relative to the basal 
variability (which may not be determined with the same precision in 
the different salt states) within a given salt diet group, and the 
levels of significance are measured relative to the same dose of 
stimulus in another salt state, rather than relative to the basal or 
previous dose in the same salt regime. This anomaly becomes more 
apparent with greater steroid variability with the 2 weeks salt 
experiments although Muller (Muller et al., 1970) also observed these 
anomalies in his, 1 and 2 week low salt diet experiments studying rat 
adrenal cortical responses in vitro in a static incubation system 
after a2 week low salt diet regime. These percentage results may not 
be a direct measure of altered sensitivity on salt regimes but 
possibly an indirect consequence of steroid output variability and 
the adrenal steroid biosynthetic capacity. High basal steroid levels 
may 'exhaust' steroid precursor availabilty in increasing further 
steroid output in the zona glomerulosa with addition of stimuli, such 
as 5HT and All described here, and thus give 'false' percentage 
values, and thus measures of response values. 
Aguilera had suggested that this initial change in the sensitivity of 
the All response was, a result of changing All receptor affinity, 
since this parameter was also measured at this time in her 
experiments (Aguilera et al., 1978b).. In this case one could 
extrapolate that 5HT receptors are also present and subject to the 
change in sensitivity observed. However, without further studies 
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and binding analysis, this cannot be the whole conclusion. It is 
more than likely that the salt regimes have an all -encompassing 
effect on the activity of the enzymes involved in the steroid 
biosynthetic pathway, including 18-hydroxylase (Aguilera et al., 
1980). 
Further analysis at 4 days revealed a change in the responsiveness of 
both the All and 5HT dose response curves, with no apparent shift in 
the curves, and thus sensitivity. Basal steroid levels again were 
markedly altered and these results appear to reflect Aguilera's 
findings for III 'dose response curves alone. The anomaly arises in 
measurement of PRA and^AII values which do not significantly change 
with salt status, although plasma aldosterone levels increase on low 
salt and decrease with high salt status., Interestingly, 'whole blood 
5HT levels show ä broad tendency to increase on low salt and decrease 
on high salt with respect to control diets, and although this is not 
statistically significant, the adrenal 5HT levels also show this 
trend being significantly different in the high vs. control group (p 
< 0.05). One'could 'argue that 5HT at this time interval may play 
some subsidiary potentiating role in the control of plasma 
aldosterone levels in low salt diet in increasing the responsiveness 
of the adrenal to All and-5HT in these limited studies. At this 
juncture it seems pertinent to mention the findings from Chapter 8, 
in which it was observed that changing endogenous 5HT levels in vivo 
affected the responsiveness of adrenal zona glomerulosa cells, both 
basally and stimulated levels. However if 5HT has any role to play 
at this time interval - and only more experiments would clarify this 
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- then its role is very slight at the local and humoral level. For 
it is also seen that after 1 and 2 weeks salt diet changes, plasma 
aldosterone, All and PRA levels match the salt diet regime whereas 
both whole blood and adrenal 5HT levels are not significantly altered 
by salt status., Here again, the responsiveness as seen by 
superimposing the dose response curves, is the only parameter that 
changes, whereas the sensitivity is not altered for either 5HT or 
All. The percentage above basal interpretation is not helpful in 
this analysis except perhaps in the high salt state. Sensitivity is 
an obscure parameter to measure but basal steroid level changes 
correlate overall with changes, in All plasma levels in these 
experiments, rather than any significant changes in 5HT levels. 
Aguilera (1978b) suggested that in rats, All was the primary 
regulator of the adrenal responsiveness during altered Na+ status 
since studies using rats fed low salt diets and captopril, to prevent 
All formation, did not show an increase in plasma aldosterone; 
hypophysectomised rats also appeared to respond to a low Na+ diet 
with an increase in plasma aldosterone although this was not as great 
as that seen in intact rats. The fact that All levels changed after 36 
hours would tend to suggest that All is essential at the onset of 
altered Na+ status, in the homeostatic control of aldosterone levels 
and that 5HT does not augment this in vivo. It is unlikely that 
acute Na+ restriction would result in changes in the extracellular 
concentration of ions and in vitro changes in K+ and Na+ 
concentrations in the incubation medium within the physiological 
range do not appear to change the binding characteristics of All to 
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zona glomerulosa cells (Douglas et al., 1976b., Fredlund et al., 
1977). Circulating All may influence All receptor numbers or 
affinity even after such a short time but this may not necessarily 
correlate with changes in physiological responsiveness; for example 
Douglas et al., 1976a observed that within 19 hours of rat 
nephrectomy, adrenal All receptors were reduced in number whereas the 
responsiveness was increased and the converse was found in uterine 
tissue; in a longer time study of 4 days altered Na' status, it was 
observed in the monkey, adrenal All receptors decreased, whereas 
there was an increase in adrenal sensitivity on low salt diets, so 
the time scale in the rat for changing sensitivity and/or receptor 
number, may not always change in the same direction. Indeed basal 
steroid levels were altered in these experiments after 36 hours 
compared to no change in Aguilera's study and she argued that All 
receptor numbers did not alter after this time, hence similar basal 
levels; in Aguliera's study the normal rat diet contained 0.31-0.37% 
Na+, low salt diet contained 0.06-0.1% Na+, and high salt 2.8-3.1% 
Na+ and was investigated in a different strain of rat, (male 
Sprague-Dawley as opposed to female Wistar in these studies); the 
rats in these experiments were fed a wholemeal flour diet with 1% 
calcium carbonate in normal and low regimes (Fattah et al., 1977) 
which may have affected the basal steroid levels. That the basal 
levels of aldosterone are altered after 36 hours when All levels are 
increased in low Na+ and decreased in high'Na+, could be due to 
several factors as well as All. Unless 5HT interacts specifically 
with All receptors, the overriding influence on basal and stimulated 
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steroid response curves in vitro appears to be determined both by 
All and Na+ er se. Indeed in Man, Dawson-Hughes et al., 1981 
showed that the dose response curves to infusions of All in low salt 
diets was more sensitive than the dose response curve in AII-infused 
individuals. Other cases can be cited which show the same results, 
where low Na+ affects the sensitivity of the zona glomerulosa to 
stimuli including the more physiologically important All, K+ and ACTH 
both in vivo and in vitro (Ganong et al., 1965; Kinson et al., 1968; 
McCaa et al., 1974; - Palmore 1969; Pratt et al., 
1981; ). Further, 
one can argue that in the in vivo situation, the All levels as 
measured in these experiments, change with salt status such that the 
adrenal is confronted with higher -levels in low salt and 
lower levels 
in high salt, thus sensitivity as defined in in vitro experiments as a 
change in the effective lowest stimulatory dose cannot be equated 
with the in vivo doses, since they change accordingly anyway; thus. 
Na+ Per se or another factor controls All levels, which are therefore 
a joint or secondary controller of adrenal sensitivity (compared to 
Aguilera's description - see above) whereas Na+ does not influence 
5HT levels but the overall responsiveness to 5HT is controlled by 
another overriding factor i. e. All and/or Na+. 
In all species studied, low Na+ causes an increase in pregnenolone 
biosynthesis and 18- hydroxylase activity, which is important in the 
final steps for conversion of corticosterone to aldosterone. In 
vitro studies carried out by Marusic and Mulrow (1975), demonstrated 
that short term Na+ restriction caused an increased conversion, to ,. 
aldosterone in isolated mitochondrial studies. Similarly, Haning et 
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al., showed in 1970 that [3H]-corticosterone was converted to [3H]- 
aldosterone more markedly on low Na+ diets compared, to control. 
Fattah (1976,1977) also reported an increase in the conversion of 18- 
OHDOC and 18-OHB to aldosterone, in low salt status, and as 
originally suggested by Vinson et al., 1973, this could represent 
enhanced binding of the non-diffusible steroid (18-OHDOC), to an 
endogenous protein in the adrenal that allows greater enzymic 
conversion to aldosterone through 11- 2 -hydroxylation. In 
vivo, the direct stimulatory effects of Na+ on adrenal responsiveness 
was demonstrated in the dog, an acute lowering of plasma Na+ by 
infusion of 5% glucose into the arterial supply of the isolated 
adrenal of hypophyseetomised-nephrectomised dogs (Davis et al., 1963) 
or into, the arterial supply of adrenal autotransplants in the neck of 
sheep (Blair-West et al., 1962) caused a prompt rise in aldosterone 
biosynthesis. Davis et al., 1968, and Tait et al., 1970 have 
suggested that Na+ ions stimulate aldosterone biosynthesis at a step 
lying between corticosterone and aldosterone as well as between 
cholesterol and pregnenolone. Aguliera also demonstrated that All 
infusions over 4 days, could almost reproduce the effects of low Na+ 
diet on the activity of 18-hydroxylase, plasma aldosterone and All 
receptor numbers (Aguilera 1980). All is also known to have a 
trophic effect on the zona glomerulosa which augments an increase in 
mass stimulated aldosterone biosynthesis, but the effects are linked 
to a chronic influence and could include the 36 hours study. In the 
converse situation in which aldosterone levels are suppressed by 
changing salt diet after 36 hours, All levels are suppressed, but 
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Aguilera (1984) had previously shown that infusions of All in high 
salt status,, could not increase adrenal responsiveness or plasma 
aldosterone levels to control values. Thus it has been argued that 
other modulators independent of reduced All levels, in high salt 
status, are responsible for the changing sensitivity and aldosterone 
biosynthetic capacity of the adrenal gland. In infusion studies with 
All or metoolopramide (dopamine antagonist) infused separately into 
rats for 48 hours on high salt diets, there was no change in plasma 
aldosterone, 18-hydroxylase activity or All receptor number but 
coinfusion of MCP and All, elevated plasma aldosterone levels to 
levels observed after All infusions into control rats 
(Aguilera et al ., 1984); a, comparable observation has also been 
observed in v ivo in Man (Gordon et al., 1983). In measuring 5HT 
levels on high salt, which could also, possibly, influence the adrenal 
responsiveness in high salt status, 5HT levels did not appear-to 
alter after any time interval. Further experiments in which 5HT 
concentration per, number of platelets were made, would probably give 
a better index as to changes in levels with salt status. Having said 
this it has been cited in Nahmod's paper (Nahmod et al 1978) that 
Goldstein (1973) found that All stimulates the release of 5HT from 
mast cells, further Osim et al., 1983 was able to show that 
prelabelled platelets carrying [ 14C]-5HT differentially deposited 
C14C]-5HT into gut, thyroid and the adrenal gland, and this was 
enhanced. after 5HTP, treatment with resultant increase in 5HT 
biosynthsis. 
r 
In this regard All in the brain was also found to 
increase tryptophan hydroxylase activity with a resultant increase in 
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5HT biosynthsis (Nahmod et al., 1978). The possibility exists 
therefore, that at 4 , days a critical point in 5HT turnover - in fact 
3-4 days is the half-life of a platelet- and release in adrenal 
tissue or associated mast cells and platelets is reached, which is 
manifest as an increase in 5HT concentration with changes in 
extracellular volume. At longer time studies, All and or Na+ may 
increase the biosynthesis of 5HT in brain and peripheral regions 
including the adrenal gland and/or increase the release of 5HT from 
mast cells within the adrenal connective tissue. However the overall 
turnover and-. metabolism may balance out, since as indicated in the 
metabolism chapter, the adrenal gland appears to have a high 
monoamine oxidase activity. In a dynamic study, the possibilty that 
release of 5HT is increased at the adrenal over a shorter time scale 
in low salt status with the converse occuring in high salt status, 
may describe and contribute to some of the changes seen in the 
adrenal basal and stimulated levels of steroid output; this 
hypothesis can only be adequately tested by studying rats kept on 
altered salt regimes with altered endogenous 5HT levels imposed such 
as used- in' Chapter 8. 
That whole blood 5HT at the level of the adrenal and measured in 
platelets, did not 'appear to altered significantly at any time except 
after 4 days, may indicate that 5HT has indirect modulatory effects 
at higher control centres, or that 5HT levels on a platelet count 
basis may need to be investigated to show any change. In the case of 
primary hyperaldosteronism, Gross et al., 1981 showed that the 
increased adrenal sensitivity to All could be reduced by 
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administration of the 5HT antagonist, cyproheptadine, and suggested 
that central serotonergic mechanisms either directly or by 
stimulating the release of other central factors, could augment an 
increased adrenal sensitisation state in hyperaldsoteronism that 
paralled that seen in low Na+ status. Several groups have shown that 
other mechanisms exist to regulate aldosterone secretion as well as 
All. In the rat, Palmore (1969) demonstrated that rats kept on a low 
Na+ diet for 8 days, secreted aldosterone even after 18 hours post- 
bilateral nephrectomy; further there was a 100% increase in 
aldosterone secretion following Na+ depletion by peritoneal dialysis 
in Na+ replete-nephrectomised rats, which suggested a- non-renal 
factor in the control of plasma aldosterone. 
Adrenal renin has also been postulated to be important in modulating 
adrenal sensitivity in low salt status. Doi et al., 1984 was able 
to show a positive correlation between adrenal renin concentration 
and plasma aldosterone in nephreetomised rats and thus, independent of 
renal renin, but this does not alone argue a formidable regulatory 
role in aldosterone biosynthesis on altered sodium regimes. 
In nephrectomised dogs on low Na+ diets, McCaa (McCaaet al., 1974) 
observed thatýthe plasma aldosterone response to infused All could be 
maintained provided the pituitary was intact; removal in 
nephrectomised-hypophyseotomised dogs prevented an increase in plasma 
aldosterone in low salt status which could be restored by 
administration of pituitary extracts. As mentioned previously, 
pituitary factors may be involved in controlling plasma aldosterone 
levels on altered Na+ diets. McCaa et al., 1974 showed that 
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nephrectomised humans retained the capacity to maintain basal 
aldosterone levels in the absence of the renin-angiotensin system and 
could increase plasma aldosterone levels in response to all 
physiological stimuli. The pituitary factor(s) were not ACTH or 
growth hormone or its releasing factor, since growth hormone 
deficient patients are able to respond to increasing plasma 
aldosterone levels on low salt diets, whereas in panhypopituitary 
patients administered somatotropin, the aldosterone response was not 
restored and this suggested other pituitary factor involvement. 
Coghlan et al., 1979 was able to show in Na+ depleted sheep, an 
increase in plasma aldosterone within minutes of drinking a 
bicarbonate solution and suggested a central neural involvement in 
altering aldosterone levels in salt depletion. 
Idiopathic hyperaldosteronism and the increased plasma aldosterone 
response curve to physiological stimuli including ACTH and All has 
been postulated as caused by overactive serotonergic pathways 
stimulating pituitary factor release (Gross et al., 1981, Shenker 
1985). In low salt status, All levels are increased both 
peripherally and in the brain and in the latter region are known to 
increase 5HT biosynthesis within serotonergic neurones so this would 
be in keeping with an increased central serotonergic involvement. 
The converse may hold true for high salt diets, or may be related to 
an increase in other humoral factors such as ANF, which inhibits the 
All response in normal salt status adrenals in vitro (Chartier 1984), 
and is released from atrial granules during volume expansion and/or 
high salt states' (Atarashi 1984); or dopamine both peripherally 
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and/or centrally. In this regard Alexander (Alexander et al., 1974) 
noted an increase in dopamine excretion in high salt status parallel 
to an increased synthesis of the amine in high salt. Dopamine at the 
level of the adrenal may exert the tonic inhibitory influence 
independent of 5HT levels, which appear not to change, or within the 
central regions, increased dopamine production may exert an 
inhibitory effect on 5HT release from serotonergic terminals 
impinging on pituitary cells. 
That 5HT levels do not appear to change with salt diet, does not rule 
out a dynamic, local paracrinal role of 5HT in modulating adrenal 
sensitivity, since measurements of 5HT in these studies only gives an 
overall static picture of levels. It could be argued that 5HT 
biosynthesis may be increased on low Na"' diets with All levels 
increasing biosynthesis, since tryptophan hydroxylase is present 
(albeit in low amounts) within adrenal tissue (see Chapter 8); 
additionally, contaminating mast cells may release 5HT more readily 
after Na+ depletion, and would thus modulate adrenal responsiveness. 
Equally however, mast cells could take up 5HT more avidly in low salt 
diets although investigations are needed to confirm this theory, so 
the average concentrations within the adrenal gland would appear not 
to change. In the high salt state, 5HT synthesis may be depressed by 
lower circulating All levels, but if dopamine exerts a local 
inhibitory influence on 5HT release the overall picture would be of 
no change in 5HT levels within the adrenal. Thus, dynamic changes 
are possibly the key to determining a local paracrinal role of 5HT 
within the adrenal gland in altered Na+ status. The effects of salt 
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status on platelet uptake of 5HT may also be an important local 
factor in determing adrenal responsiveness although there does not 
appear to be reports of such studies being done. That the effects 
of salt are rapid and dynamic, would tend to argue that if 5HT has a 
modulatory role, the turnover and synthesis would parallel these 
changes. One limiting factor would be the localisation and specific 
activity of tryptophan hydroxylase, the rate limiting step in 5HT 
biosynthesis. As mentioned previously (Chapter 9) the enzyme is 
present in very low amounts within the adrenal and is more abundant 
in central regions, thus it would be more reasonable to suggest a 
central rather than a direct local adrenal involvement of 5HT in the 
altered sensitivity of the adrenal. 
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Chapter 11 
D*WNOHISTOCll 4ICAL STAINING FOR SEROTONIN IN THE ADRENAL 
11.1 Immunohistochemical Staining - Binding of the 5HT Antibody 
The immunochemical procedure as applied to biogenie amines such as 
5HT, is based on the phenomenon of small molecules, which by 
themselves are completely devoid of antigenicity, becoming 
immunogenic after coupling to a carrier protein (Landsteiner 1947). 
With the advent of the raising of specific monoclonal antibodies to 
5HT, it has become possible to localise 5HT containing cells in 
several species of animal tissues. The most extensive application of 
this has been in rat brain and the central nervous system (CNS) 
(Buffa et al., 1980., Steinsbusch et al., 1978) and also in 
enterochromaffin cells in the gut lining of rat (Nilsson, et al., 
1985) and in pancreatic beta cells in the guinea pig (Lundqvist et 
al., 1978) to quote but a few examples. The 5HT antibody in most 
instances, is coupled to a paraformaldehyde molecule, since fixation 
of tissues is most optimal with this fixative. Paraformaldehyde 
forms methyl bridges with amino groups within peptide bonds in the 
tissues, but only with the -NH2 groups i. e. at a high pH close to 
the pKa value for the amino acids R-NH3 = R-NH2 + Hý 
The reaction is 
R-NH2 + HO-CH2-OH -> R-NH-CH2-OH + H2O 
R-NH-CH2-OH + H-R -> R-NH-CH2-R + H2O 
Hence, the concentration of fixative and the pH, are critical factors 
in determining how effective the localisation of antigen in the 
tissue will be. The degree of fixation and the temperature, 
determines the intensity of staining due to localisation of the 
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antigen (Berod et al., 1981). Because of this fixation treatment, 
all tissue is made accessible for antibody attachment previously 
coupled to paraformaldehyde. 
11.2 Detecting 5HT Binding 
Once the antibody binds its specific antigen, it becomes necessary to 
detect the immunoreaction, and there are two ways in which this can 
be done: 1) direct staining in which the antibody is attached to a 
detectable marker; 2) indirect staining or the sandwich technique, 
in which-the primary antibody i. e. that binding to the antibody, 
acts as an antigen to the secondary antibody linked to a detectable 
visual marker, normally an immunoglobulin. The markers can be 
heavy metals, fluorophores or enzymes. In this case horseradish 
peroxidase was used to activate the detection, of the dye, 3', 3- 
diaminobenzidine tetrahydrochloride (DAB), attached to biotin 
molecules, in the very sensitive avidin-biotin (ABC) technique 
described below. 
11.3 The Avidin-Biotin Technique 
The avidin-biotin interaction in immunoenzymatic techniques provides 
a simple and sensitive method to localise the antigens in the 
formalin and paraformaldehyde fixed tissue preparations. The 
initial reaction requires (as in other primary techniques) the 
localisation of the antigen, and in this case 5HT, which is treated 
with a 5HT antibody. Biotin is a small vitamin molecule which is 
coupled to the antibody. This coupling of biotin to an antibody or 
an enzyme peroxidase (in the final stage), makes it capable of 
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binding avidin molecules. Avidin is a 68,000 kDa glycoprotein 
found in egg white, and with a very high affinity for biotin 
(Kd 10-15M) as well as multiple binding sites for biotin. 
The next stage can be modified with either sequential additions of 
avidin, followed by the biotin-peroxidase coupled molecule (indirect 
bridged avidin biotin technique (IBAB), or by complex addition of 
avidin-biotin peroxidase in pre-determined ratios - the ABC 
technique. The ABC technique is the method of choice in the 
reaction shown (Fig. 11.1). 
For immunohistochemistry, the tissue must be previously fixed. The 
choice of fixative in most cases is 4% paraformaldehyde and can 
either be perfused into the tissue by intracardiac perfusion or post- 
fixed by removing tissue slices and then post-fixing the tissue 
slices in fixative solution or vapour as used here, placing fresh 
tissue sections in a closed chamber containing paraformaldehyde 
solid. 
11.4 METHODS 
11.4.1 Tissue Preparation 
Female Wistar rats (180-200g) were killed by cervical dislocation and 
whole adrenals removed and immediately transferred to a metal beaker 
containing isopentane (antifreeze), suspended in a flask of liquid 
nitrogen. Whole glands were kept at -700C until processing for 
tissue sectioning. 
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11.4.2 Mount of Tissue Sections 
The adrenals were transferred to mounting blocks and fixed in 
position with a few drops of tissue fixing solution, Depex (mounting 
medium, Gurr Microscopy Materials, BDH) placed on the top of small 
cork blocks and left to set, before securing the adrenals using a 
pair of fine forceps, into position on top of the cork surface. 
This manoeuvre allowed anchorage of the tissue for cutting thin 
sections, once they had been loaded into the cryostat. All 
procedures were carried out at approximately -200C using a water bath 
of dry ice and absolute alcohol. The cryostat model (HR Mark 2 
Cryostat, Sleep London) was kept refrigerated at a -250C and the 
mounting blocks with fresh tissue, placed at the correct angle for 
cutting with the cryostat blade. The blade cutting width was set at 
8µ (Hökfelt, et al., 1981., Verhofstadt et al., 1983) and sequential 
tissue sections collected from the cryostat blade by placing a pre- 
cooled chrome-alum coated glass slide over the blade surface to allow 
adsorption of tissue slices onto the slides. The slides were then 
gently lifted off and placed into slide trays containing 
paraformaldehyde powder. Tissue slides were not completely immersed, 
but rather equilibrated with paraformaldehyde vapour for 24 hours at 
40C, to allow post-fixation of the tissue slices. This was thought 
to be the best method of fixing such thin tissue sections. 
Previous experimentation using whole adrenals perfused with fixative 
prior to cutting, caused brittleness to the tissue, making it 
intolerant of thin sectioning treatment. Brain tissue from the 
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dorsal raphe (Osborne 1982) region was also post-fixed and out at 2511 
as previously carried out in other studies (Steinsbusch et al., 
1978); this acted as a control for 5HT staining since the technique 
using these reagents has already been optimised in this tissue. 
11.4.3 Preparation of antiserum 
Antibodies to 5HT-BSA were raised in rabbits (5HT rabbit antibody - 
Immunonuclear Corporation, Stillwater, Minnesota) as described 
previously (Steinbusch et al., 1978). The specificity has already 
been determined and studied in detail. The antiserum reacts with 5HT 
and 6-hydroxy-tetrahydro- P-carbolinev which is the form of 5HT in 
formaldehyde fixed tissue. 
11.4.4 Preparation of Secondary Antibody 
Anti-rabbit immunoglobulin G (IgG) was raised in goat serum and 
coupled to biotin, as described above; the ABC kit was purchased from 
Vector U. K. (Vectastain ABC). 
11.4.5 Immunocytochemieal Procedures 
The post-fixed tissue slides were placed in tissue slide trays and 
thoroughly rinsed with phosphate buffered saline (PBS) and then 
incubated at room temperature for lhour in 20% goat serum. This was 
thought to be the optimal concentration of serum which would reduce 
the non-specific binding of 5HT antiserum in the tissue. The anti- 
rabbit antibody circulates in goat serum, which also contains several 
plasma proteins capable of binding to 'foreign' matter and treating 
it as antigenic. Hence, drowning out these potential antigenic sites 
in the tissue section with goat serum (untreated with anti-rabbit 
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antibody), allows correction and optimisation of binding to the 
serotonergic sites of interest. Sections were washed three times 
in PBS and then incubated with 5HT antiserum at a final concentration 
of 1: 200 at room temperature for 48 hours. The slides were then 
rinsed in PBS with azide and Triton (0.075 %) - to ensure antibody 
penetration through the cell membrane - twice for 5 minutes each. 
The biotin - antibody moiety was then added at 1: 200 concentration in 
PBS azide and Triton, for 45 minutes at room temperature. PBS 
without azide or Triton (since at this stage it affects the final 
stage reaction), was then used in two 5 minute rinses of the treated 
slides. At this stage, a series of sections were 'primed'with a 
peroxide solution (1 - 3% peroxide solution in 30% methanol diluted 
in PBS) in 10041 aliquots, to inactivate the red blood cell enzyme, 
catalase, which reacts with peroxides. Thus, this reduces the non- 
specific staining, since the DAB' complex may cause a co1orimetric 
reaction when red blood cells (containing peroxidase activity) react 
with it; therefore specific 5HT containing cells treated with the 
enzyme-linked biotin complex would be drowned out with colour 
staining of DAB to endogenous catalase-linked reactions within red 
blood cells. The sections treated in this way were incubated with 
hydrogen peroxide (1 - 3%) for 30 minutes after which time, the 
slides were given 3x5 minute washes in PBS and then treated in the 
same way as the 'non-primed' sections, with the AB complex. 
The AB complex was made up by addition of1: 100 final concentration of 
solution A in the Vector kit to 1: 100 of B (avidin and biotin with 
the enzyme peroxidase attached), and this was introduced'onto the 
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slides and incubated for 30 minutes at room temperature. The slides 
were then rinsed in 50 mM Tris buffer (pH7.4) twice for a further 
five minutes each before the colorimetric enzymatic reaction using 
3', 3-diaminobenzidine tetra chloride (DAB) took place. DAB 
(Polysciences) is sold in bottled solid form, and in the anhydrous 
state is carcinogenic. All steps in its final aqueous preparation 
were therefore carried out in a fume cupboard. A 10 ml solution 
containing Tris buffer, was injected into the top of the rubber- 
topped bottle of 5 mg DAB powder (0.5 mg/ml) and thoroughly mixed in 
the fume cupboard. A few drops of this solution were placed onto the 
treated slides in the fume cupboard and left to incubate at room 
temperature for 10 minutes. After this time, a further addition of 
this mixture containing 140 pl of H202 (3%) - the reducing compound 
required for the colour reaction - was added to the preformed mixture 
and incubated on the slides for a further 10 minutes. 
Two 5 minute washes followed in Tris buffer and the treated slides 
were mounted and dried for 6-8 hours. Slides were then dipped 
into increasing concentrations of absolute alcohol starting at 50% 
alcohol concentration up to two immersions in 100% alcohol. Each 
immersion was for approximately 2 minutes. This procedure removed 
both extra- and intracellular water from the tissue. The slides 
were then placed in a solution of the non-aqueous medium, xylene, 
before finally being mounted. Slides were placed in slide holders 
at a slight tilt and a few drops of Depex were placed on to the 
tissue. The cover slip was then gently lowered over the solution, to 
allow diffusion uniformly and without air bubbles, across the whole 
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of the cover slip. The slides were then left to set for at least 4 
hours before being visualised under the light microscope. 
Several sections of post-fixed adrenal tissue were treated with only 
haemotoxylin and oil red 0 stains for the differentiation of cell 
structure and lipid deposition respectively. 
11.5 Haematoxylin Staining for Cell Structure 
11.5.1 Materials 
Haematoxylin 1g was dissolved in 10 ml of absolute alcohol and 20 g 
of potassium alum previously dissolved in hot water was added. The 
solution was boiled, and 0.5 g of mercuric acid added, to 'ripen' the 
stain, until the solution turned dark purple. The solution was 
cooled rapidly under tap water and filtered into stock bottles and 
left for several hours. 
Eosin stain was prepared by mixing 1g Eosin powder to 100 ml of 
distilled water. 
11.5.2 Staining Method 
Tissues slides were placed in a solution of 5% acetic acid/ethanol 
and then removed into distilled water after a couple of minutes. 
After washing, the slides were placed for 2 minutes in the 
haematoxylin stain. The deep purple stain on the slides became a 
deep blue when they were later dipped into hot water (600C). The 
slides were then put into cold distilled water; immediately 
afterwards, the slides were quickly dipped in and out of Eosin stain 
and washed twice in cold water. 
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The dehydration process involved sequential dipping into alcohols of 
increasing concentration (50%, 90%, and 2x 100%). The slides were then 
immersed into xylene and mounted. 
11.6 OIL RED 0 METHOD FOR COLOURING FITS 
11.6.1 Stock Solution of Oil Red O 
A saturated solution (0.5%) of oil red 0 in absolute isopropyl 
alcohol is required. Oil red 0 is a strong colourant of fats, but it 
requires a high concentration of fatty matter to be drawn out of its 
alcoholic solution in the section, and is appropriate to use in 
studying adrenal steroid-producing cells. 
11.6.2 Staining Solution 
A stock solution of oil red 0 (60m1) was mixed with distilled water 
(40 ml) and kept indefinitely after filtering 
11.6.3 Staining Method 
Fresh sections must be used in this staining procedure. Sections 
were rinsed in 60% isopropyl alcohol. They were then immersed in 
oil red 0 solution for 10 minutes and briefly rinsed in 60% isopropyl 
alcohol. 
At this stage, the sections were washed in distilled water and then 
counter-stained in haematoxylin stain for a further 1 minute, before 
being dried and mounted. 
A few drops of warmed glycerol solution was placed on top of the 
tissue slides, and the'coverslip slowly put into position before 
dehydration treatment as outlined above. 
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11.7 LIGHT MICROSCOPY 
Sections were examined and photographed using a Nikon biological 
microscope (Optiphot), at the magnifications quoted (coo Results) and 
corrected up for printing and developing. 
The equation for the magnification process ist 
Magnification of objective (variable) x Magnification of projection 
lens (constant 2.5) x 16 where 16 a the magnification of the 
transparency up to print size. 
11.8 RESULTS 
11.8.1 Haematoxylin and Oil W Staining 
Figure 11.1 shows a low powered section (x 160) of the gross 
morphology of the rat adrenal gland in transverse section. There is 
a band of blue haematoxylin stain in the capsule, devoid of any oil red 0 
staining, since steroid is not present in this region. The whole of 
the cortex, from the zona glomerulosa zone to the zona reticularis, 
is stained with both haemotoxylinand oil reddemons trating that 
steroid is present in all cortical zones. However, there is no 
clear cut differentiation between the amount of steroid present in 
varying regions, although it is known that the largest amounts of 
steroid are present in the zona faseieulata, the intermediary zone 
concerned principally with corticosterone production in the rat. 
The central blue stained region corresponds to the steroid free 
medullary zone. In all regions, there are varying sizes of cortical 
and medullary sinusoids, demonstrating the multiple networks of the 
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vascular drainage system which exist in the gland (see discussion). 
Figure 11.2 (x 400) shows the outer cortical regions stained with 
eosin and oil red 0. The capsule is clearly distinguished as an 
amorphous band of fibrous tissue stained blue. Just below this 
region, lies the zona glomerulosa cells, distinguished by the close 
clusters of ovoid type cells. The haematoxylin stain reveals the 
large nuleus of these cells with characteristically little cytoplasm. 
The oil red 0 for steroid is present but sparsely scattered l 
throughout the zone. 
The larger area below the zona glomerulosa zone is known as the zona 
fasciculata, and as can be seen here, comprises much larger cells 
than the glomerulosa layer, with more cytoplasm per cell. Hence 
there is a greater abundance of lipid droplets per cell. The cells 
appeared to be arranged in parallel longitudinal arrangements 
radiating towards the centre of the gland. 
Figure 11.3 taken at x800 magnification, focuses on the inner zone of 
the cortex and the medulla. This region consists of a narrow band 
of cells with large nucleus to cytoplasm ratio. Thus, there is less 
steroid per cell compared to the zona faseiculata and further, the 
cells appeared to occur in clusters anastomising around sinusoids. 
This zone is known as the zona reticularis region, and impinges on 
the medullary zone. The cells in the medulla are much larger than 
the cortical cells and do not stain for lipid. They appear to have 
large nuclei and are arranged in dense clusters broken up by the 
sinusoid network. 
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11.8.2 DAB Staff for 5HT 
Figure 11.4 shows under low power magnification (x 160) the staining 
pattern seen when adrenal sections were treated with the DAs stain 
without prior peroxide treatment. As can be seen, the characteristic 
brown stain is less intense in this section, compared with the brain 
section described below. Further, it appears to be diffusely 
spread throughout the adrenal section and confined to most sinusoidal 
regions. Note that there is no sign of any staining in the capsular 
region, or even the medullary cell region. 
Figures 11.5 and 11.6 both were observed at x 800 magnification and 
show more clearly the localisation of the stain. In figure 11.5 the 
medullary region is stained with haematoxylin and DA19 and it clearly 
shows that 5HT is not to be found within the cytoplasm of medullary 
cells. There is however, diffuse brown staining in the regions 
lining the medullary sinusoids although it does not appear to be 
contained in any distinguishable structure. 
Figure 11.6 focuses on the cortical region, and is stained with 
haematoxylin and DAB. Here again, the paler diffuse brown stain is 
restricted to the sinusoids and is not seen in any cellular 
structures. 
Figure 11.7 shows a section of the dorsal raphe of rat brain under x 
400 magnification. The section was treated with DAB stain. Within 
the central region and the fasciculatus longitudinali medialis, there 
is intense dark brown staining against a more diffuse brown stain 
throughout the dorsal raphe section. 
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Figure 11.8 (x 1600) shows more clearly with DAB stain alone, the 
localisation of 5HT to the dorsal raphe region in a distinct network 
of 5HT-containing neurones with cytoplasmic extensions. 
Figure 11.9 shows a low power adrenal section (x 400) after pre- 
treatment with peroxide and haemotoxylin stain, counter-stained with 
DAi3. There is no diffuse brown stain even within the sinusoidal 
regions. 
Figure 11.10 shows the same section under x 800 magnification. There 
is no brown staining within the inner zones of the adrenal, however 
it is difficult to assess whether there is any 5HT within the deeper 
staining capsular region. 
11.9 DISCUSSION 
From these results, it can be said that the technique for 5HT 
staining has worked in brain tissue, thus demonstrating that in these 
experiments, the procedure is optimised and the reagents are viable. 
% As has already been reported, ' 5HT was localised-iii the dorsal raphe 
(Buffa et a1., 1980., Steinbusch et il., 1978), using sensitive 
immunohistochemical techniqües, and was further confirmed 
in these 
experiments. 
However, in the adrenal gland sections using exactly the same 
procedure and preparation, the 5HT was not found in piny 'cellular 
structures throughout the gland. This is in contrast to the 
immunohistochemical observations of Verhofstadt (1983) and Holzwarth 
(1983). In these experiments, whole adrenals were pre-fixed with u% 
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paraformaldehyde before being processed in a similar fashion to the 
above procedure. They were able to localise 5HT-containing cells 
within the rat adrenal medullary cell cytoplasm and further, they 
found negative staining for 5HT in nerve fibres preserved in sectioning. 
However, it may be worthy of note that pre-treatment of the adrenal 
sections with H202 without DAB, removed the diffuse brown staining 
originally found in untreated sections - frequently around the 
sinusoidal regions but sometimes intracellularly. This treatment, 
routinely used in brain section staining, has the effect of removing 
nonspecific catalytic reactions which would otherwise give less 
defined results. This strongly suggests that in these experiments, 
there was clearly no 5HT present either in the medulla or in cortical 
cells. - Petrovic (1984) using immunohistochemical staining in the rat 
kidney and adrenal, was not able to localise it within the adrenal, 
although it was evident within the kidney. Nerve fibres which also 
possibly contain 5HT, were never seen under the rigours of this 
processing, unlike other -studies(Kleitman et al., 1985., Mikhail et 
al., 1961,1965., Lever 1953) where! nerve fibres . were-visualised. . 
Endothelial cells inactivate 5HT by monoamine oxidase activity, and 
may also have peroxidase activity, 
_which 
could have, caused a similar 
colorimetric reaction as ocoursin the presence of red blood-cells, 
thus accounting for the. dark brown staining in. the sinusoid. wall 
linings. What can be definitely concluded from these results is 
that at this concentration of ABC complex, there is no visible sign 
of 5HT-containing cellular structures in the rat adrenal, despite 
large quantities of 5HT (0.6-1µg/g wet weight - Verhofstadt et al., 
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1981., Kuriyama et al., 1984., Synder et al., 1965 - see chapter 8) 
being found by biochemical measurement, in amounts comparable to 
those found in brain tissue (0.5 -2 ug/g (Kuriyama et al., 1984., 
Osborne 1982). Alternatively, 5HT may only be present in the blood 
and would therefore not appear in tissue sections where the slides 
had been 'primed'. However, this is not likely to be the complete 
story since the adrenal gland contains high amounts of 5HT even when 
perfused, thus, effectively removing blood 5HT (see Chapters 8 and 
9). 
No nerve fibres were visualised in any tissue sections, reducing the 
likelihood of locating neural 5HT within the adrenal gland. 
It has already been discussed that in brain tissue and platelets, 
specific binding proteins exist which protect 5HT from enzymatic 
degradation (Tamar et al., 1980). However the protein structures in 
brain for binding 5HT, differ from the platelet glycoproteins and 
albumin. In this study, the possibility that 5HT is bound to a 
protein molecule different from the one recognised by the 5HT 
antibody in the brain or platelets, is an alternative explanation for 
the negative results. 
From these observations, it can only be said that 5HT could not be 
found in any region of the adrenal parenchyma, but the procedure was 
optimal for brain staining of 5HT. Further, it was not possible to 
visualise serotoninergic nerve fibres under the rigours of this 
procedural technique. 
There exists the possibility that 5HT, if an endogenous amine of rat 
tissue, could indeed have been stored, but like for example in the 
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eye structure of Aplysia, where 5HT is measured biochemically but not 
visualised histochemical ly (Lubosky-Moor et al., 1976) could not be 
visualised. In the studies carried out by Lubosky-Moor, fluorescence 
techniques were used to visualise catecholamines in several tissues 
of the A1 sia, and 5HT was found in the heart and neural structures, 
but not in the eye, although it was measured biochemically with 
levels as high as 0.05 µg/g tissue (Corrent at al., 1978). These 
levels are at the lower end of the measured levels in the adrenal 
studies (Chapter 8), and despite a more sensitive antibody detection 
method for 5HT, it could, as indicated above, be due to a different 
type of binding association in adrenal tissue compared with other 
tissues. These results still beg the question, whether 5HT is an 
endogenous amine of the rat adrenal, or a blood-borne factor. Under 
the rigours of this technique, it favours the latter conclusion but 
would require considerable time in optimising the technique, to 
support these initial findings. 
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Chapter 12 
SWWY AND CONCLUSIONS 
12.1 Lessons Learned 
The accumulated data goes some way in describing a physiological role 
for serotonin in the control of aldosterone biosynthesis in the rat 
model.. 
The drug antagonism studies, although requiring further 
investigation, tend to suggest a 5HT-response which is only loosely 
coupled to-cAMP-stimulated steroidogenesis and then, only measured at 
higher doses of serotonin. More interestingly, the serotonergio 
interaction of the antagonists with angiotensin II and ACTH may 
indicate a 5HT interaction and potentiation of the steroid response 
to important physiological stimuli. 
However, the, data in Chapter 7-does not exclude the possibility, that 
5HT is interacting through its own specific receptor - 5HT1 as these 
studies suggest - and is coupled to both cAMP and a Ca2+ and/or the 
PI system as discussed in other systems - in the second messenger 
response, which would result in complex but feasible interaction and 
potentiation of the steroid. response, to ACTH and, AIL The, Tait$ 
(1972) studied the potentiating effects. of 5HT onthe potassium dose 
response curves, and suggested that at higher, doses of K+,., i. e. , )8.4 
mMKi', the steroid response was maximal even in, the presence ofY10-6M 
5HT, a dose known to increase cAMP levels, and so the two stimuli 
worked through the same second messenger; in contrast at lower doses 
of K+, the effects of K+ were potentiated in the presence of 10-6M 
5HT, indicating a separate mechanism of action. Kojima's study 
(1985) indicates that at 8mMK+, calcium has important effects on 
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inducing the transient phase increase in aldosterone secretion with 
cAMP being important in the sustained response; thus by 
extrapolation 5HT at 10-6M may be acting predominantly through the 
cAMP mechanism of stimulation. However, to verify the theory of 
these results would require looking at the potentiating effect of 
several doses of 5HT with various doses of the other stimuli and more 
readily, at the second messenger systems for 5HT alone at increasing 
doses, to discern what second messengers are involved in its 
mechanism of action. Further, the antagonism studies using 5HT 
antagonists rather than the 5HT molecule in steroid experiments, 
cannot be extrapolated to mean that they are having effects beyond a 
putative 5HT receptor site, i. e. at the intracellular level. 
Moreover, the anatagonists themselves have specific pharmacological 
profiles and may exert effects on the plasma membrane which are 
separate from their binding to putative 5HT receptor sites. 
In the salt studies, 5HT levels measured in serum, were not 
significantly altered, but this does not rule out the possibility 
that 5HT turnover may be altered. Further investigations measuring 
5HT levels on a number of platelets basis would-yield more. -. -: 
information in altered sodium status, and define ifx any, a role for 
5HT in the changing basal and stimulated steroid, outputs°inthe 
adrenal gland. 
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Within the gland itself, 5HT was measurable in relatively high 
amounts per unit weight of tissue. Although levels did not 
significantly alter - this can be interpreted in several ways: 1. the 
measurement did not take into account the rate of turnover within the 
tissue which could have changed in altered salt status - enzyme 
activity and particularly tryptophan hydroxylase activity would need 
to be measured to demonstrate this; 2.5HT in the adrenal gland is 
not involved in physiological changes occuring in vivo e. g. salt 
status. This latter theory would argue against an important 
paracrinal role for 5HT in salt balance, in contrast to the 
suggestion that dopamine may be involved in the blunted response to 
All in high salt status (Aguilera 1984). However, the biochemical 
measurements of 5HT in the adrenal gland are interesting in that 
large amounts appear to be present in the inner cortex and medulla. 
To further quantify and determine the derivation of 5HT, similar 
determinations for norepinephrine (NE) and epinephrine (E) ratios 
within the regions of the adrenal gland compared with 5HT: NE: E 
ratios, should be determined. In this way, -the ratios if constant, 
would define the site of origin for 5HT, as previously described for 
dopamine since it has already been established'that"NE and E are' 
present within the adrenal in- constant- ratios (Hannah 1984). " , 
As indicated in Chapter 11, the negative staining for 5HT may be a 
consequence of its binding to'an inaccesible protein. Indeed' 
Kuriyama (1984) and Bertler (1960), have suggested that 5HT in the 
medulla-may be bound within epinephrine containing chromaffin 
granules, but may be under different physiological control. This has 
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been demonstrated in, for example, the rat model when 5HT was 
selectively retained in the chromaffin granules of stressed rats 
although within the same granules, epinephrine was released (Kuriyama 
et al., 1984). 
The metabolism studies using isolated glomerulosa and inner cortical 
and medullary cells, also indicated a greater storage of 5HT within 
the inner adrenal regions, and rapid metabolism in the zona 
glomerulosa. Osborne (1982), stipulated that a neurotransmitter role 
is considered if the compound is stored within the tissue. However 
with immunohistochemical staining, serotonergic nerve fibres were 
not seen. Alternatively, another suggested role for biogenic amines 
in a paracrinal capacity, is captured in., the idea postulated, by Green 
(1962) in which mast cells may release their store of 5HT ( 5HT is 
found in rat and mice mast cells), within the adrenal tissue, and be 
taken up by chromaffin granules; thus, exogenous 5HT may be derived 
from this source. A similar study using exogenous labelled 5HT was 
described in the rat vas deferens (Thoa et al., 1969) and here it was 
suggested that sympathetic norepinephrine containing nerve. endings 
were responsible for the uptake of exogenous 5HT. Rosenkrantz, in 
1960, also postulated a role for platelet-derived 5HT in the adrenal 
gland, particularly during haemmorrhage, when damaged platelets 
within the gland accumulate and would release exogenous 5HT which 
could: 1. enter the chromaffin cells, or; 2. directly stimulate 
aldosterone biosynthesis - an important homeostatic mechanism in 
this state. Catecholamines as described in Chapter 2, have some 
influence on steroidogenesis, at least in vitro, particularly in 
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relation to the effects of dopamine in the adrenal. In a similar 
fashion, the catecholamines: 5HT ratios within the gland, may 
influence and facilitate the 5HT-mediated steroidogenic response in 
vivo, compared to the desensitising effect which catecholamines have 
on the dopamine-aldosterone response of cultured zona glomerulosa 
cells (De Lean et al., 1984b). 
Overall therefore, a fine control mechanism of catecholamines on the 
5HT and dopamine-steroidogenic response may exist, which is 
determined by the physiological status. 
The administration of precursors are interesting in that there 
appears to be an effect in vivo which is only apparent when the 
adrenal cells are removed from other physiological influences, such 
as circulating All and. ACTH, and incubated in vitro. As indicated 
in the discussion section of Chapter 8, a central role for 5HT, 
indirectly affecting other factors such as ACTH, perhaps acutely, 
must not be excluded. Connors and Rosenkrantz (1962) indicated in 
their work, that adminstration of 5HT decreases adrenal abscorbic 
acid levels in the, same way that ACTH administration also has the 
same effect. This could be due to direct central release of ACTH or 
a more direct effect at the level of the adrenal. The reported high 
levels of L-aromatic amino acid decarboxylase activity in the adrenal 
gland (Vaccari et al., 1977) make it possible that administration of 
the precursor of 5HT, 5HTP, allows local conversion within the gland 
to 5HT, which is responsible for increasing hydroxylating activity of 
the steroidogenic enzymes, and thus elevating basal steroid levels 
secreted by the adrenal, in 5HTP-treated rats. Connors and 
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Rosencrantz (1962) observed an increase in hydroxylating capacity of 
the adrenal using isolated rabbit adrenal slices incubated with 5HT - 
the converse may be true in PCPA-treated rats. 
Histochemical observations on the adrenal were not made with 
PCPA/5HTP treatment, which may also have elucidated the effects on 
steroid biosynthetic capacity being due to gross morphological 
changes in the gland. In these experiments 5HTP administration 
increased adrenal steroidogenic capacity, and unless adrenal size 
increased, 5HT may have directly increased steroid enzyme capacity. 
Alternatively, increased 5HT levels may have increased central All 
and/or peripheral All levels acutely, but chronic studies measuring 
plasma concentrations of All did not show any change; central All 
effects may have been responsible through neural adrenal connections, 
for increasing basal steroid levels. The converse situation in 
which steroids increase 5HT biosynthesis is well documented (Azmitra 
et al., 1974) and so the possibilty exists that administered 5HTP 
acted centrally and increased the release of pituitary factors 
involved in increased steroid biosynthesis in the in vitro studies. 
Further investigations to exclude a. nonspecific effect on 
steroidogenic capacity in all regions of the adrenal would be needed, 
using isolated zona fasciculata cells as well as glomerulosa cells. 
The investigations delineate a stimulatory role for 5HT in the zona 
glomerulosa but exogenously-derived 5HT from platelet and/or mast 
cells which may be temporarily stored in the medullary region, make 
it more than likely that this biogenic amine is only a potentiator of 
the major physiological stimuli. In particular, the drug antagonism 
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studies suggest that the mechanism of action for 5HT may not be 
solely through 5HT receptors (yet to be defined in the zona 
glomerulosa) but act through an interaction with ACTH- and AII- 
stimulated steroidogenesis at the post-receptor site. To postulate, 
conditions in which 5HT may be involved in modulating the aldosterone 
response may include haemorrhagic states; in altered salt status 
further investigations in altered salt diets, may indicate a role for 
5HT in changing the adrenal sensitivity to All, perhaps the most 
important physiological regulator of aldosterone in the rat and Man, 
and therefore by exptrapolation indicate a significant role for 5HT. 
The field of research into 5HT in the adrenal is only now beginning 
to unfold. 
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